Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
J Acquir Immune Defic Syndr
    March 2021

  1. Bacterial Vaginosis and Risk of HIV Infection in the Context of CD101 Gene Variation: Erratum.
    J Acquir Immune Defic Syndr. 2021;86:387.
    >> Share

  2. PLUZNIK JA, Nijhawan AE, Spaulding AC
    Does Anything Work? Improving HIV Care Engagement for Individuals Transitioning out of Correctional Settings.
    J Acquir Immune Defic Syndr. 2021;86:286-287.
    >> Share

    February 2021
  3. NOWAK RG, Liska TA, Bentzen SM, Kim E, et al
    Herpes Simplex Virus Type-2 shedding and genital ulcers during early HIV in Zimbabwean women.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95936.
    >> Share

  4. TRUONG HM, Fatch R, McFarland W, Raymond HF, et al
    HIV Prevention Responsibility Beliefs Among Men Who Have Sex with Men in the PrEP Era.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95935.
    >> Share

  5. VAN WYK J, Ait-Khaled M, Santos J, Scholten S, et al
    Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95934.
    >> Share

  6. KOHN JN, Loop MS, Kim-Chang JJ, Garvie PA, et al
    Trajectories of depressive symptoms, neurocognitive function and viral suppression with antiretroviral therapy among youth with HIV over 36 months.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95933.
    >> Share

  7. NIJHAWAN AE, Mathews WC, Raifman J, Fleming J, et al
    Hospitalization rates among persons with HIV who gained Medicaid or private insurance after the Affordable Care Act in 2014.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95945.
    >> Share

  8. MGODI NM, Takuva S, Edupuganti S, Karuna S, et al
    A phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection in women in sub-Saharan Africa: baseline findings.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95944.
    >> Share

  9. PALEFSKY JM, Poongulali S, Lensing S, Lee J, et al
    AIDS Malignancy Consortium 054: Safety and Immunogenicity of the Quadrivalent vaccine in Indian Women Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95943.
    >> Share

  10. PRICE JT, Vwalika B, Edwards JK, Cole SR, et al
    Maternal HIV infection and spontaneous versus provider-initiated preterm birth in an urban Zambian cohort.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95942.
    >> Share

  11. HUANG SH, Huang WC, Lin SW, Chuang YC, et al
    Impact of efavirenz mid-dose plasma concentration on long-term weight change among virologically suppressed people living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95941.
    >> Share

  12. PELCHEN-MATTHEWS A, Borges AH, Reekie J, Rasmussen LD, et al
    Prevalence and Outcomes for Heavily Treatment-Experienced (HTE) Individuals Living with Human Immunodeficiency Virus in a European Cohort.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95940.
    >> Share

  13. EDUPUGANTI S, Mgodi N, Karuna ST, Andrew P, et al
    Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95939.
    >> Share

  14. CACHAY ER, Torriani FJ, Hill L, Rajagopal A, et al
    HCV knowledge and Recent Diagnosis Affect HCV Treatment Willingness in Persons Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95938.
    >> Share

  15. VERA JH, Eftychiou N, Schuerer M, Rullmann M, et al
    CLINICAL UTILITY OF beta-AMYLOID PET IMAGING IN PEOPLE LIVING WITH HIV WITH COGNITIVE SYMPTOMS.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95937.
    >> Share

  16. FARAHANI M, Radin E, Saito S, Sachathep K, et al
    Population Viral Load, Viremia and Recent HIV-1 Infections: Findings from Population-based HIV Impact Assessments (PHIAs) in Zimbabwe, Malawi, and Zambia.
    J Acquir Immune Defic Syndr. 2021 Feb 5. pii: 00126334-900000000-95947.
    >> Share

  17. SHARMA A, Hoover DR, Shi Q, Gustafson DR, et al
    High Frequency of Recurrent Falls among Pre-frail and Frail Women with and without HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 2. pii: 00126334-900000000-95950.
    >> Share

  18. PAGKAS-BATHER J, Khosropour CM, Golden MR, Thibault C, et al
    Population-level Effectiveness of HIV pre-exposure prophylaxis among MSM and Transgender Persons with Bacterial Sexually Transmitted Infections.
    J Acquir Immune Defic Syndr. 2021 Feb 2. pii: 00126334-900000000-95949.
    >> Share

  19. PATEL VV, Felsen UR, Fisher M, Fazzari MJ, et al
    Clinical Outcomes and Inflammatory Markers by HIV Serostatus and Viral Suppression in a Large Cohort of Patients Hospitalized With COVID-19.
    J Acquir Immune Defic Syndr. 2021;86:224-230.
    >> Share

  20. MUCCINI C, Crowell TA, Pinyakorn S, Kroon E, et al
    Brief Report: Syphilis Incidence and Effect on Viral Load, CD4, and CD4/CD8 Ratio in a Thai Cohort of Predominantly Men Who Have Sex With Men Living With HIV.
    J Acquir Immune Defic Syndr. 2021;86:219-223.
    >> Share

  21. CRANE HM, Nance RM, Whitney BM, Heckbert SR, et al
    Brief Report: Differences in Types of Myocardial Infarctions Among People Aging With HIV.
    J Acquir Immune Defic Syndr. 2021;86:208-212.
    >> Share

  22. CHOW EPF, Hocking JS, Ong JJ, Phillips TR, et al
    Brief Report: Changes in PrEP Use, Sexual Practice, and Use of Face Mask During Sex Among MSM During the Second Wave of COVID-19 in Melbourne, Australia.
    J Acquir Immune Defic Syndr. 2021;86:153-156.
    >> Share

    January 2021
  23. SABERI P, Ming K, Hojilla JC, Scott HM, et al
    HIV pre-exposure prophylaxis in the time of COVID-19: How a robust and responsive HIV PrEP intervention can avert loss of HIV prevention coverage during a global pandemic.
    J Acquir Immune Defic Syndr. 2021 Jan 29. pii: 00126334-900000000-95952.
    >> Share

  24. WAIRIMU F, Ward NC, Liu Y, Dwivedi G, et al
    Cardiac transplantation in HIV positive patients: a narrative review.
    J Acquir Immune Defic Syndr. 2021 Jan 29. pii: 00126334-900000000-95951.
    >> Share

  25. TIEN-HUAN L, Ismael FC, Suzue S, Rommel B, et al
    Evaluating Nonresponse Weighting Adjustment for the Population-Based HIV Impact Assessments Surveys: On Incorporating Survey Outcomes.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95955.
    >> Share

  26. JOHNSON KA, Chen MJ, Kohn R, Sachdev D, et al
    Acute HIV at the time of initiation of Pre or Post Exposure Prophylaxis: Impact on drug-resistance and clinical outcomes.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95954.
    >> Share

  27. PAMPATI S, Emrick K, Siegler AJ, Jones J, et al
    Changes in sexual behavior, PrEP adherence, and access to sexual health services due to the COVID-19 pandemic among a cohort of PrEP-using MSM in the South.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95953.
    >> Share

  28. VAN DER HEIJDEN WA, Wan J, Van de Wijer L, Jaeger M, et al
    Plasmatic coagulation capacity correlates with inflammation and abacavir-use during chronic HIV-infection.
    J Acquir Immune Defic Syndr. 2021 Jan 26. pii: 00126334-900000000-95956.
    >> Share

  29. GOODRICH S, Siika A, Mwangi A, Nyambura M, et al
    Development, assessment and outcomes of a community-based model of anti-retroviral care in western Kenya through a cluster-randomized control trial.
    J Acquir Immune Defic Syndr. 2021 Jan 21. pii: 00126334-900000000-95957.
    >> Share

  30. ONGOLLY FK, Dolla A, Ngure K, Irungu EM, et al
    "I just decided to stop: " Understanding PrEP discontinuation among individuals initiating PrEP in HIV care centers in Kenya.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95963.
    >> Share

  31. COBURN SB, Shiels M, Silverberg M, Horberg M, et al
    Secular Trends in Breast Cancer Risk among Women with HIV Initiating ART in North America.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95962.
    >> Share

  32. ZHANG L, Abohashem S, Osborne MT, Naddaf N, et al
    Lower Socioeconomic Status Associates with Greater Systemic and Arterial Inflammation in HIV.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95961.
    >> Share

  33. CHEN Y, Gao Y, Zhou Y, Li X, et al
    Human Immunodeficiency Virus Infection and Incident Heart Failure: A Meta-analysis of Prospective Studies.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95958.
    >> Share

  34. BUSZA J, Hensen B, Birdthistle I, Chabata ST, et al
    What's in a name? A mixed method study on how young women who sell sex characterise male partners and their use of condoms.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95964.
    >> Share

  35. CRABLE EL, Blue TR, McKenzie M, Rich JD, et al
    Effect of case management on HIV outcomes for community corrections population: Results of an 18-month randomized controlled trial.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95960.
    >> Share

  36. MUCCINI C, Galli L, Poli A, Chiurlo M, et al
    Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95959.
    >> Share

  37. RANA MN, Kim CH, Sullivan CE, Longenecker CT, et al
    Performance of Methods to Estimate Low-Density Lipoprotein Cholesterol in Women with and without HIV infection.
    J Acquir Immune Defic Syndr. 2021 Jan 18. pii: 00126334-900000000-95966.
    >> Share

  38. BIEN-GUND CH, Ho JI, Bair EF, Marcus N, et al
    Financial incentives and real-time adherence monitoring to promote daily adherence to HIV treatment and viral suppression among people living with HIV: a pilot study.
    J Acquir Immune Defic Syndr. 2021 Jan 15. pii: 00126334-900000000-95965.
    >> Share

  39. DIRAJLAL-FARGO S, Williams PL, Broadwell C, McFARLAND EJ, et al
    Youth living with perinatally-acquired HIV have lower physical activity levels as they age compared to HIV-exposed uninfected youth.
    J Acquir Immune Defic Syndr. 2021 Jan 13. pii: 00126334-900000000-95968.
    >> Share

  40. RAO A, Rucinski K, Jarrett B, Ackerman B, et al
    Perceived interruptions to HIV prevention and treatment services associated with COVID-19 for gay, bisexual, and other men who have sex with men in 20 countries.
    J Acquir Immune Defic Syndr. 2021 Jan 13. pii: 00126334-900000000-95967.
    >> Share

  41. GATHE JC, Hardwicke RL, Garcia F, Weinheimer S, et al
    Efficacy, pharmacokinetics and safety over 48 weeks with ibalizumab-based therapy in treatment-experienced adults infected with HIV-1: A Phase 2a study.
    J Acquir Immune Defic Syndr. 2021;Publish Ahead of Print.
    >> Share

  42. MEGGI B, Bollinger T, Zitha A, Mudenyanga C, et al
    Performance of a True Point-of-Care Assay for HIV-1/2 Viral Load Measurement at Antenatal and Postpartum Services.
    J Acquir Immune Defic Syndr. 2021;Publish Ahead of Print.
    >> Share

  43. HENRY RT, Jiamsakul A, Law M, Losso M, et al
    Factors Associated With And Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial Participants.
    J Acquir Immune Defic Syndr. 2021;Publish Ahead of Print.
    >> Share

  44. SPRING S, O'Bryan J, McMahon J, Woolley I, et al
    Acceptability of Injectable Antiretroviral Therapy in Australian Travelers With HIV.
    J Acquir Immune Defic Syndr. 2021;86:e13-e15.
    >> Share

  45. FABBIANI M, Borghetti A, Squillace N, Colafigli M, et al
    Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy.
    J Acquir Immune Defic Syndr. 2021;86:119-127.
    >> Share

  46. DUNN D, Price H, Vudriko T, Kityo C, et al
    New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings.
    J Acquir Immune Defic Syndr. 2021;86:98-103.
    >> Share

  47. ELLSWORTH GB, Burke LA, Wells MT, Mishra S, et al
    Randomized Pilot Study of an Advanced Smart-Pill Bottle as an Adherence Intervention in Patients With HIV on Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2021;86:73-80.
    >> Share

  48. ONONO M, Odwar T, Wahome S, Helova A, et al
    Behavioral Interventions can Mitigate Adverse Pregnancy Outcomes Among Women Conceiving on ART and Those Initiated on ART During Pregnancy: Findings From the MOTIVATE Trial in Southwestern Kenya.
    J Acquir Immune Defic Syndr. 2021;86:46-55.
    >> Share

  49. SCHNEIDER JA, Young L, Ramachandran A, Michaels S, et al
    A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago.
    J Acquir Immune Defic Syndr. 2021;86:31-37.
    >> Share

  50. PAHWA S, Deeks S, Zou S, Tomitch N, et al
    NIH Workshop on HIV-Associated Comorbidities, Coinfections, and Complications: Summary and Recommendation for Future Research.
    J Acquir Immune Defic Syndr. 2021;86:11-18.
    >> Share

    December 2020
  51. OLALI AZ, Sharma A, Shi Q, Hoover DR, et al
    Change in circulating undercarboxylated osteocalcin (ucOCN) is associated with fat accumulation in HIV-seropositive women.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  52. MCQUILLAN GM, Kruszon-Moran D, Gu Q, Masciotra S, et al
    Prevalence and trends in HIV infection and testing among adults in the United States: The National Health and Nutrition Examination Surveys, 1999-2018.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  53. MOSKOWITZ DA, Moran KO, Matson M, Alvarado-Avila A, et al
    The PrEP cascade in a national cohort of adolescent men who have sex with men.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  54. FELNER JK, Mittal ML, Hoenigl M, Amico KR, et al
    Constructions of HIV Risk Among a Diverse Sample of HIV-Negative Young Men who have Sex with Men who are Repeat Testers.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  55. MULATU MS, Wang G, Song W, Keatley J, et al
    HIV Testing, Diagnosis of HIV Infection, Linkage to Medical Care, and Interview for Partner Services among Transgender Persons - United States, 2012-2017.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  56. MOSHIRI N, Smith DM, Mirarab S
    HIV Care Prioritization using Phylogenetic Branch Length.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  57. O'HALLORAN JA, Wang K, Spence AB, Williams DW, et al
    Integrase Strand Transfer Inhibitor Start or Switch Impacts Learning in Women with HIV.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  58. LEDERMAN MM
    AIDS in the Heartland- Hemophilia was the Harbinger of Things to Come.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  59. BLAIR CS, Lake JE, Passaro RC, Chavez-Gomez S, et al
    HIV-1 Seroconversion is Not Associated with Prolonged Rectal Mucosal Inflammation.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  60. PETOUMENOS K, Kuwanda L, Ryom L, Mocroft A, et al
    Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study\.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  61. WEISER JK, Tie Y, Beer L, Fanfair RN, et al
    Racial/ethnic and Income Disparities in the Prevalence of Comorbidities that Are Associated With Risk for Severe COVID-19 Among Adults Receiving HIV Care, United States, 2014-2019.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  62. KATZ IT, Musinguzi N, Bell K, Cross A, et al
    The Impact of Disease Stage on Early Gaps in ART in the "Treatment for All" Era - A Multisite Cohort Study.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  63. SAMRI A, Chalouni M, Blanco J, Behrens G, et al
    Influence of the ARV regimen on the early changes in plasma HIV RNA and immune activation at initiation of antiretroviral therapy in naive HIV-1-infected patients.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  64. TOLENTINO A, Amaral S, Souza LS, Zeballos D, et al
    Frequency of falls and associated risk factors in people living with HIV: a systematic review with meta-analysis and meta-regression.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  65. STEK C, Buyze J, Menten J, Schutz C, et al
    Diagnostic accuracy of the INSHI consensus case definition for the diagnosis of paradoxical tuberculosis-IRIS.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  66. CHOW EPF, Ong JJ, Denham I, Fairley CK, et al
    HIV testing and diagnoses during the COVID-19 pandemic in Melbourne, Australia.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  67. MALLARINO-HAEGER C, Abebe KZ, Jackson EK, Zyhowski A, et al
    Brief Report: Dipyridamole Decreases Gut Mucosal Regulatory T-Cell Frequencies Among People With HIV on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2020;85:665-669.
    >> Share

  68. GINGRICH D, Deitchman AN, Kantor A, Huang L, et al
    Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV.
    J Acquir Immune Defic Syndr. 2020;85:651-658.
    >> Share

  69. HSIEH YL, Jahn A, Menzies NA, Yaesoubi R, et al
    Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi.
    J Acquir Immune Defic Syndr. 2020;85:643-650.
    >> Share

  70. TORGERSEN J, Kallan MJ, Carbonari DM, Park LS, et al
    Brief Report: Accuracy of FIB-4 for Cirrhosis in People Living With HIV and Hepatocellular Carcinoma.
    J Acquir Immune Defic Syndr. 2020;85:530-534.
    >> Share

  71. LINNEMAYR S, Barreras JL, Izenberg M, Brooks RA, et al
    Longitudinal Assessment of Changes in Mental and Sexual Health Outcomes Due to COVID-19 Among Latinx SMM and TGW.
    J Acquir Immune Defic Syndr. 2020;85:e90-e92.
    >> Share

  72. PEREZ-VALERO I, Llibre JM, Castagna A, Pulido F, et al
    Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation.
    J Acquir Immune Defic Syndr. 2020 Dec 10. doi: 10.1097/QAI.0000000000002595.
    >> Share

  73. ELLIS RJ, Iudicello J, Sun-Suslow N, Grelotti D, et al
    Social isolation is linked to inflammation in aging people with HIV and uninfected individuals.
    J Acquir Immune Defic Syndr. 2020 Dec 8. doi: 10.1097/QAI.0000000000002596.
    >> Share

  74. ABRAMS EJ, Mofenson LM, Pozniak A, Lockman S, et al
    Enhanced and timely investigation of ARVs for use in pregnant women.
    J Acquir Immune Defic Syndr. 2020 Dec 8. doi: 10.1097/QAI.0000000000002597.
    >> Share

  75. NAIDOO K, Mansoor LE, Katz AW, Garcia M, et al
    Qualitative perceptions of dapivirine vaginal ring adherence and drug level feedback following an open-label extension trial.
    J Acquir Immune Defic Syndr. 2020 Dec 3. doi: 10.1097/QAI.0000000000002590.
    >> Share

  76. SINHA A, Mystakelis H, Rivera AS, Manion M, et al
    Association of Low CD4/CD8 Ratio With Adverse Cardiac Mechanics in Lymphopenic HIV-Infected Adults.
    J Acquir Immune Defic Syndr. 2020;85:e73-e76.
    >> Share

  77. MANSERGH G, Stephenson R, Hirshfield S, Sullivan P, et al
    Understanding HIV Sexual Protection and Its Association With Substance Use During Sex Among MSM in an Era of Multiple Primary Prevention Products.
    J Acquir Immune Defic Syndr. 2020;85:e67.
    >> Share

  78. POTEAT TC, Reisner SL, Miller M, Wirtz AL, et al
    Vulnerability to COVID-19-related Harms Among Transgender Women With and Without HIV Infection in the Eastern and Southern U.S.
    J Acquir Immune Defic Syndr. 2020;85:e67-e69.
    >> Share

  79. THORBALL CW, Borghesi A, Bachmann N, Von Siebenthal C, et al
    Host Genomics of the HIV-1 Reservoir Size and Its Decay Rate During Suppressive Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2020;85:517-524.
    >> Share

  80. LUCAS GM, Atta MG, Zook K, Vaidya D, et al
    Cross-Sectional and Longitudinal Performance of Creatinine- and Cystatin C-Based Estimating Equations Relative to Exogenously Measured Glomerular Filtration Rate in HIV-Positive and HIV-Negative Persons.
    J Acquir Immune Defic Syndr. 2020;85:e58-e66.
    >> Share

  81. RODRIGUEZ VJ, Zegarac M, La Barrie DL, Parrish MS, et al
    Validation of the Bayley Infant Neurodevelopmental Screener Among HIV-Exposed Infants in Rural South Africa.
    J Acquir Immune Defic Syndr. 2020;85:507-516.
    >> Share

  82. RIZZARDINI G, Overton ET, Orkin C, Swindells S, et al
    Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials.
    J Acquir Immune Defic Syndr. 2020;85:498-506.
    >> Share

  83. HAN WM, Bijker R, Chandrasekaran E, Pujari S, et al
    Validation of the D: A: D Chronic Kidney Disease Risk Score Model Among People Living With HIV in the Asia-Pacific.
    J Acquir Immune Defic Syndr. 2020;85:489-497.
    >> Share

  84. MANN SC, Morrow M, Coyle RP, Coleman SS, et al
    Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes Mellitus.
    J Acquir Immune Defic Syndr. 2020;85:483-488.
    >> Share

  85. BALLIVIAN J, Alcaide ML, Cecchini D, Jones DL, et al
    Impact of COVID-19-Related Stress and Lockdown on Mental Health Among People Living With HIV in Argentina.
    J Acquir Immune Defic Syndr. 2020;85:475-482.
    >> Share

  86. BK K, Tiwari S, Chhapola V, Debnath E, et al
    Brief Report: Subclinical Kidney Dysfunction in HIV-Infected Children: A Cross-Sectional Study.
    J Acquir Immune Defic Syndr. 2020;85:470-474.
    >> Share

  87. MCCLEAN M, Buzkova P, Budoff M, Estrella M, et al
    Brief Report: Cystatin C-Based Estimation of Glomerular Filtration Rate and Association With Atherosclerosis Imaging Markers in People Living With HIV.
    J Acquir Immune Defic Syndr. 2020;85:466-469.
    >> Share

  88. MILLER L, Morar N, Kapiga S, Ramjee G, et al
    Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
    J Acquir Immune Defic Syndr. 2020;85:458-465.
    >> Share

  89. HEBEL S, Kahn-Woods E, Malone-Thomas S, McNeese M, et al
    Brief Report: Discrepancies Between Self-Reported Adherence and a Biomarker of Adherence in Real-World Settings.
    J Acquir Immune Defic Syndr. 2020;85:454-457.
    >> Share

  90. BOYD AT, Odume B, Sidibe K, Onotu D, et al
    Brief Report: Programmatic Scale-up of Tuberculosis Preventive Treatment Among People Living With HIV Through Targeted Technical Assistance to High-Volume Antiretroviral Treatment Sites-Nigeria, 2018-2019.
    J Acquir Immune Defic Syndr. 2020;85:450-453.
    >> Share

  91. CONTE M, Eshun-Wilson I, Geng E, Imbert E, et al
    Brief Report: Understanding Preferences for HIV Care Among Patients Experiencing Homelessness or Unstable Housing: A Discrete Choice Experiment.
    J Acquir Immune Defic Syndr. 2020;85:444-449.
    >> Share

  92. DEAN LT, Nonyane BAS, Ugoji C, Visvanathan K, et al
    Economic Burden Among Gay, Bisexual, and Other Men Who Have Sex With Men Living With HIV or Living Without HIV in the Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2020;85:436-443.
    >> Share

  93. CHAPIN-BARDALES J, Johnson Jones ML, Kirkcaldy RD, Bernstein KT, et al
    Pre-exposure Prophylaxis Use and Detected Sexually Transmitted Infections Among Men Who Have Sex With Men in the United States-National HIV Behavioral Surveillance, 5 US Cities, 2017.
    J Acquir Immune Defic Syndr. 2020;85:430-435.
    >> Share

  94. MOORE JR, Donnell DJ, Boily MC, Mitchell KM, et al
    Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression.
    J Acquir Immune Defic Syndr. 2020;85:423-429.
    >> Share

  95. JEAN LOUIS F, Domercant JW, Ignacio C, Gianella S, et al
    High Prevalence of HIV-1 Drug Resistance and Dynamics of Transmission Among High-Risk Populations in Port-au-Prince, Haiti.
    J Acquir Immune Defic Syndr. 2020;85:416-422.
    >> Share

  96. XIA Y, Greenwald ZR, Milwid RM, Trottier C, et al
    Pre-exposure Prophylaxis Uptake Among Men Who Have Sex With Men Who Used nPEP: A Longitudinal Analysis of Attendees at a Large Sexual Health Clinic in Montreal (Canada).
    J Acquir Immune Defic Syndr. 2020;85:408-415.
    >> Share

  97. DE ANDA S, Njoroge A, Njuguna I, Dunbar MD, et al
    Predictors of First-Time and Repeat HIV Testing Among HIV-Positive Individuals in Kenya.
    J Acquir Immune Defic Syndr. 2020;85:399-407.
    >> Share

  98. MOORE M, Boily MC, Mitchell KM, Donnell DD, et al
    Identifying Regions of Greatest Need for Ending the HIV Epidemic: A Plan for America.
    J Acquir Immune Defic Syndr. 2020;85:395-398.
    >> Share

  99. BRUMMEL SS, Taha TE, Angelidou KN, Saidi F, et al
    Impact of Antiretroviral Therapy on Maternal Health after Cessation of Breastfeeding.
    J Acquir Immune Defic Syndr. 2020 Dec 1. doi: 10.1097/QAI.0000000000002586.
    >> Share

    November 2020
  100. HUANG YS, Cheng CY, Liou BH, Lu PL, et al
    Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide as maintenance treatment in HIV/HBV-coinfected patients.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002589.
    >> Share

  101. MIN HAN W, Ueaphongsukkit T, Chattranukulchai P, Siwamogsatham S, et al
    Incident liver cirrhosis, associated factors and cardiovascular disease risks among people living with HIV: a longitudinal study.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002585.
    >> Share

  102. MAZAHERI-TEHRANI E, Mohraz M, Nasi M, Chester J, et al
    NLRP3 and IL-1beta gene expression is elevated in monocytes from HIV treated patients with neurocognitive disorders.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002588.
    >> Share

  103. PINTYE J, O'Malley G, Kinuthia J, Abuna F, et al
    Influences on early discontinuation and persistence of daily oral PrEP use among Kenyan adolescent girls and young women: a qualitative evaluation from a PrEP implementation program.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002587.
    >> Share

  104. CELERINO DA SILVA R, Segat L, Kuhn L, Bogo Chies JA, et al
    Association of single nucleotide polymorphisms in HLA-C and ZNRD1 genes with HIV-1 mother to child transmission in Zambia population.
    J Acquir Immune Defic Syndr. 2020 Nov 23. doi: 10.1097/QAI.0000000000002584.
    >> Share

  105. UNG MJ, Fairley CK, Martin SJ, Ong JJ, et al
    Pre-exposure Prophylaxis for HIV - an opportunity for the global control of sexually transmitted infections.
    J Acquir Immune Defic Syndr. 2020 Nov 23. doi: 10.1097/QAI.0000000000002582.
    >> Share

  106. PATHMANATHAN I, Nelson R, de Louvado A, Thompson R, et al
    High Coverage of Antiretroviral Treatment with Annual Home-Based HIV Testing, Follow-up Linkage Services, and Implementation of Test and Start: Findings from the Chokwe Health Demographic Surveillance System, Mozambique, 2014-2019.
    J Acquir Immune Defic Syndr. 2020 Nov 21. doi: 10.1097/QAI.0000000000002583.
    >> Share

  107. SILHOL R, Baral S, Bowring AL, Mukandavire C, et al
    Quantifying the evolving contribution of HIV interventions and key populations to the HIV epidemic in Yaounde, Cameroon.
    J Acquir Immune Defic Syndr. 2020 Nov 20. doi: 10.1097/QAI.0000000000002580.
    >> Share

  108. HAMILL MM, Hu F, Kokogho A, Shoyemi E, et al
    Factors Associated with Condom Failure in a Longitudinal Cohort of Men who have Sex with Men and Transgender Women in Abuja and Lagos, Nigeria.
    J Acquir Immune Defic Syndr. 2020 Nov 20. doi: 10.1097/QAI.0000000000002559.
    >> Share

  109. OLIVEIRA VH, Borsari AL, CArdenas JDG, Alves Junior CM, et al
    Low Agreement Between Initial and Revised European Consensus on Definition and Diagnosis of Sarcopenia Applied to People Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Nov 18. doi: 10.1097/QAI.0000000000002576.
    >> Share

  110. VAN BILSEN WPH, Zimmermann HML, Boyd A, Coyer L, et al
    Sexual behavior and its determinants during COVID-19 restrictions among men who have sex with men in Amsterdam.
    J Acquir Immune Defic Syndr. 2020 Nov 18. doi: 10.1097/QAI.0000000000002581.
    >> Share

  111. SEKIZIYIVU AB, Bancroft E, Rodriguez EM, Sendagala S, et al
    Task shifting for initiation and monitoring of antiretroviral therapy for HIV-infected adults in Uganda: The SHARE Trial.
    J Acquir Immune Defic Syndr. 2020 Nov 17. doi: 10.1097/QAI.0000000000002567.
    >> Share

  112. MACGIBBON J, Lea T, Ellard J, Murphy D, et al
    Access to subsidised healthcare affects HIV pre-exposure prophylaxis (PrEP) uptake among gay and bisexual men in Australia: results of national surveys 2013-19.
    J Acquir Immune Defic Syndr. 2020 Nov 16. doi: 10.1097/QAI.0000000000002572.
    >> Share

  113. ABDO M, Langan SJ, MaWhinney S, Sun J, et al
    The Effect of Statin Therapy on Age-Associated Changes in Physical Function Among Men With and Without HIV in the Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2020 Nov 16. doi: 10.1097/QAI.0000000000002579.
    >> Share

  114. BOGART LM, Ojikutu BO, Tyagi K, Klein DJ, et al
    COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002570.
    >> Share

  115. MULATO A, Acosta R, Chang S, Martin R, et al
    Simulating HIV Breakthrough and Resistance Development During Variable Adherence to Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002562.
    >> Share

  116. SCHNITTMAN SR, Zepf R, Cocohoba J, Sears D, et al
    Heplisav-B Seroprotection in People with HIV: A Single-Center Experience.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002573.
    >> Share

  117. ATKINS K, Rucinski K, Mudavanhu M, Holmes L, et al
    Sexual Relationship Types, Partner HIV Self-Testing, and Pre-Exposure Prophylaxis Among South African Adolescent Girls and Young Women: A Latent Class Analysis.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002569.
    >> Share

  118. GOSWAMI S, Hu X, Chen Q, Qiu J, et al
    Profiles of MicroRNAs in Interleukin-27-Induced HIV-Resistant T cells: Identification of a Novel Anti-Viral MicroRNA.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002565.
    >> Share

  119. CASALE M, Cluver L, Boyes M, Toska E, et al
    Bullying and ART non-adherence among South African adolescents living with HIV: effects, risk and protective factors.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002574.
    >> Share

  120. JOHNSON LM, Green HD Jr, Koch B, Stockman JK, et al
    Role of social networks and social norms in future PrEP use in a racially-diverse sample of at-risk women and members of their social networks.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002571.
    >> Share

  121. BERES LK, Schwartz S, Simbeza S, McGready J, et al
    Patterns and Predictors of Incident Return to HIV Care Among Traced, Disengaged Patients in Zambia: Analysis of a prospective cohort.
    J Acquir Immune Defic Syndr. 2020 Nov 4. doi: 10.1097/QAI.0000000000002554.
    >> Share

  122. BULTERYS MA, Sharma M, Mugwanya K, Stein G, et al
    Correlates of HIV status non-disclosure by pregnant women living with HIV to their male partners in Uganda: a cross-sectional study.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002566.
    >> Share

  123. PIZZIRUSSO M, Carrion-Park C, Clark US, Gonzalez J, et al
    Physical and mental health screening in a New York City HIV cohort during the COVID-19 pandemic: A preliminary report.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002564.
    >> Share

  124. MAYER ME, White E, Montano MA, Lama JR, et al
    Sexual Behavior among Men Who Have Sex with Men: the Need for More Targeted Outreach to Men Who Also Have Sex with Cisgender Women.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002568.
    >> Share

  125. MIMIAGA MJ, Hughto JMW, Klasko-Foster L, Jin H, et al
    Substance use, mental health problems, and physical and sexual violence additively increase HIV risk between male sex workers and their male clients in Northeastern United States.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002563.
    >> Share

  126. SUMMERS NA, Lahiri CD, Angert CD, Aldredge A, et al
    Metabolic Changes Associated With the Use of Integrase Strand Transfer Inhibitors Among Virally Controlled Women.
    J Acquir Immune Defic Syndr. 2020;85:355-362.
    >> Share

  127. BEBELL LM, Siedner MJ, Ngonzi J, Le MH, et al
    Brief Report: Chronic Placental Inflammation Among Women Living With HIV in Uganda.
    J Acquir Immune Defic Syndr. 2020;85:320-324.
    >> Share

    October 2020
  128. ZHAO H, Li J, Li S, Wang Y, et al
    Comparative analysis of presentation and outcome after liver resection of patients with hepatocellular carcinoma with and without HIV.
    J Acquir Immune Defic Syndr. 2020 Oct 30. doi: 10.1097/QAI.0000000000002561.
    >> Share

  129. CHAHINE A, Koru-Sengul T, Feaster DJ, Dilworth SE, et al
    Blue Monday: Co-Occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis.
    J Acquir Immune Defic Syndr. 2020 Oct 30. doi: 10.1097/QAI.0000000000002560.
    >> Share

  130. KUNIHOLM MH, Bramah-Lawani M, Fitzpatrick M, Nouraie M, et al
    Association of monocyte migration marker CD11b with pulmonary function in people living with HIV.
    J Acquir Immune Defic Syndr. 2020 Oct 28. doi: 10.1097/QAI.0000000000002544.
    >> Share

  131. ROTH AM, Tran NK, Felsher MA, Gadegbeku AB, et al
    Integrating HIV pre-exposure prophylaxis with community-based syringe services for women who inject drugs: Results from the Project SHE demonstration study.
    J Acquir Immune Defic Syndr. 2020 Oct 28. doi: 10.1097/QAI.0000000000002558.
    >> Share

  132. RUDERMAN SA, Crane HM, Nance RM, Whitney BM, et al
    Weight gain following antiretroviral therapy (ART) initiation in ART-naive people living with HIV in the current treatment era.
    J Acquir Immune Defic Syndr. 2020 Oct 28. doi: 10.1097/QAI.0000000000002556.
    >> Share

  133. SCHNEIDER JA, Young L, Ramachandran A, Michaels S, et al
    A Pragmatic Randomized Controlled Trial to Increase Pre-Exposure Prophylaxis Uptake for HIV prevention: 55-week results from PrEPChicago.
    J Acquir Immune Defic Syndr. 2020 Oct 23. doi: 10.1097/QAI.0000000000002518.
    >> Share

  134. EHRENKRANZ P, Grimsrud A, Holmes CB, Preko P, et al
    Expanding the vision for differentiated service delivery: a call for more inclusive and truly patient-centered care for people living with HIV.
    J Acquir Immune Defic Syndr. 2020 Oct 23. doi: 10.1097/QAI.0000000000002549.
    >> Share

  135. DAVIS SM, Habel MA, Pretorius C, Yu T, et al
    Modeling the Impact of Voluntary Medical Male Circumcision (VMMC) on Cervical Cancer in Uganda.
    J Acquir Immune Defic Syndr. 2020 Oct 23. doi: 10.1097/QAI.0000000000002552.
    >> Share

  136. TEIXEIRA DA SILVA D, Bouris A, Ramachandran A, Blocker O, et al
    Embedding a Linkage to Pre-Exposure Prophylaxis (PrEP) Care Intervention in Social Network Strategy and Partner Notification Services: Results from a Pilot Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002548.
    >> Share

  137. GOYAL R, Hu C, Klein PW, Hotchkiss J, et al
    DEVELOPMENT OF A MATHEMATICAL MODEL TO ESTIMATE THE COST-EFFECTIVENESS OF THE RYAN WHITE HIV/AIDS PROGRAM.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002546.
    >> Share

  138. SRINIVASAN K, Heylen E, Raj T, Nyblade L, et al
    Reduction in stigma drivers partially mediates the effect of a stigma reduction intervention among nursing students in India: The DriSti cluster randomized controlled trial.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002543.
    >> Share

  139. HOOVER KW, Khalil GM, Cadwell BL, Rose CE, et al
    Benchmarks for HIV Testing: What is Needed to Achieve Universal Testing Coverage at U.S. Ambulatory Healthcare Facilities.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002553.
    >> Share

  140. GANESH P, Heller T, Chione B, Gumulira J, et al
    NEAR POINT OF CARE HIV VIRAL LOAD: TARGETED TESTING AT LARGE FACILITIES.
    J Acquir Immune Defic Syndr. 2020 Oct 21. doi: 10.1097/QAI.0000000000002555.
    >> Share

  141. GHARE SS, Chilton PM, Rao AV, Joshi-Barve S, et al
    Epigenetic mechanisms underlying HIV-Infection induced susceptibility of CD4+ T cells to enhanced activation-induced FasL expression and cell death.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002526.
    >> Share

  142. BRAUNSTEIN SL, Robbins RS, Ramaswamy C, Daskalakis D, et al
    DRUG OVERDOSE DEATHS AMONG PEOPLE WITH HIV IN NEW YORK CITY, 2007-2017.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002545.
    >> Share

  143. PHILLIPS TR, Fairley CK, Bradshaw FAChSHM CS, Hocking JS, et al
    Group sex among men who have sex with men in the era of PrEP: A cross-sectional study.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002550.
    >> Share

  144. TRUONG HM, Mehrotra ML, Grant RM
    Seroadaptive Behaviors Varied among Geographically-Diverse iPrEx Participants.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002551.
    >> Share

  145. GOYAL R, Luca D, Klein P, Morris E, et al
    Cost-Effectiveness of the Health Resources and Services Administration's Ryan White HIV/AIDS Program.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002547.
    >> Share

  146. GEIDELBERG L, Mitchell KM, Alary M, Mboup A, et al
    A mathematical model impact analysis of a real-life pre-exposure prophylaxis and treatment-as-prevention study among female sex workers in Cotonou, Benin.
    J Acquir Immune Defic Syndr. 2020 Oct 16. doi: 10.1097/QAI.0000000000002535.
    >> Share

  147. MODY A, Sikombe K, Beres LK, Simbeza S, et al
    Profiles of HIV Care Disruptions Among Adult Patients Lost to Follow-up in Zambia: A Latent Class Analysis.
    J Acquir Immune Defic Syndr. 2020 Oct 16. doi: 10.1097/QAI.0000000000002530.
    >> Share

  148. VERHEIJ E, Wit FW, Verboeket SO, Schim van der Loeff MF, et al
    Frequency, risk factors and mediators of frailty transitions during long-term follow-up among people with HIV and HIV-negative AGEhIV Cohort participants.
    J Acquir Immune Defic Syndr. 2020 Oct 16. doi: 10.1097/QAI.0000000000002532.
    >> Share

  149. HU R, Yan H, Liu M, Tang L, et al
    Virologic and immunologic outcomes for HIV patients with coronavirus disease 2019.
    J Acquir Immune Defic Syndr. 2020 Oct 15. doi: 10.1097/QAI.0000000000002540.
    >> Share

  150. WOZNICA DM, Fernando NB, Bonomo EJ, Owczarzak J, et al
    Interventions to improve HIV care continuum outcomes among individuals released from prison or jail: Systematic literature review.
    J Acquir Immune Defic Syndr. 2020 Oct 15. doi: 10.1097/QAI.0000000000002523.
    >> Share

  151. AMELE S, Peters L, Rodger A, Lundgren J, et al
    Effectiveness and safety of IFN-free DAA HCV therapy in HIV/HCV co-infected persons: Results from a pan-European study.
    J Acquir Immune Defic Syndr. 2020 Oct 15. doi: 10.1097/QAI.0000000000002541.
    >> Share

  152. AFFI R, Gabillard D, Dunyach-Remy C, Ntakpe JB, et al
    0.1. Association of plasma sVCAM-1 and sCD14 with mortality in HIV-1 infected West African adults with high CD4 counts.
    J Acquir Immune Defic Syndr. 2020 Oct 14. doi: 10.1097/QAI.0000000000002533.
    >> Share

  153. MCLAUGHLIN TA, Nizam A, Hayara FO, Ouma GS, et al
    Schistosoma mansoni infection is associated with a higher probability of tuberculosis disease in HIV-infected adults in Kenya.
    J Acquir Immune Defic Syndr. 2020 Oct 14. doi: 10.1097/QAI.0000000000002536.
    >> Share

  154. AGUILERA-ALONSO D, Sainz T, Jimenez DE Ory S, Bernardino I, et al
    Clinical, Immunological and Virological Outcomes among youths with perinatal HIV after Transition to Adult Units in Spain from 1997 to 2016.
    J Acquir Immune Defic Syndr. 2020 Oct 14. doi: 10.1097/QAI.0000000000002539.
    >> Share

  155. CALZA L, Bon I, Borderi M, Colangeli V, et al
    COVID-19 OUTCOMES IN PATIENTS WITH UNCONTROLLED HIV-1 INFECTION.
    J Acquir Immune Defic Syndr. 2020 Oct 13. doi: 10.1097/QAI.0000000000002537.
    >> Share

  156. ECKARD AR, Hughes HY, Hagood NL, O'Riordan MA, et al
    Fecal Calprotectin is Elevated in HIV and Related to Systemic Inflammation.
    J Acquir Immune Defic Syndr. 2020 Oct 13. doi: 10.1097/QAI.0000000000002538.
    >> Share

  157. SACHDEV D, Mara E, Hsu L, Scheer S, et al
    COVID-19 Susceptibility and Outcomes among People Living with HIV in San Francisco.
    J Acquir Immune Defic Syndr. 2020 Oct 8. doi: 10.1097/QAI.0000000000002531.
    >> Share

  158. SHARMA M, Kariithi E, Kemunto E, Otieno G, et al
    High acceptability of assisted partner notification services among HIV-positive females in Kenya: Results from an ongoing implementation study.
    J Acquir Immune Defic Syndr. 2020 Oct 8. doi: 10.1097/QAI.0000000000002527.
    >> Share

  159. PETERS M, Margevicius S, Kityo C, Mirembe G, et al
    The Association of Kidney Disease with Abnormal Cardiac Structure and Function among Ugandans with HIV Infection.
    J Acquir Immune Defic Syndr. 2020 Oct 8. doi: 10.1097/QAI.0000000000002529.
    >> Share

  160. ALBAUGH NW, Nonyane BAS, Mmolawa L, Siwelana T, et al
    Proportion and predictors of adult TB contacts accepting HIV testing during an active TB case finding intervention in South Africa.
    J Acquir Immune Defic Syndr. 2020 Oct 7. doi: 10.1097/QAI.0000000000002509.
    >> Share

  161. HAMMOUD MA, Grulich A, Holt M, Maher L, et al
    Substantial decline in use of HIV pre-exposure prophylaxis (PrEP) following introduction of COVID-19 physical distancing restrictions in Australia: Results from a prospective observational study of gay and bisexual men.
    J Acquir Immune Defic Syndr. 2020 Oct 7. doi: 10.1097/QAI.0000000000002514.
    >> Share

  162. DE BAETSELIER I, Tsoumanis A, Florence E, Van den Berghe W, et al
    Did pre-exposure prophylaxis roll-out influence the epidemic of rectal lymphogranuloma venereum in Belgium? Results from the national surveillance system.
    J Acquir Immune Defic Syndr. 2020 Oct 6. doi: 10.1097/QAI.0000000000002524.
    >> Share

  163. ONONO M, Odwar T, Wahome S, Helova A, et al
    Behavioral interventions can mitigate adverse pregnancy outcomes among women conceiving on antiretroviral therapy (ART) and those initiated on ART during pregnancy: Findings from the MOTIVATE trial in southwestern Kenya.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002521.
    >> Share

  164. JIN H, Biello K, Garofalo R, Lurie M, et al
    Examining the longitudinal predictive relationship between HIV treatment outcomes and pre-exposure prophylaxis use by serodiscordant male couples.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002522.
    >> Share

  165. FABBIANI M, Borghetti A, Squillace N, Colafigli M, et al
    INTEGRASE INHIBITORS USE AND CMV INFECTION PREDICT IMMUNE RECOVERY IN PEOPLE LIVING WITH HIV STARTING FIRST-LINE THERAPY.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002525.
    >> Share

  166. KAPITO-TEMBO AP, Bauleni A, Wesevich A, Ongubo D, et al
    Growth and neurodevelopment outcomes in HIV, tenofovir and efavirenz exposed breastfed infants in PMTCT Option B+ program in Malawi.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002515.
    >> Share

  167. STRATHDEE SA, Martin NK, Pitpitan EV, Stockman JK, et al
    What the HIV Pandemic Experience can Teach the U.S. about the COVID-19 Response.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002520.
    >> Share

  168. RAJU S, McCormack MC, Drummond MB, Ramamurthi HC, et al
    Association of Lung Function With HIV-Related Quality of Life and Health Care Utilization in a High-Risk Cohort.
    J Acquir Immune Defic Syndr. 2020;85:219-226.
    >> Share

  169. MACCARTHY S, Wagner Z, Barreras JL, Kim A, et al
    Brief Report: Using Behavioral Economics to Increase HIV Knowledge and Testing Among Latinx Sexual Minority Men and Transgender Women: A Quasi-Experimental Pilot Study.
    J Acquir Immune Defic Syndr. 2020;85:189-194.
    >> Share

  170. BOETTIGER DC, Kerr S, Chattranukulchai P, Siwamogsatham S, et al
    Reclassification of Statin Indication Among People Living With HIV Using Coronary Artery Calcium Scoring.
    J Acquir Immune Defic Syndr. 2020;85:e26-e29.
    >> Share

  171. SURIAL B, Beguelin C, Chave JP, Stockle M, et al
    Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction-A Prospective Cohort Study.
    J Acquir Immune Defic Syndr. 2020;85:227-232.
    >> Share

  172. BHARTI AR, McCutchan JA, Umlauf A, Okwuegbuna OK, et al
    Asymptomatic Malaria Co-infection of HIV-infected Adults in Nigeria: Prevalence of and Impact on Cognition, Mood and Biomarkers of Systemic Inflammation.
    J Acquir Immune Defic Syndr. 2020 Oct 1. doi: 10.1097/QAI.0000000000002516.
    >> Share

    September 2020
  173. HICKEY MD, Ayieko J, Kwarisiima D, Opel FJ, et al
    Improved Viral Suppression with Streamlined Care in the SEARCH Study.
    J Acquir Immune Defic Syndr. 2020 Sep 24. doi: 10.1097/QAI.0000000000002508.
    >> Share

  174. HARGREAVES JR, Pliakas T, Hoddinott G, Mainga T, et al
    HIV stigma and viral suppression among people living with HIV in the context of universal test and treat: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa.
    J Acquir Immune Defic Syndr. 2020 Sep 24. doi: 10.1097/QAI.0000000000002504.
    >> Share

  175. WANGA V, Mackelprang RD, Thomas KK, Donnell D, et al
    Bacterial vaginosis and risk of HIV infection in the context of CD101 gene variation.
    J Acquir Immune Defic Syndr. 2020 Sep 18. doi: 10.1097/QAI.0000000000002505.
    >> Share

  176. WU L, Schumacher C, Chandran A, Fields E, et al
    Patterns of PrEP Retention among HIV Pre-Exposure Prophylaxis Users in Baltimore City, Maryland.
    J Acquir Immune Defic Syndr. 2020 Sep 15. doi: 10.1097/QAI.0000000000002506.
    >> Share

  177. THIVALAPILL N, Jasumback CL, Perry SH, Dlamini L, et al
    Predicting Sexually Transmitted Infections Among HIV+ Adolescents and Young Adults: A Novel Risk Score to Augment Syndromic Management in Eswatini.
    J Acquir Immune Defic Syndr. 2020 Sep 15. doi: 10.1097/QAI.0000000000002512.
    >> Share

  178. AHRENSTORF G, Jablonka A, Ernst D, Bange FC, et al
    Improved prognosis of infection with M. genavense in immune compromized HIV patients after introduction of combined antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2020 Sep 15. doi: 10.1097/QAI.0000000000002513.
    >> Share

  179. VITELLI M, Mazelle H, Joncour AL, Amelot A, et al
    A Diagnosis Can Hide Another: The Value of Brain Biopsy in Neurological Lesion of HIV Patients.
    J Acquir Immune Defic Syndr. 2020 Sep 14. doi: 10.1097/QAI.0000000000002511.
    >> Share

  180. ANDERSON AM, Jang JH, Easley KA, Fuchs D, et al
    Cognitive and neuronal link with inflammation: a longitudinal study in people with and without HIV infection.
    J Acquir Immune Defic Syndr. 2020 Sep 11. doi: 10.1097/QAI.0000000000002484.
    >> Share

  181. MUGO C, Wang J, Begnel ER, Njuguna IN, et al
    Home- and clinic-based pediatric HIV index case testing in Kenya: Uptake, HIV prevalence, linkage to care, and missed opportunities.
    J Acquir Immune Defic Syndr. 2020 Sep 11. doi: 10.1097/QAI.0000000000002500.
    >> Share

  182. JIMENEZ-SOUSA MA, Jimenez JL, Bellon JM, Fernandez-Rodriguez A, et al
    CYP27B1 rs10877012 T allele was linked to non-AIDS progression in ART-naive HIV-infected patients: a retrospective study.
    J Acquir Immune Defic Syndr. 2020 Sep 11. doi: 10.1097/QAI.0000000000002485.
    >> Share

  183. HSIEH YL, Jahn A, Menzies NA, Yaesoubi R, et al
    An evaluation of 6-month versus continuous isoniazid preventive therapy for M. tuberculosis in adults living with HIV/AIDS in Malawi.
    J Acquir Immune Defic Syndr. 2020 Sep 9. doi: 10.1097/QAI.0000000000002497.
    >> Share

  184. CLARKE DF, Lommerse J, Acosta EP, Cababasay MP, et al
    IMPACT OF LOW BIRTH WEIGHT AND PREMATURITY ON NEONATAL RALTEGRAVIR PHARMACOKINETICS: IMPAACT P1097.
    J Acquir Immune Defic Syndr. 2020 Sep 9. doi: 10.1097/QAI.0000000000002492.
    >> Share

  185. SPRING S, O'Bryan J, McMahon J, Woolley I, et al
    Acceptability of injectable anti-retroviral therapy in Australian travellers with HIV.
    J Acquir Immune Defic Syndr. 2020 Sep 9. doi: 10.1097/QAI.0000000000002501.
    >> Share

  186. MARTIN EA, Lai MT, Ngo W, Feng M, et al
    Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development.
    J Acquir Immune Defic Syndr. 2020 Sep 9. doi: 10.1097/QAI.0000000000002496.
    >> Share

  187. YANUAR SAFRI A, Gaff J, Octaviana F, Dewanto Setiawan D, et al
    Demographic and genetic associations with markers of small and large fibre sensory neuropathy in HIV patients treated without stavudine.
    J Acquir Immune Defic Syndr. 2020 Sep 7. doi: 10.1097/QAI.0000000000002503.
    >> Share

  188. GATECHOMPOL S, Teeratakulpisarn N, Wittawatmongkol O, Teeraananchai S, et al
    Incidence, persistence, and factors associated with HPV infection among male adolescents with and without perinatally acquired HIV infection.
    J Acquir Immune Defic Syndr. 2020 Sep 4. doi: 10.1097/QAI.0000000000002499.
    >> Share

  189. MCCREE DH, Chesson HW, Eppink ST, Beer L, et al
    Changes in Racial and Ethnic Disparities in Estimated Diagnosis Rates of Heterosexually-acquired HIV Infection among Heterosexual Males in the United States, 2014-2018.
    J Acquir Immune Defic Syndr. 2020 Sep 4. doi: 10.1097/QAI.0000000000002495.
    >> Share

  190. BALLIVIAN J, Alcaide ML, Cecchini D, Jones DL, et al
    Impact of COVID-19-related stress and lockdown on mental health among people living with HIV in Argentina.
    J Acquir Immune Defic Syndr. 2020 Sep 3. doi: 10.1097/QAI.0000000000002493.
    >> Share

  191. CYRUS M, Katherine W, Alvin O, Irene NN, et al
    Time to repeat viral load testing among unsuppressed adolescents and young adults living with HIV in Kenya.
    J Acquir Immune Defic Syndr. 2020 Sep 3. doi: 10.1097/QAI.0000000000002498.
    >> Share

  192. ANSARI AW, Ahmad F, Shankar EM, Yong YK, et al
    Brief Report: Diminished Coinhibitory Molecule 2B4 Expression Is Associated With Preserved iNKT Cell Phenotype in HIV Long-Term Nonprogressors.
    J Acquir Immune Defic Syndr. 2020;85:73-78.
    >> Share

  193. SHEKHAR R, Barton A, Sheikh AB, Upadhyay S, et al
    Coronavirus Disease of 2019 in Patients With Well-Controlled Human Immunodeficiency Virus on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2020;85:e1-e4.
    >> Share

    August 2020
  194. DIAZ P, Ferketich A, Wewers ME, Browning K, et al
    INCREASED COTININE CONCENTRATIONS ARE ASSOCIATED WITH REDUCED EXPRESSION OF CATHELICIDIN (LL-37) AND NOD-2 in ALVEOLAR MACROPHAGES OF PLWH WHO SMOKE.
    J Acquir Immune Defic Syndr. 2020 Aug 25. doi: 10.1097/QAI.0000000000002491.
    >> Share

  195. POTEAT TC, Reisner SL, Miller M, Wirtz AL, et al
    Letter to the Editor: Vulnerability to COVID-19-related Harms Among Transgender Women With and Without HIV Infection in the Eastern and Southern U.S.
    J Acquir Immune Defic Syndr. 2020 Aug 25. doi: 10.1097/QAI.0000000000002490.
    >> Share

  196. FRANCIS F, Gough EK, Edens TJ, Berejena C, et al
    Cessation of long-term cotrimoxazole prophylaxis in HIV-infected children does not alter the carriage of antimicrobial resistance genes.
    J Acquir Immune Defic Syndr. 2020 Aug 25. doi: 10.1097/QAI.0000000000002489.
    >> Share

  197. MOORE JR, Donnell DJ, Boily MC, Mitchell KM, et al
    Model-based predictions of HIV incidence among African women using HIV risk behaviors and community-level data on male HIV prevalence and viral suppression.
    J Acquir Immune Defic Syndr. 2020 Aug 24. doi: 10.1097/QAI.0000000000002481.
    >> Share

  198. DANIELA K VS, Paul A A, Joseph S, Christopher FK, et al
    The impact of markers of HIV infection on change in liver stiffness in people with HIV and hepatitis C virus co-infection after treatment and cure of hepatitis C.
    J Acquir Immune Defic Syndr. 2020 Aug 24. doi: 10.1097/QAI.0000000000002487.
    >> Share

  199. JEAN LOUIS F, Domercant JW, Ignacio C, Gianella S, et al
    High Prevalence of HIV-1 Drug Resistance and Dynamics of Transmission Among High-Risk Populations in Port-au-Prince, Haiti.
    J Acquir Immune Defic Syndr. 2020 Aug 24. doi: 10.1097/QAI.0000000000002475.
    >> Share

  200. HEBEL S, Kahn-Woods E, Malone-Thomas S, McNeese M, et al
    Discrepancies between self-reported adherence and a biomarker of adherence in real-world settings.
    J Acquir Immune Defic Syndr. 2020 Aug 20. doi: 10.1097/QAI.0000000000002486.
    >> Share

  201. XIA Y, Greenwald ZR, Milwid RM, Claire T, et al
    Pre-exposure prophylaxis uptake among men who have sex with men who used non-occupational post-exposure prophylaxis: a longitudinal analysis of attendees at a large sexual health clinic in Montreal (Canada).
    J Acquir Immune Defic Syndr. 2020 Aug 19. doi: 10.1097/QAI.0000000000002472.
    >> Share

  202. BOYD AT, Odume B, Sidibe K, Onotu D, et al
    Programmatic scale-up of tuberculosis preventive treatment among people living with HIV through targeted technical assistance to high-volume antiretroviral treatment sites-Nigeria, 2018-2019.
    J Acquir Immune Defic Syndr. 2020 Aug 19. doi: 10.1097/QAI.0000000000002483.
    >> Share

  203. MANSERGH G, Stephenson R, Hirshfield S, Sullivan P, et al
    Understanding HIV Sexual Protection and Its Association with Substance Use During Sex among MSM in an Era of Multiple Primary Prevention Products.
    J Acquir Immune Defic Syndr. 2020 Aug 18. doi: 10.1097/QAI.0000000000002480.
    >> Share

  204. LUCAS GM, Atta MG, Zook K, Vaidya D, et al
    Cross-sectional and longitudinal performance of creatinine- and cystatin C-based estimating equations relative to exogenously measured glomerular filtration rate in HIV-positive and HIV-negative persons.
    J Acquir Immune Defic Syndr. 2020 Aug 18. doi: 10.1097/QAI.0000000000002471.
    >> Share

  205. RODRIGUEZ VJ, Zegarac M, La Barrie DL, Parrish MS, et al
    Validation of the Bayley Infant Neurodevelopmental Screener among HIV-exposed infants in rural South Africa.
    J Acquir Immune Defic Syndr. 2020 Aug 18. doi: 10.1097/QAI.0000000000002479.
    >> Share

  206. CONTE M, Eshun-Wilson I, Geng E, Imbert E, et al
    Understanding preferences for HIV care among patients experiencing homelessness or unstable-housing: A discrete choice experiment.
    J Acquir Immune Defic Syndr. 2020 Aug 18. doi: 10.1097/QAI.0000000000002476.
    >> Share

  207. SIEWE FODJO JN, Faria de Moura Villela E, Van Hees S, Tiberio Dos Santos T, et al
    Impact of the COVID-19 pandemic on the medical follow-up and psychosocial well-being of people living with HIV: A cross-sectional survey.
    J Acquir Immune Defic Syndr. 2020 Aug 18. doi: 10.1097/QAI.0000000000002468.
    >> Share

  208. ANDA S, Njoroge A, Njuguna R, Dunbar MD, et al
    Predictors of first-time and repeat HIV testing among HIV positive individuals in Kenya.
    J Acquir Immune Defic Syndr. 2020 Aug 18. doi: 10.1097/QAI.0000000000002469.
    >> Share

  209. THORBALL CW, Borghesi A, Bachmann N, Von Siebenthal C, et al
    Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment.
    J Acquir Immune Defic Syndr. 2020 Aug 18. doi: 10.1097/QAI.0000000000002473.
    >> Share

  210. CALON M, Menon K, Carr A, Henry RG, et al
    Additive and Synergistic Cardiovascular Disease Risk Factors and HIV Disease Markers' Effects on White Matter Microstructure in Virally Suppressed HIV.
    J Acquir Immune Defic Syndr. 2020;84:543-551.
    >> Share

  211. VECCHIO A, Robertson K, Saylor D, Nakigozi G, et al
    Neurocognitive Effects of Antiretroviral Initiation Among People Living With HIV in Rural Uganda.
    J Acquir Immune Defic Syndr. 2020;84:534-542.
    >> Share

  212. AUDSLEY J, Avihingsanon A, Littlejohn M, Bowden S, et al
    Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?
    J Acquir Immune Defic Syndr. 2020;84:527-533.
    >> Share

  213. SUN-SUSLOW N, Paolillo EW, Morgan EE, Letendre S, et al
    Brief Report: Frailty and HIV Disease Severity Synergistically Increase Risk of HIV-Associated Neurocognitive Disorders.
    J Acquir Immune Defic Syndr. 2020;84:522-526.
    >> Share

  214. DE ALMEIDA SM, Ribeiro CE, Tang B, de Pereira AP, et al
    Neurocytoskeleton Proteins in Cerebrospinal Fluid of People With HIV-1 Subtypes B and C.
    J Acquir Immune Defic Syndr. 2020;84:514-521.
    >> Share

  215. EGAN JE, Ho K, Stall R, Drucker MT, et al
    Feasibility of Short-Term PrEP Uptake for Men Who Have Sex With Men With Episodic Periods of Increased HIV Risk.
    J Acquir Immune Defic Syndr. 2020;84:508-513.
    >> Share

  216. HIRSCHHORN LR, Brown RN, Friedman EE, Greene GJ, et al
    Black Cisgender Women's PrEP Knowledge, Attitudes, Preferences, and Experience in Chicago.
    J Acquir Immune Defic Syndr. 2020;84:497-507.
    >> Share

  217. ANDRASIK MP, Sesay FA, Isaacs A, Oseso L, et al
    Social Impacts Among Participants in HIV Vaccine Trial Network (HVTN) Preventive HIV Vaccine Trials.
    J Acquir Immune Defic Syndr. 2020;84:488-496.
    >> Share

  218. NAUGLE DA, Dosso A, Tibbels NJ, Van Lith LM, et al
    Addressing Uptake of HIV Testing and Linkage to Care Among Men in Cote d'Ivoire: An Evaluation of the Brothers for Life Program Implementation.
    J Acquir Immune Defic Syndr. 2020;84:480-487.
    >> Share

  219. MA H, Wang L, Gichangi P, Mochache V, et al
    Venue-Based HIV Testing at Sex Work Hotspots to Reach Adolescent Girls and Young Women Living With HIV: A Cross-sectional Study in Mombasa, Kenya.
    J Acquir Immune Defic Syndr. 2020;84:470-479.
    >> Share

  220. MURENZI G, Kim HY, Munyaneza A, Tuyisenge P, et al
    Anogenital Human Papillomavirus and HIV Infection in Rwandan Men Who Have Sex With Men.
    J Acquir Immune Defic Syndr. 2020;84:463-469.
    >> Share

  221. ZHANG W, Hu Q, Tang W, Jin X, et al
    HIV Self-Testing Programs to Men Who Have Sex With Men Delivered by Social Media Key Opinion Leaders and Community-Based Organizations are Both Effective and Complementary: A National Pragmatic Study in China.
    J Acquir Immune Defic Syndr. 2020;84:453-462.
    >> Share

  222. DASGUPTA S, Tie Y, Bradley H, Beer L, et al
    Characteristics of Sexual Partnerships Among Men With Diagnosed HIV Who Have Sex With Men, United States and Puerto Rico-2015-2019.
    J Acquir Immune Defic Syndr. 2020;84:443-452.
    >> Share

  223. SEVELIUS JM, Poteat T, Luhur WE, Reisner SL, et al
    HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States.
    J Acquir Immune Defic Syndr. 2020;84:437-442.
    >> Share

  224. BK K, Tiwari S, Chhapola V, Debnath E, et al
    Subclinical kidney dysfunction in HIV infected children: a cross-sectional study.
    J Acquir Immune Defic Syndr. 2020 Aug 5. doi: 10.1097/QAI.0000000000002470.
    >> Share

  225. CANETTI D, Galli L, Gianotti N, Celotti A, et al
    Simplification to High Genetic Barrier 2-Drug Regimens in People Living With HIV Harboring 4-Class Resistance Enrolled in the PRESTIGIO Registry.
    J Acquir Immune Defic Syndr. 2020;84:e24-e28.
    >> Share

  226. LI MJ, Su E, Garland WH, Oksuzyan S, et al
    Trajectories of Viral Suppression in People Living With HIV Receiving Coordinated Care: Differences by Comorbidities.
    J Acquir Immune Defic Syndr. 2020;84:387-395.
    >> Share

  227. NERLANDER LM, Handanagic S, Hess KL, Lutnick A, et al
    HIV Prevalence Among Women Who Exchange Sex for Money or Drugs-4 U.S. Cities.
    J Acquir Immune Defic Syndr. 2020;84:345-354.
    >> Share

  228. HARRIS M, Brouillette MJ, Scott SC, Smaill F, et al
    Impact of Loneliness on Brain Health and Quality of Life Among Adults Living With HIV in Canada.
    J Acquir Immune Defic Syndr. 2020;84:336-344.
    >> Share

  229. WANG L, Tan DHS, Mishra S
    Evidence of Nonrandom Mixing by Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men Partnerships in Melbourne, 2016 to 2018.
    J Acquir Immune Defic Syndr. 2020;84:e22-e23.
    >> Share

    July 2020
  230. HAMMOUD MA, Maher L, Holt M, Degenhardt L, et al
    Physical distancing due to COVID-19 disrupts sexual behaviours among gay and bisexual men in Australia: Implications for trends in HIV and other sexually transmissible infections.
    J Acquir Immune Defic Syndr. 2020 Jul 29. doi: 10.1097/QAI.0000000000002462.
    >> Share

  231. MCCLEAN M, Buzkova P, Budoff M, Estrella M, et al
    Cystatin C based estimation of glomerular filtration rate and association with atherosclerosis imaging markers in people living with HIV.
    J Acquir Immune Defic Syndr. 2020 Jul 27. doi: 10.1097/QAI.0000000000002467.
    >> Share

  232. BOARD AR, Oster AM, Song R, Gant Z, et al
    Geographic distribution of HIV transmission networks in the United States.
    J Acquir Immune Defic Syndr. 2020 Jul 27. doi: 10.1097/QAI.0000000000002448.
    >> Share

  233. VALLABHAJOSYULA S, Subramaniam AV, Sundaragiri PR, Cheungpasitporn W, et al
    Influence of Human Immunodeficiency Virus Infection on the Management and Outcomes of Acute Myocardial Infarction with Cardiogenic Shock.
    J Acquir Immune Defic Syndr. 2020 Jul 27. doi: 10.1097/QAI.0000000000002442.
    >> Share

  234. SINHA A, Mystakelis H, Rivera AS, Manion M, et al
    Association of low CD4/CD8 ratio with Adverse Cardiac Mechanics in Lymphopenic HIV-Infected Adults.
    J Acquir Immune Defic Syndr. 2020 Jul 23. doi: 10.1097/QAI.0000000000002465.
    >> Share

  235. PELLOQUIN R, Abdo M, MaWhinney S, Jankowski CM, et al
    Physical Function and Frailty Tools in Mortality Prediction of Middle-Aged Adults with HIV.
    J Acquir Immune Defic Syndr. 2020 Jul 23. doi: 10.1097/QAI.0000000000002455.
    >> Share

  236. EUBANKS A, Dembele Keita B, Anoma C, Dah E, et al
    Reaching a different population of MSM in West Africa with the integration of PrEP into a comprehensive prevention package. (CohMSM-PrEP ANRS 12369 - Expertise France).
    J Acquir Immune Defic Syndr. 2020 Jul 23. doi: 10.1097/QAI.0000000000002453.
    >> Share

  237. SHRESTHA RK, Schommer JC, Taitel MS, Garza OW, et al
    Costs and cost-effectiveness of the Patient-centered HIV Care Model: A collaboration between community-based pharmacists and primary medical providers.
    J Acquir Immune Defic Syndr. 2020 Jul 23. doi: 10.1097/QAI.0000000000002458.
    >> Share

  238. GROV C, Westmoreland D, Morrison C, Carrico AW, et al
    The crisis we are not talking about: One-in-three annual HIV seroconversions among sexual and gender minorities were persistent methamphetamine users.
    J Acquir Immune Defic Syndr. 2020 Jul 22. doi: 10.1097/QAI.0000000000002461.
    >> Share

  239. HAN WM, Bijker R, Chandrasekaran E, Pujari S, et al
    Validation of the D: A: D Chronic Kidney Disease Risk Score Model among people living with HIV in the Asia-Pacific.
    J Acquir Immune Defic Syndr. 2020 Jul 22. doi: 10.1097/QAI.0000000000002464.
    >> Share

  240. MILLER L, Morar N, Kapiga S, Ramjee G, et al
    Prevention, Partners, and Power Imbalances: Women's views on how male partners affected their adherence to vaginal microbicide gels during HIV prevention trials in Africa.
    J Acquir Immune Defic Syndr. 2020 Jul 22. doi: 10.1097/QAI.0000000000002463.
    >> Share

  241. MANN SC, Morrow M, Coyle RP, Coleman SS, et al
    Lower Cumulative Antiretroviral Exposure in People Living with Hiv and Diabetes Mellitus.
    J Acquir Immune Defic Syndr. 2020 Jul 22. doi: 10.1097/QAI.0000000000002460.
    >> Share

  242. GAO G, Wang A, Wang S, Qian F, et al
    A retrospective evaluation on the efficacy of Lopinavir/ritonavir and chloroquine to treat non-severe COVID-19 patients.
    J Acquir Immune Defic Syndr. 2020 Jul 22. doi: 10.1097/QAI.0000000000002452.
    >> Share

  243. NARSI K, Tomita A, Ramlall S
    Cognitive reserve and its determinants in newly HIV diagnosed antiretroviral-naive adults from peri-urban and informal settlements: Evidence from an HIV hyperendemic South African setting.
    J Acquir Immune Defic Syndr. 2020 Jul 21. doi: 10.1097/QAI.0000000000002457.
    >> Share

  244. ACOSTA RK, Willkom M, Andreatta K, Liu H, et al
    Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-Existing NRTI Resistance.
    J Acquir Immune Defic Syndr. 2020 Jul 21. doi: 10.1097/QAI.0000000000002454.
    >> Share

  245. JOHN SA, Petroll AE, Walsh JL, Quinn KG, et al
    Reducing the discussion divide by digital questionnaires in healthcare settings: Disruptive innovation for HIV testing and pre-exposure prophylaxis (PrEP) screening.
    J Acquir Immune Defic Syndr. 2020 Jul 21. doi: 10.1097/QAI.0000000000002459.
    >> Share

  246. PAIROJ C, Weerayut T, Sarawut S, Sudarat S, et al
    Echocardiographic findings among virally suppressed HIV-infected Aging Asians compared to HIV-negative individuals.
    J Acquir Immune Defic Syndr. 2020 Jul 21. doi: 10.1097/QAI.0000000000002456.
    >> Share

  247. PEEBLES K, Palanee-Phillips T, Balkus JE, Beesham I, et al
    Age-specific risk scores do not improve HIV-1 prediction among women in South Africa.
    J Acquir Immune Defic Syndr. 2020 Jul 17. doi: 10.1097/QAI.0000000000002436.
    >> Share

  248. KEEN P, Lee E, Grulich AE, Prestage G, et al
    Sustained, low prevalence of undiagnosed HIV among gay and bisexual men in Sydney, Australia coincident with increased testing and pre-exposure prophylaxis use: results from repeated, bio-behavioural studies 2014-2018.
    J Acquir Immune Defic Syndr. 2020 Jul 17. doi: 10.1097/QAI.0000000000002451.
    >> Share

  249. JANKOWSKI CM, Mawhinney S, Wilson MP, Campbell TB, et al
    Body Composition Changes in Response to Moderate or High-Intensity Exercise Among Older Adults with or without HIV Infection.
    J Acquir Immune Defic Syndr. 2020 Jul 16. doi: 10.1097/QAI.0000000000002443.
    >> Share

  250. O'BRIEN BE, Williams PL, Huo Y, Kacanek D, et al
    Repeat Pregnancies Among US Women Living with HIV in the SMARTT Study: Temporal Changes in HIV Disease Status and Predictors of Preterm Birth.
    J Acquir Immune Defic Syndr. 2020 Jul 16. doi: 10.1097/QAI.0000000000002445.
    >> Share

  251. VAN WYK J, Orkin C, Rubio R, Bogner J, et al
    Durable Suppression and Low Rate of Virologic Failure 3 Years After Switch to Dolutegravir + Rilpivirine 2-Drug Regimen: 148-Week Results From the SWORD-1 and -2 Randomized Clinical Trials.
    J Acquir Immune Defic Syndr. 2020 Jul 13. doi: 10.1097/QAI.0000000000002449.
    >> Share

  252. GUDIPATI S, Brar I, Murray S, McKinnon JE, et al
    Descriptive Analysis of Patients Living with HIV Affected By COVID-19.
    J Acquir Immune Defic Syndr. 2020 Jul 13. doi: 10.1097/QAI.0000000000002450.
    >> Share

  253. TORDOFF DM, Barbee LA, Khosropour CM, Hughes JP, et al
    Derivation and Validation of an HIV Risk Prediction Score Among Gay, Bisexual and Other Men Who Have Sex With Men to Inform PrEP Initiation in an STD Clinic Setting.
    J Acquir Immune Defic Syndr. 2020 Jul 8. doi: 10.1097/QAI.0000000000002438.
    >> Share

  254. STALTER R, Mugwanya K, Thomas K, Donnell D, et al
    Sexual behaviors following PrEP discontinuation among HIV serodiscordant couples in Kenya and Uganda.
    J Acquir Immune Defic Syndr. 2020 Jul 8. doi: 10.1097/QAI.0000000000002434.
    >> Share

  255. BOERWINKLE AH, Strain JF, Burdo T, Doyle J, et al
    Comparison of [11C]-PBR28 binding between persons living with HIV and HIV uninfected individuals.
    J Acquir Immune Defic Syndr. 2020 Jul 8. doi: 10.1097/QAI.0000000000002435.
    >> Share

  256. BRUMFIELD S, Dube A, Reniers G, Helleringer S, et al
    Comparing approaches to collecting self-reported data on HIV status in population-based surveys.
    J Acquir Immune Defic Syndr. 2020 Jul 8. doi: 10.1097/QAI.0000000000002441.
    >> Share

  257. VALLEJO A, Molina-Pinelo S, De Felipe B, Abad-Fernandez M, et al
    Toll-like receptor 9 1635A/G polymorphism is associated with HIV-1 rebound after four weeks of interruption of antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2020 Jul 8. doi: 10.1097/QAI.0000000000002437.
    >> Share

  258. TUKEI BB, Fatti G, Tiam A, Ngorima-Mabhena N, et al
    Twelve-month outcomes of community-based differentiated models of multi-month dispensing of antiretroviral treatment among stable HIV-infected adults in Lesotho: a cluster randomized non-inferiority trial.
    J Acquir Immune Defic Syndr. 2020 Jul 7. doi: 10.1097/QAI.0000000000002439.
    >> Share

  259. BALMACEDA JB, Abd-Elmoniem KZ, Liu CY, Purdy JB, et al
    Adiponectin Levels Linked to Subclinical Myocardial Fibrosis in HIV.
    J Acquir Immune Defic Syndr. 2020 Jul 6. doi: 10.1097/QAI.0000000000002440.
    >> Share

  260. RUCINSKI KB, Schwartz SR, Mishra S, Phaswana-Mafuya N, et al
    High HIV prevalence and low HIV-service engagement among young women who sell sex: A pooled analysis across nine sub-Saharan African countries.
    J Acquir Immune Defic Syndr. 2020 Jul 3. doi: 10.1097/QAI.0000000000002432.
    >> Share

  261. SURIAL B, Beguelin C, Chave JP, Stockle M, et al
    Switching from TDF to TAF in HIV/HBV co-infected individuals with renal dysfunction - a prospective cohort study.
    J Acquir Immune Defic Syndr. 2020 Jul 2. doi: 10.1097/QAI.0000000000002429.
    >> Share


  262. Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials: Erratum.
    J Acquir Immune Defic Syndr. 2020;84:e21.
    >> Share

  263. RAMIREZ-MARRERO FA, Perez-Frontera S, Amalbert-Birriel MA, Matos M, et al
    Brief Report: Effects of Low-Volume High-Intensity Interval Training in Hispanic HIV+ Women: A Nonrandomized Study.
    J Acquir Immune Defic Syndr. 2020;84:285-289.
    >> Share

  264. PHILBIN MM, Parish CL, Kinnard EN, Reed SE, et al
    Multisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2020;84:263-270.
    >> Share

  265. MACNEAL K, Tukei V, Sacks E, Mokone M, et al
    Use of Point-of-Care Nucleic Acid Tests Beyond Early Infant Diagnosis of HIV: A Retrospective Case Review in Lesotho.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S78-S83.
    >> Share

  266. ADETUNJI O, Mukherjee S, Sacks E, Ciaranello A, et al
    Front-Line Human Resource Time-Use for Early Infant HIV Diagnosis: A Comparative Time-Motion Study at Centralized and Point-of-Care Health Facilities in Zimbabwe.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S70-S77.
    >> Share

  267. MUKHERJEE S, Cohn J, Ciaranello AL, Sacks E, et al
    Estimating the Cost of Point-of-Care Early Infant Diagnosis in a Program Setting: A Case Study Using Abbott m-PIMA and Cepheid GeneXpert IV in Zimbabwe.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S63-S69.
    >> Share

  268. ALEMNJI G, Peter T, Vojnov L, Alexander H, et al
    Building and Sustaining Optimized Diagnostic Networks to Scale-up HIV Viral Load and Early Infant Diagnosis.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S56-S62.
    >> Share

  269. KATIRAYI L, Ochuka B, Mafaune H, Chadambuka A, et al
    "We Need it the Same Day": A Qualitative Study of Caregivers and Community Members' Perspectives Toward the Use of Point-of-Care Early Infant Diagnosis.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S49-S55.
    >> Share

  270. BIANCHI F, Clemens S, Arif Z, Sacks E, et al
    Acceptability of Routine Point-of-Care Early Infant Diagnosis in Eight African Countries: Findings From a Qualitative Assessment of Clinical and Laboratory Personnel.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S41-S48.
    >> Share

  271. TCHENDJOU P, Nzima V, Lekeumo S, Sacks E, et al
    HIV Mother-to-Child Transmission in Cameroon: EID Positivity Yields and Key Risk Factors by Health Service Points After Usage of POC EID Systems.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S34-S40.
    >> Share

  272. MAFAUNE HW, Sacks E, Chadambuka A, Musarandega R, et al
    Effectiveness of Maternal Transmission Risk Stratification in Identification of Infants for HIV Birth Testing: Lessons From Zimbabwe.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S28-S33.
    >> Share

  273. KHUMALO PN, Sacks E, Chouraya C, Tsabedze B, et al
    The Cascade of Care From Routine Point-of-Care HIV Testing at Birth: Results From an 18-Months Pilot Program in Eswatini.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S22-S27.
    >> Share

  274. MCCANN NC, Cohn J, Flanagan C, Sacks E, et al
    Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S12-S21.
    >> Share

  275. SACKS E, Cohn J, Ochuka B, Mafaune H, et al
    Impact of Routine Point-of-Care Versus Laboratory Testing for Early Infant Diagnosis of HIV: Results From a Multicountry Stepped-Wedge Cluster-Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S5-S11.
    >> Share

  276. MOFENSON LM, Cohn J, Sacks E
    Challenges in the Early Infant HIV Diagnosis and Treatment Cascade.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S1-S4.
    >> Share

  277. YAGER J, Castillo-Mancilla J, Ibrahim ME, Brooks KM, et al
    Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study.
    J Acquir Immune Defic Syndr. 2020;84:323-330.
    >> Share

  278. BOFFA JM, Fisher DA, Mayan MJ, Sauve RS, et al
    Effectiveness of Isoniazid Preventive Therapy to Reduce Tuberculosis Incidence in the Context of Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2020;84:e14-e17.
    >> Share

  279. KASPER P, Phiri S, Chaweza T, Tweya H, et al
    Ambulatory Blood Pressure Monitoring in PLHIV in Malawi: Preliminary Findings.
    J Acquir Immune Defic Syndr. 2020;84:e11-e14.
    >> Share

    June 2020
  280. LANE CE, Widen EM, Collins SM, Young SL, et al
    HIV-exposed, uninfected infants in Uganda experience poorer growth and body composition trajectories than HIV-unexposed infants.
    J Acquir Immune Defic Syndr. 2020 Jun 24. doi: 10.1097/QAI.0000000000002428.
    >> Share

  281. BOETTIGER DC, Kerr S, Chattranukulchai P, Siwamogsatham S, et al
    Re-classification of statin indication among people living with HIV using coronary artery calcium scoring.
    J Acquir Immune Defic Syndr. 2020 Jun 22. doi: 10.1097/QAI.0000000000002430.
    >> Share

  282. MORRIS SE, Dziobek-Garrett L, Strehlau R, Schroter J, et al
    Quantifying the dynamics of HIV decline in perinatally-infected neonates on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2020 Jun 22. doi: 10.1097/QAI.0000000000002425.
    >> Share

  283. CALZA L, Bon I, Borderi M, Colangeli V, et al
    NO SIGNIFICANT EFFECT OF COVID-19 ON IMMUNOLOGICAL AND VIROLOGICAL PARAMETERS IN PATIENTS WITH HIV-1 INFECTION.
    J Acquir Immune Defic Syndr. 2020 Jun 19. doi: 10.1097/QAI.0000000000002427.
    >> Share

  284. TARLETON J, Chen BA, Meyn LA, Hendrix CW, et al
    Pharmacokinetic and pharmacodynamic impacts of depot medroxyprogesterone acetate use on HIV pre-exposure prophylaxis in women.
    J Acquir Immune Defic Syndr. 2020 Jun 18. doi: 10.1097/QAI.0000000000002421.
    >> Share

  285. WEISER JK, Vu QM, Dasgupta S, Nelson NP, et al
    Estimated Additional Number of Adults in HIV Care Who have an Indication for Hepatitis A Vaccination Following 2020 US Guideline Update.
    J Acquir Immune Defic Syndr. 2020 Jun 15. doi: 10.1097/QAI.0000000000002426.
    >> Share

  286. HU Y, Ma J, Huang H, Vermund SH, et al
    Coinfection with HIV and SARS-CoV-2 in Wuhan, China: A 12-person case series.
    J Acquir Immune Defic Syndr. 2020 Jun 12. doi: 10.1097/QAI.0000000000002424.
    >> Share

  287. KARMEN-TUOHY S, Carlucci PM, Zervou FN, Zacharioudakis IM, et al
    Outcomes among HIV-positive patients hospitalized with COVID-19.
    J Acquir Immune Defic Syndr. 2020 Jun 12. doi: 10.1097/QAI.0000000000002423.
    >> Share

  288. GROVER S, Mehta P, Wang Q, Bhatia R, et al
    Association between CD4 count and chemoradiation therapy outcomes among cervical cancer patients with HIV.
    J Acquir Immune Defic Syndr. 2020 Jun 12. doi: 10.1097/QAI.0000000000002420.
    >> Share

  289. SALONER R, Cherner M, Iudicello JE, Heaton RK, et al
    Cerebrospinal Fluid Norepinephrine and Neurocognition in HIV and Methamphetamine Dependence.
    J Acquir Immune Defic Syndr. 2020 Jun 10. doi: 10.1097/QAI.0000000000002422.
    >> Share

  290. TORIBIO M, Awadalla M, Cetlin M, Fulda ES, et al
    Vascular Dysfunction and Monocyte Activation among Women with HIV.
    J Acquir Immune Defic Syndr. 2020 Jun 8. doi: 10.1097/QAI.0000000000002419.
    >> Share

  291. OBERMAIER B, Ananth S, Tibroni N, Pierini V, et al
    Patient-derived HIV-1 Nef alleles reveal uncoupling of CD4 downregulation and SERINC5 antagonism functions of the viral pathogenesis factor.
    J Acquir Immune Defic Syndr. 2020 Jun 8. doi: 10.1097/QAI.0000000000002418.
    >> Share

  292. HAPP LP, Monroe AK, Young HA, Ma Y, et al
    Individual- and clinic-level factors associated with achieving glycemic control in a large cohort of people with HIV in care-Washington, D.C.
    J Acquir Immune Defic Syndr. 2020 Jun 8. doi: 10.1097/QAI.0000000000002416.
    >> Share

  293. WULANDARI EAT, Wijaya IP, Karim B, Ariyanto I, et al
    Periodontitis and cytomegalovirus associate with atherosclerosis among HIV patients after 5 years on ART.
    J Acquir Immune Defic Syndr. 2020 Jun 8. doi: 10.1097/QAI.0000000000002417.
    >> Share

  294. KALICHMAN SC, Eaton LA, Berman M, Kalichman MO, et al
    Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living with HIV, Atlanta, Georgia.
    J Acquir Immune Defic Syndr. 2020 Jun 5. doi: 10.1097/QAI.0000000000002414.
    >> Share

  295. ETOORI D, Gomez-Olive FX, Reniers G, Rice B, et al
    Outcomes after being lost to follow-up differ for pregnant and postpartum women when compared to the general HIV treatment population in rural South Africa.
    J Acquir Immune Defic Syndr. 2020 Jun 4. doi: 10.1097/QAI.0000000000002413.
    >> Share

  296. GOMEZ-OLIVE FX, Houle B, Rosenberg M, Kabudula C, et al
    HIV incidence among older adults in a rural South African setting: 2010-2015.
    J Acquir Immune Defic Syndr. 2020 Jun 2. doi: 10.1097/QAI.0000000000002404.
    >> Share

  297. INDRAVUDH PP, Hensen B, Nzawa R, Chilongosi R, et al
    Who is reached by HIV self-testing? Individual factors associated with self-testing within a community-based programme in rural Malawi.
    J Acquir Immune Defic Syndr. 2020 Jun 1. doi: 10.1097/QAI.0000000000002412.
    >> Share

    May 2020
  298. OKOH AK, Bishburg E, Grinberg S, Nagarakanti S, et al
    COVID-19 pneumonia in patients with HIV - A Case Series.
    J Acquir Immune Defic Syndr. 2020 May 28. doi: 10.1097/QAI.0000000000002411.
    >> Share

  299. BLAIR CS, Li S, Chau G, Cottle L, et al
    Hormonal Contraception Use and Cabotegravir Pharmacokinetics in HIV-Uninfected Women Enrolled in HPTN 077.
    J Acquir Immune Defic Syndr. 2020 May 21. doi: 10.1097/QAI.0000000000002409.
    >> Share

  300. SABIN CA, Harding R, Doyle N, Redline S, et al
    Associations between widespread pain and sleep quality in people with HIV.
    J Acquir Immune Defic Syndr. 2020 May 21. doi: 10.1097/QAI.0000000000002410.
    >> Share

  301. OKAFOR CN, Hucks-Ortiz C, Hightow-Weidman LB, Magnus M, et al
    Associations between Self-Reported Substance Use Behaviors and PrEP Acceptance and Adherence among Black MSM in the HPTN 073 Study.
    J Acquir Immune Defic Syndr. 2020 May 21. doi: 10.1097/QAI.0000000000002407.
    >> Share

  302. NEL A, Malherbe M, van Niekerk N, Beksinska M, et al
    Performance and Acceptability of the FC2 Female Condom(R) when Used With and Without a Silicone Placebo Vaginal Ring - A Randomized, Crossover Trial.
    J Acquir Immune Defic Syndr. 2020 May 20. doi: 10.1097/QAI.0000000000002408.
    >> Share

  303. SIVRO A, Mwatelah R, Kambaran C, Gebrebrhan H, et al
    Sex work is associated with increased vaginal microbiome diversity in young women from Mombasa, Kenya.
    J Acquir Immune Defic Syndr. 2020 May 18. doi: 10.1097/QAI.0000000000002406.
    >> Share

  304. EL KAMARI V, Hileman CO, Kosco J, Mccomsey GA, et al
    Sleeve Gastrectomy compared to Roux-en-Y Gastric Bypass in individuals living with HIV.
    J Acquir Immune Defic Syndr. 2020 May 15. doi: 10.1097/QAI.0000000000002392.
    >> Share

  305. SEAMAN SM, Van Pilsum Rasmussen SE, Nguyen AQ, Halpern SE, et al
    Willingness to Accept HIV-infected and Increased Infectious Risk Donor Organs among Transplant Candidates Living with HIV.
    J Acquir Immune Defic Syndr. 2020 May 14. doi: 10.1097/QAI.0000000000002405.
    >> Share

  306. LOKKEN EM, Wanje G, Richardson BA, Mutunga E, et al
    Incidence and correlates of pregnancy in HIV-positive Kenyan sex workers.
    J Acquir Immune Defic Syndr. 2020 May 14. doi: 10.1097/QAI.0000000000002402.
    >> Share

  307. GRYAZNOV D, Chammartin F, Stoeckle M, Anagnostopoulos A, et al
    Smartphone app and carbon monoxide self-monitoring support for smoking cessation: A randomised controlled trial nested into the Swiss HIV Cohort Study.
    J Acquir Immune Defic Syndr. 2020 May 13. doi: 10.1097/QAI.0000000000002396.
    >> Share

  308. SEVELIUS JM, Poteat T, Luhur WE, Reisner SL, et al
    HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States.
    J Acquir Immune Defic Syndr. 2020 May 13. doi: 10.1097/QAI.0000000000002403.
    >> Share

  309. LOUISA SJ, Lin Serene WX, Gollamudi S
    A case of HIV and SARS-CoV-2 co-infection in Singapore.
    J Acquir Immune Defic Syndr. 2020 May 11. doi: 10.1097/QAI.0000000000002401.
    >> Share

  310. PEREIRA B, Mazzitelli M, Milinkovic A, Moyle G, et al
    Use of Coronary Artery Calcium Scoring to improve cardiovascular risk stratification and guide decisions to start statin therapy in People living with HIV.
    J Acquir Immune Defic Syndr. 2020 May 7. doi: 10.1097/QAI.0000000000002400.
    >> Share

  311. ANSARI AW, Ahmad F, Shankar EM, Kong YY, et al
    Diminished Co-inhibitory Molecule 2B4 expression is Associated with Preserved iNKT cell Phenotype in HIV Long-term Non-progressors.
    J Acquir Immune Defic Syndr. 2020 May 7. doi: 10.1097/QAI.0000000000002399.
    >> Share

  312. HATZENBUEHLER ML, McKetta S, Goldberg N, Sheldon A, et al
    Trends in State Policy Support for Sexual Minorities and HIV-Related Outcomes among Men Who Have Sex with Men in the United States, 2008-2014.
    J Acquir Immune Defic Syndr. 2020 May 7. doi: 10.1097/QAI.0000000000002395.
    >> Share

  313. CREPAZ N, Song R, Lyss S, Hall HI, et al
    Trends in time from HIV diagnosis to first viral suppression following revised U.S. HIV treatment guidelines, 2012-2017.
    J Acquir Immune Defic Syndr. 2020 May 5. doi: 10.1097/QAI.0000000000002398.
    >> Share

  314. FEARON E, Chabata ST, Magutshwa S, Ndori-Mharadze T, et al
    Estimating the population size of female sex workers in Zimbabwe: comparison of estimates obtained using different methods in twenty sites and development of a national-level estimate.
    J Acquir Immune Defic Syndr. 2020 May 5. doi: 10.1097/QAI.0000000000002393.
    >> Share

  315. NEL A, Malherbe M, van Niekerk N, Beksinska M, et al
    Performance of Male Condoms when Used With and Without a Silicone Placebo Vaginal Ring - A Randomized, Crossover Trial.
    J Acquir Immune Defic Syndr. 2020 May 4. doi: 10.1097/QAI.0000000000002397.
    >> Share

  316. KAPOGIANNIS BG, Koenig LJ, Xu J, Mayer KH, et al
    The HIV Continuum of Care for Adolescents and Young Adults Attending 13 Urban US HIV Care Centers of the NICHD-ATN-CDC-HRSA SMILE Collaborative.
    J Acquir Immune Defic Syndr. 2020;84:92-100.
    >> Share

  317. EDELMAN EJ, Li Y, Barry D, Brennan Braden J, et al
    Trajectories of Self-Reported Opioid Use Among Patients With HIV Engaged in Care: Results From a National Cohort Study.
    J Acquir Immune Defic Syndr. 2020;84:26-36.
    >> Share

  318. CLARK E, Royse KE, Dong Y, Chang E, et al
    Stable Incidence and Poor Survival for HIV-Related Burkitt Lymphoma Among the US Veteran Population During the Antiretroviral Era.
    J Acquir Immune Defic Syndr. 2020;84:18-25.
    >> Share

    April 2020
  319. DE ALMEIDA SM, Ribeiro CE, Tang B, de Pereira AP, et al
    Neurocytoskeleton proteins in cerebrospinal fluid of people with HIV-1 subtypes B and C.
    J Acquir Immune Defic Syndr. 2020 Apr 27. doi: 10.1097/QAI.0000000000002389.
    >> Share

  320. SUN-SUSLOW N, Paolillo EW, Morgan EE, Letendre S, et al
    Frailty and HIV disease severity synergistically increase risk of HIV-associated Neurocognitive Disorders.
    J Acquir Immune Defic Syndr. 2020 Apr 27. doi: 10.1097/QAI.0000000000002391.
    >> Share

  321. LEE SA, Telwatte S, Hatano H, Kashuba ADM, et al
    Antiretroviral Therapy Concentrations Differ in Gut vs. Lymph Node Tissues and Are Associated With HIV Viral Transcription by a Novel RT-ddPCR Assay.
    J Acquir Immune Defic Syndr. 2020;83:530-537.
    >> Share

  322. ANDRASIK MP, Sesay FA, Isaacs A, Oseso L, et al
    Social Impacts among Participants in HIV Vaccine Trial Network (HVTN) preventive HIV vaccine trials.
    J Acquir Immune Defic Syndr. 2020 Apr 15. doi: 10.1097/QAI.0000000000002369.
    >> Share

  323. ZHANG W, Hu Q, Tang W, Jin X, et al
    HIV self-testing programs to men who have sex with men delivered by social media key opinion leaders and community-based organizations are both effective and complementary: a national pragmatic study in China.
    J Acquir Immune Defic Syndr. 2020 Apr 14. doi: 10.1097/QAI.0000000000002375.
    >> Share

  324. NAUGLE DA, Dosso A, Tibbels NJ, Van Lith LM, et al
    Addressing uptake of HIV testing and linkage to care among men in Cote d'Ivoire: An evaluation of the Brothers for Life program implementation.
    J Acquir Immune Defic Syndr. 2020 Apr 14. doi: 10.1097/QAI.0000000000002379.
    >> Share

  325. WANSOM T, Pinyakorn S, Kolsteeg CJ, Kroon ED, et al
    Group sex and methamphetamine use fuel an explosive epidemic of Hepatitis C among HIV-infected men who have sex with men in Bangkok, Thailand.
    J Acquir Immune Defic Syndr. 2020 Apr 9. doi: 10.1097/QAI.0000000000002356.
    >> Share

  326. LAVERGNE S, Umlauf A, McCutchan A, Heaton R, et al
    Impact of Latent Tuberculosis Infection on Neurocognitive Functioning and Inflammation in HIV-Infected and Uninfected South Indians.
    J Acquir Immune Defic Syndr. 2020 Apr 9. doi: 10.1097/QAI.0000000000002368.
    >> Share

  327. NYIRENDA M, Ngongondo M, Kang M, Umbleja T, et al
    Early progression and immune reconstitution inflammatory syndrome during treatment of mild-to-moderate Kaposi sarcoma in sub-Saharan Africa and South America: Incidence, long-term outcomes and effects of early chemotherapy.
    J Acquir Immune Defic Syndr. 2020 Apr 4. doi: 10.1097/QAI.0000000000002361.
    >> Share


  328. Characteristics and Care Outcomes Among Persons Living With Perinatally Acquired HIV Infection in the United States, 2015: Erratum.
    J Acquir Immune Defic Syndr. 2020;83:e28.
    >> Share


  329. Should Urine-LAM Tests Be Used in TB Symptomatic HIV-Positive Patients When No CD4 Count Is Available? A Prospective Observational Cohort Study From Malawi: Erratum.
    J Acquir Immune Defic Syndr. 2020;83:e28.
    >> Share

  330. CASTILHO JL, Rebeiro PF, Shepherd BE, Nash R, et al
    Mood Disorders and Increased Risk of Noncommunicable Disease in Adults With HIV.
    J Acquir Immune Defic Syndr. 2020;83:397-404.
    >> Share

  331. VAUGHAN J, Perner Y, McAlpine E, Wiggill T, et al
    Brief Report: HIV-Associated Hodgkin Lymphoma Involving the Bone Marrow Identifies a Very High-Risk Subpopulation in the Era of Widescale Antiretroviral Therapy Use in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2020;83:345-349.
    >> Share

  332. CROCKETT KB, Entler KJ, Brodie E, Kempf MC, et al
    Brief Report: Linking Depressive Symptoms to Viral Nonsuppression Among Women With HIV Through Adherence Self-Efficacy and ART Adherence.
    J Acquir Immune Defic Syndr. 2020;83:340-344.
    >> Share

  333. PAUL RH, Cho KS, Luckett PM, Strain JF, et al
    Machine learning analysis reveals novel neuroimaging and clinical signatures of frailty in HIV.
    J Acquir Immune Defic Syndr. 2020 Apr 1. doi: 10.1097/QAI.0000000000002360.
    >> Share

    March 2020
  334. KAPLAN A, Simon TG, Henson JB, Wang T, et al
    Relationship between Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease in Persons with HIV.
    J Acquir Immune Defic Syndr. 2020 Mar 31. doi: 10.1097/QAI.0000000000002359.
    >> Share

  335. KAPETANOVIC S, Norato G, Nair G, Julnes PS, et al
    Effect of HIV and Interpersonal Trauma on Cortical Thickness, Cognition, and Daily Functioning.
    J Acquir Immune Defic Syndr. 2020 Mar 30. doi: 10.1097/QAI.0000000000002358.
    >> Share

  336. O'HALLORAN JA, Sahrmann J, Butler AM, Olsen MA, et al
    Integrase Strand Transfer Inhibitors are associated with lower risk of incident Cardiovascular Disease in People Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Mar 25. doi: 10.1097/QAI.0000000000002357.
    >> Share

  337. RAMIREZ-MARRERO FA, Perez-Frontera S, Amalbert-Birriel MA, Matos M, et al
    Effects of low volume high intensity interval training in Hispanic HIV+ Women: a non-randomized study.
    J Acquir Immune Defic Syndr. 2020 Mar 20. doi: 10.1097/QAI.0000000000002353.
    >> Share

  338. CATTANEO D, Riva A, Columpsi P, Lapadula G, et al
    Dosing of dolutegravir in TB/HIV co-infected patients on rifampicin: twice is (always) better than once.
    J Acquir Immune Defic Syndr. 2020 Mar 19. doi: 10.1097/QAI.0000000000002352.
    >> Share

  339. KAMITANI E, Johnson WD, Wichser ME, Adegbite AH, et al
    Growth in proportion and disparities of HIV PrEP use among key populations identified in the United States national goals: systematic review & meta-analysis of published surveys.
    J Acquir Immune Defic Syndr. 2020 Mar 19. doi: 10.1097/QAI.0000000000002345.
    >> Share

  340. LALLEMANT M, Amzal B, Sripan P, Urien S, et al
    Perinatal antiretroviral intensification to prevent intrapartum HIV transmission when antenatal antiretroviral therapy is initiated less than 8 weeks prior to delivery.
    J Acquir Immune Defic Syndr. 2020 Mar 19. doi: 10.1097/QAI.0000000000002350.
    >> Share

  341. DAS S, Allston A, Kharfen M
    Detecting spatial cores and temporal trends of repeat STIs to plan Pre-Exposure Prophylaxis (PrEP) scale-up in DC.
    J Acquir Immune Defic Syndr. 2020 Mar 19. doi: 10.1097/QAI.0000000000002348.
    >> Share

  342. KOSTEV K
    Sex Differences in People Aging with HIV in Germany.
    J Acquir Immune Defic Syndr. 2020 Mar 19. doi: 10.1097/QAI.0000000000002349.
    >> Share

  343. OYARO P, Kwena Z, Bukusi EA, Baeten JM, et al
    Is HIV self-testing a strategy to increase repeat testing among pregnant and postpartum women? A pilot mixed methods study.
    J Acquir Immune Defic Syndr. 2020 Mar 19. doi: 10.1097/QAI.0000000000002347.
    >> Share

  344. PAOLILLO EW, Pasipanodya EC, Moore RC, Pence BW, et al
    Cumulative Burden of Depression and Neurocognitive Decline among Persons with HIV: A Longitudinal Study.
    J Acquir Immune Defic Syndr. 2020 Mar 16. doi: 10.1097/QAI.0000000000002346.
    >> Share

  345. DAVEY S, Ajibola G, Maswabi K, Sakoi M, et al
    Mother-to-Child HIV Transmission with in utero Dolutegravir vs. Efavirenz in Botswana.
    J Acquir Immune Defic Syndr. 2020 Mar 16. doi: 10.1097/QAI.0000000000002338.
    >> Share

  346. HENSEN B, Schaap AJ, Mulubwa C, Floyd S, et al
    Who accepts and who uses community-based secondary distribution HIV self-testing (HIVST) kits? Findings from the intervention arm of a cluster-randomised trial of HIVST distribution nested in four HPTN 071 (PopART) communities in Zambia.
    J Acquir Immune Defic Syndr. 2020 Mar 13. doi: 10.1097/QAI.0000000000002344.
    >> Share

  347. SPINELLI MA, Rodrigues WC, Wang G, Vincent M, et al
    HIGH ACCURACY OF A REAL-TIME URINE ANTIBODY-BASED TENOFOVIR POINT-OF-CARE TEST COMPARED TO LABORATORY-BASED ELISA IN DIVERSE POPULATIONS.
    J Acquir Immune Defic Syndr. 2020 Mar 10. doi: 10.1097/QAI.0000000000002322.
    >> Share

  348. SEWELL WC, Powell VE, Mayer KH, Ochoa A, et al
    Non-Daily Use of HIV Preexposure Prophylaxis in a Large Online Survey of Primarily Men Who Have Sex with Men in the U.S.
    J Acquir Immune Defic Syndr. 2020 Mar 9. doi: 10.1097/QAI.0000000000002332.
    >> Share

  349. KORTE JE, Kisa R, Vrana-Diaz CJ, Malek AM, et al
    HIV oral self-testing for male partners of women attending antenatal care in central Uganda: uptake and linkage to care post-test in a randomized trial.
    J Acquir Immune Defic Syndr. 2020 Mar 9. doi: 10.1097/QAI.0000000000002341.
    >> Share

  350. NELSON KM, Perry NS, Stout CD, Carey MP, et al
    Sexual debut among 14-17-year-old sexual minority males: A preliminary investigation of early HIV risk and sexual health needs.
    J Acquir Immune Defic Syndr. 2020 Mar 6. doi: 10.1097/QAI.0000000000002342.
    >> Share

  351. SILHOL R, Boily MC, Dimitrov D, German D, et al
    Understanding the HIV epidemic among MSM in Baltimore: a modelling study estimating the impact of past HIV interventions and who acquired and contributed to infections.
    J Acquir Immune Defic Syndr. 2020 Mar 3. doi: 10.1097/QAI.0000000000002340.
    >> Share

  352. PHILBIN MM, Parish C, Kinnard EN, Reed SE, et al
    A multi-site study of women living with HIV's perceived barriers to, and interest in, long-acting injectable anti-retroviral therapy.
    J Acquir Immune Defic Syndr. 2020 Mar 2. doi: 10.1097/QAI.0000000000002337.
    >> Share

  353. SHIAU S, Yin MT, Strehlau R, Burke M, et al
    Deficits in bone architecture and strength in children living with HIV on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2020 Mar 2. doi: 10.1097/QAI.0000000000002309.
    >> Share

  354. VOGELZANG M, Terris-Prestholt F, Vickerman P, Delany-Moretlwe S, et al
    The cost-effectiveness of HIV pre-exposure prophylaxis among heterosexual men in South Africa: a cost-utility modelling analysis.
    J Acquir Immune Defic Syndr. 2020 Mar 2. doi: 10.1097/QAI.0000000000002327.
    >> Share

  355. SAJDEYA R, Cook RL
    Need to Improve Dose Measurements in Studies of Marijuana Use for Pain.
    J Acquir Immune Defic Syndr. 2020;83:e23.
    >> Share

  356. BRANAS F, Sanchez-Conde M, Carli F, Menozzi M, et al
    Sex Differences in People Aging With HIV.
    J Acquir Immune Defic Syndr. 2020;83:284-291.
    >> Share

  357. MOLINARO M, Sacktor N, Nakigozi G, Anok A, et al
    Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder.
    J Acquir Immune Defic Syndr. 2020;83:278-283.
    >> Share

  358. ATTIA EF, Bhatraju PK, Triplette M, Kosamo S, et al
    Endothelial Activation, Innate Immune Activation, and Inflammation Are Associated With Postbronchodilator Airflow Limitation and Obstruction Among Adolescents Living With HIV.
    J Acquir Immune Defic Syndr. 2020;83:267-277.
    >> Share

    February 2020
  359. GORI A, Antinori A, Vergori A, Cossu MV, et al
    Effectiveness of switching to darunavir/cobicistat in virologically-suppressed HIV-positive patients receiving ritonavir-boosted protease inhibitor-based regimen: the "STORE" Study.
    J Acquir Immune Defic Syndr. 2020 Feb 24. doi: 10.1097/QAI.0000000000002331.
    >> Share

  360. FATTI G, Ngorima-Mabhena N, Mothibi E, Muzenda T, et al
    Outcomes of Three versus Six-Monthly Dispensing of Antiretroviral Treatment (ART) for Stable HIV Patients in Community ART Refill Groups: A Cluster-Randomized Trial in Zimbabwe.
    J Acquir Immune Defic Syndr. 2020 Feb 21. doi: 10.1097/QAI.0000000000002333.
    >> Share

  361. GILLIS JL, Grennan T, Grewal R, Ogilvie G, et al
    Racial disparities in anal cancer screening among men living with HIV: findings from a clinical cohort study.
    J Acquir Immune Defic Syndr. 2020 Feb 21. doi: 10.1097/QAI.0000000000002335.
    >> Share

  362. HERSBERGER M, Schlaepfer E, Buehler M, Bochud PY, et al
    Polymorphisms of SOCS-1 are associated with rapid HIV progression rate.
    J Acquir Immune Defic Syndr. 2020 Feb 21. doi: 10.1097/QAI.0000000000002319.
    >> Share

  363. STABELL AC, Wilson M, Jankowski CM, MaWhinney S, et al
    The Impact of a Structured, Supervised Exercise Program on Daily Step Count in Sedentary Older Adults With and Without HIV.
    J Acquir Immune Defic Syndr. 2020 Feb 20. doi: 10.1097/QAI.0000000000002326.
    >> Share

  364. TAYLOR K, Lamb M, Lahuerta M, Ahoua L, et al
    Patterns and Predictors of HIV Status Disclosure in the 12 Months Following Diagnosis in Mozambique.
    J Acquir Immune Defic Syndr. 2020 Feb 20. doi: 10.1097/QAI.0000000000002334.
    >> Share

  365. SHUTER J, Kim RS, Durant S, Stanton CA, et al
    Long-term follow-up of smokers living with HIV after an intensive behavioral tobacco treatment intervention.
    J Acquir Immune Defic Syndr. 2020 Feb 14. doi: 10.1097/QAI.0000000000002330.
    >> Share

  366. PUTTKAMMER N, Parrish C, Desir Y, Hyppolite N, et al
    Toward Universal HIV Treatment in Haiti: Time Trends in ART Retention Following Expanded ART Eligibility in a National Cohort from 2011-17.
    J Acquir Immune Defic Syndr. 2020 Feb 14. doi: 10.1097/QAI.0000000000002329.
    >> Share

  367. CHIKANDIWA A, Faust H, Chersich MF, Mayaud P, et al
    Human papillomavirus seroprevalence and seroconversion among men living with HIV: Cohort study in South Africa.
    J Acquir Immune Defic Syndr. 2020 Feb 14. doi: 10.1097/QAI.0000000000002328.
    >> Share

  368. WELTY S, Motoku J, Muriithi C, Rice B, et al
    RECENT HIV INFECTION SURVEILLANCE IN ROUTINE HIV TESTING IN NAIROBI, KENYA: A FEASIBILITY STUDY.
    J Acquir Immune Defic Syndr. 2020 Feb 13. doi: 10.1097/QAI.0000000000002317.
    >> Share

  369. ATKINS D, Wagner AD, Zhang J, Njuguna IN, et al
    Use of the Consolidated Framework for Implementation Research (CFIR) to Characterize Healthcare Workers' Perspectives on Financial Incentives to Increase Pediatric HIV Testing.
    J Acquir Immune Defic Syndr. 2020 Feb 10. doi: 10.1097/QAI.0000000000002323.
    >> Share

  370. GODFREY C, Hughes MD, Ritz J, Coelho L, et al
    SEX DIFFERENCES IN OUTCOMES FOR INDIVIDUALS PRESENTING FOR THIRD-LINE ANTIRETROVIRAL THERAPY.
    J Acquir Immune Defic Syndr. 2020 Feb 10. doi: 10.1097/QAI.0000000000002324.
    >> Share

  371. PAINTSIL E, Kyriakides TC, Antwi S, Renner L, et al
    Clinic-Based Pediatric Disclosure Intervention Trial Improves Pediatric HIV Status Disclosure in Ghana.
    J Acquir Immune Defic Syndr. 2020 Feb 10. doi: 10.1097/QAI.0000000000002316.
    >> Share

  372. HAWKS LC, McGinnis KA, Howell BA, Khan MR, et al
    Frequency and duration of incarceration and mortality among US Veterans with and without HIV.
    J Acquir Immune Defic Syndr. 2020 Feb 10. doi: 10.1097/QAI.0000000000002325.
    >> Share

  373. JUMARE J, Akolo C, Ndembi N, Bwala S, et al
    Elevated Plasma Levels of sCD14 and MCP-1 are associated with HIV Associated Neurocognitive Disorders among Antiretroviral Naive Individuals in Nigeria.
    J Acquir Immune Defic Syndr. 2020 Feb 7. doi: 10.1097/QAI.0000000000002320.
    >> Share

  374. CRAW JA, Beer L, Tie Y, Jaenicke T, et al
    Viral rebound among persons with diagnosed HIV who achieved viral suppression, United States.
    J Acquir Immune Defic Syndr. 2020 Feb 7. doi: 10.1097/QAI.0000000000002321.
    >> Share

  375. JAO J, Kacanek D, Yu W, Williams PL, et al
    Neurodevelopment of HIV-Exposed Uninfected Infants Born to Women with Perinatally-Acquired HIV in the United States.
    J Acquir Immune Defic Syndr. 2020 Feb 5. doi: 10.1097/QAI.0000000000002318.
    >> Share

  376. KEEN P, Hammoud MA, Bourne A, Bavinton BR, et al
    Use of HIV Pre-exposure Prophylaxis (PrEP) Associated With Lower HIV Anxiety Among Gay and Bisexual Men in Australia Who Are at High Risk of HIV Infection: Results From the Flux Study.
    J Acquir Immune Defic Syndr. 2020;83:119-125.
    >> Share


  377. A Meta-analysis Assessing Diarrhea and Pneumonia in HIV-Exposed Uninfected Compared With HIV-Unexposed Uninfected Infants and Children: Erratum.
    J Acquir Immune Defic Syndr. 2020;83:e13-e14.
    >> Share


  378. Using Interrupted Time Series Analysis to Measure the Impact of Legalized Syringe Exchange on HIV Diagnoses in Baltimore and Philadelphia: Erratum.
    J Acquir Immune Defic Syndr. 2020;83:e12.
    >> Share

  379. LIPPMAN SA, West R, Gomez-Olive FX, Leslie HH, et al
    Treatment as Prevention-Provider Knowledge and Counseling Lag Behind Global Campaigns.
    J Acquir Immune Defic Syndr. 2020;83:e9-e12.
    >> Share

  380. ARYA M, Marren RE, Marek HG, Pasalar S, et al
    Success of Supplementing National HIV Testing Recommendations With a Local Initiative in a Large Health Care System in the U.S. South.
    J Acquir Immune Defic Syndr. 2020;83:e6-e9.
    >> Share

  381. QIN S, Vodovotz L, Zamora R, Fitzpatrick M, et al
    Association Between Inflammatory Pathways and Phenotypes of Pulmonary Dysfunction Using Cluster Analysis in Persons Living With HIV and HIV-Uninfected Individuals.
    J Acquir Immune Defic Syndr. 2020;83:189-196.
    >> Share

  382. WADLEY AL, Lazarus E, Gray GE, Mitchell D, et al
    Pain in Clients Attending a South African Voluntary Counseling and Testing Center Was Frequent and Extensive But Did Not Depend on HIV Status.
    J Acquir Immune Defic Syndr. 2020;83:181-188.
    >> Share

  383. AIZIRE J, Brooks KM, Mirochnick M, Flynn PM, et al
    Antenatal Intracellular Concentrations of Tenofovir Diphosphate and Emtricitabine Triphosphate and Associations Between Tenofovir Diphosphate and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) Trial.
    J Acquir Immune Defic Syndr. 2020;83:173-180.
    >> Share

  384. THOMSEN MT, Wiegandt YL, Gelpi M, Knudsen AD, et al
    Prevalence of and Risk Factors for Low Bone Mineral Density Assessed by Quantitative Computed Tomography in People Living With HIV and Uninfected Controls.
    J Acquir Immune Defic Syndr. 2020;83:165-172.
    >> Share

  385. MILLHAM LRI, Scott JA, Sax PE, Shebl FM, et al
    Clinical and Economic Impact of Ibalizumab for People With Multidrug-Resistant HIV in the United States.
    J Acquir Immune Defic Syndr. 2020;83:148-156.
    >> Share

  386. HUGHES E, Mwebaza N, Huang L, Kajubi R, et al
    Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.
    J Acquir Immune Defic Syndr. 2020;83:140-147.
    >> Share

  387. BUNGE KE, Levy L, Szydlo DW, Zhang J, et al
    Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women.
    J Acquir Immune Defic Syndr. 2020;83:135-139.
    >> Share

  388. BIELLO KB, Goedel WC, Edeza A, Safren SA, et al
    Network-Level Correlates of Sexual Risk Among Male Sex Workers in the United States: A Dyadic Analysis.
    J Acquir Immune Defic Syndr. 2020;83:111-118.
    >> Share

  389. CHOW EPF, Phillips TR, Bradshaw CS, Chen MY, et al
    Brief Report: Sexual Mixing Patterns by HIV Status and PrEP Use Among Men Who Have Sex With Men Partnerships in Melbourne, 2011-2018.
    J Acquir Immune Defic Syndr. 2020;83:99-102.
    >> Share

    January 2020
  390. MCFARLAND W, Wesson P, Turner C, Lin J, et al
    High HIV incidence among young and racial/ethnic minority transgender women in San Francisco: results of a longitudinal cohort study.
    J Acquir Immune Defic Syndr. 2020 Jan 31. doi: 10.1097/QAI.0000000000002315.
    >> Share

  391. GORROD HB, Court R, Schomaker M, Maartens G, et al
    Increased Mortality with Delayed and Missed Switch to Second-Line Antiretroviral Therapy in South Africa.
    J Acquir Immune Defic Syndr. 2020 Jan 31. doi: 10.1097/QAI.0000000000002313.
    >> Share

  392. JACQUELINE H, Landon M, Sarah H, Jean-Paul F, et al
    Cognition, structural brain changes and systemic inflammation in adolescents living with HIV on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2020 Jan 31. doi: 10.1097/QAI.0000000000002314.
    >> Share

  393. MERCURIO V, Fitzgerald W, Molodtsov I, Margolis L, et al
    Persistent immune activation in HIV-1 infected ex vivo model tissues subjected to antiretroviral therapy: Soluble and extracellular vesicle-associated cytokines.
    J Acquir Immune Defic Syndr. 2020 Jan 30. doi: 10.1097/QAI.0000000000002301.
    >> Share

  394. CLARK E, Royse KE, Dong Y, Chang E, et al
    Stable Incidence and Poor Survival for HIV-Related Burkitt Lymphoma Among the U.S. Veteran Population During the Anti-Retroviral Era.
    J Acquir Immune Defic Syndr. 2020 Jan 27. doi: 10.1097/QAI.0000000000002303.
    >> Share

  395. FISK RJ
    Expanding HIV Continuum of Care Analyses: Impacts in the American South and the Roles of Health Insurance and Multiple Substance Use.
    J Acquir Immune Defic Syndr. 2020 Jan 24. doi: 10.1097/QAI.0000000000002307.
    >> Share

  396. STAFFORD KA, Mayer BT, Fulp W, Chua J, et al
    Variability of CD4+ cell counts in HIV-1 uninfected volunteers who are eligible for a Phase I HIV vaccine study.
    J Acquir Immune Defic Syndr. 2020 Jan 24. doi: 10.1097/QAI.0000000000002306.
    >> Share

  397. MORRISON CS, Chen PL, Yamamoto H, Gao X, et al
    Concomitant Imbalances of Systemic and Mucosal Immunity Increase HIV Acquisition Risk.
    J Acquir Immune Defic Syndr. 2020 Jan 23. doi: 10.1097/QAI.0000000000002299.
    >> Share

  398. PANNEER N, France AM, Whiteside YO, Zhang T, et al
    Temporal Changes in HIV Transmission Patterns among Young Men Who Have Sex with Men, United States, 2009-2016.
    J Acquir Immune Defic Syndr. 2020 Jan 17. doi: 10.1097/QAI.0000000000002305.
    >> Share

  399. STIER EA, Abbasi W, Agyemang AF, Valle Alvarez EA, et al
    Recurrence of Anal High-Grade Squamous Intraepithelial Lesions among Women Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 16. doi: 10.1097/QAI.0000000000002304.
    >> Share

  400. ERON J, Hung CC, Baril JG, Slim J, et al
    Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis.
    J Acquir Immune Defic Syndr. 2020 Jan 16. doi: 10.1097/QAI.0000000000002302.
    >> Share

  401. TURNER D, Lockhart E, Wang W, Shore R, et al
    PrEP implementation behaviors of community-based HIV testing staff: A mixed methods approach using latent class analysis.
    J Acquir Immune Defic Syndr. 2020 Jan 13. doi: 10.1097/QAI.0000000000002289.
    >> Share

  402. PHILLIPS G 2ND, Raman AB, Felt D, McCuskey DJ, et al
    PrEP4Love: The Role of Messaging and Prevention Advocacy in PrEP Attitudes, Perceptions, and Uptake Among YMSM and Transgender Women.
    J Acquir Immune Defic Syndr. 2020 Jan 13. doi: 10.1097/QAI.0000000000002297.
    >> Share

  403. WEISS KM, Prasad P, Ramaraju R, Zlotorzynska M, et al
    Estimated Number of Men who have Sex with Men with Indications for HIV Pre-Exposure Prophylaxis in a National Sexual Network Study.
    J Acquir Immune Defic Syndr. 2020 Jan 13. doi: 10.1097/QAI.0000000000002300.
    >> Share

  404. FLAX VL, Kasasa S, Ssendagire S, Lane C, et al
    Using a quality improvement approach in the prevention of mother-to-child HIV transmission program in Uganda improves key outcomes and is sustainable in demonstration facilities: Partnership for HIV-Free Survival.
    J Acquir Immune Defic Syndr. 2020 Jan 13. doi: 10.1097/QAI.0000000000002298.
    >> Share

  405. KAPELIOS CJ, Argyris AA, Protogerou AD, Katsarolis I, et al
    Progression of subclinical vascular damage in people living with HIV is not predicted by current cardiovascular risk scores: a prospective 3-year study.
    J Acquir Immune Defic Syndr. 2020 Jan 8. doi: 10.1097/QAI.0000000000002286.
    >> Share

  406. GREENBERG L, Ryom L, Wandeler G, Grabmeier-Pfistershammer K, et al
    Uptake and discontinuation of integrase inhibitors (INSTIs) in a large cohort setting.
    J Acquir Immune Defic Syndr. 2020 Jan 8. doi: 10.1097/QAI.0000000000002250.
    >> Share

  407. EKE AC, Stek AM, Wang J, Kreitchmann R, et al
    Darunavir pharmacokinetics with an increased dose during pregnancy.
    J Acquir Immune Defic Syndr. 2020 Jan 8. doi: 10.1097/QAI.0000000000002261.
    >> Share

  408. GILLIAMS EA, Ammirati RJ, Nguyen ML, Shahane AA, et al
    Increased Retention in Care after a Palliative Care Referral among People Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 8. doi: 10.1097/QAI.0000000000002296.
    >> Share

  409. MCCLYMONT E, Coutlee F, Lee M, Albert A, et al
    Persistence of Non-Vaccine Oncogenic HPV Genotypes in Quadrivalent HPV-Vaccinated Women Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 8. doi: 10.1097/QAI.0000000000002258.
    >> Share

  410. REEPALU A, Arimide DA, Balcha TT, Bjorkman P, et al
    Interferon-gamma-inducible protein 10 - a potential marker for targeted viral load monitoring of antiretroviral treatment?
    J Acquir Immune Defic Syndr. 2020 Jan 7. doi: 10.1097/QAI.0000000000002292.
    >> Share

  411. SCHROTER J, Anelone AJN, Yates AJ, de Boer RJ, et al
    Time to viral suppression in perinatally HIV-infected infants depends on the viral load and CD4 T-cell percentage at the start of treatment.
    J Acquir Immune Defic Syndr. 2020 Jan 7. doi: 10.1097/QAI.0000000000002291.
    >> Share

  412. PUTHANAKIT T, Ananworanich J, Akapirat S, Pattanachaiwit S, et al
    Pattern and Frequency of Seroreactivity to Routinely Used Serologic Tests in Early Treated Infants with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 7. doi: 10.1097/QAI.0000000000002254.
    >> Share

  413. ATTIA EF, Bhatraju PK, Triplette M, Kosamo S, et al
    Endothelial activation, innate immune activation, and inflammation are associated with post-bronchodilator airflow limitation and obstruction among adolescents living with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 7. doi: 10.1097/QAI.0000000000002255.
    >> Share

  414. STEPHENSON R, Bratcher A, Mimiaga MJ, Garofalo R, et al
    Accuracy in self-report of viral suppression among HIV-positive men with HIV-negative male partners.
    J Acquir Immune Defic Syndr. 2020 Jan 7. doi: 10.1097/QAI.0000000000002240.
    >> Share

  415. MANTOVANI E, Lugoboni F, Federico A, Zipeto D, et al
    Benzodiazepine use and HIV-associated neurocognitive impairment: which comes first?
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002278.
    >> Share

  416. FAZELI PL, Waldrop-Valverde D, Yigit I, Turan B, et al
    An exploratory study of correlates of allostatic load in older people living with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002293.
    >> Share

  417. KING EM, Nesbitt A, Albert AYK, Pick N, et al
    Prolonged Amenorrhea and Low Hip Bone Mineral Density in Women Living with HIV-a Controlled, Cross-Sectional Study.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002282.
    >> Share

  418. KAMKWALALA AR, Wang X, Maki PM, Williams DW, et al
    Higher peripheral monocyte activation markers are associated with smaller frontal and temporal cortical volumes in women with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002283.
    >> Share

  419. WEBEL A, Davey CH, Schexnayder J, Currie J, et al
    The Impact of Perceived Cardiovascular Risk on Cardiovascular Disease Prevention Behaviors in People With and Without HIV Infection.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002290.
    >> Share

  420. MOYO F, Mazanderani AH, Murray T, Technau KG, et al
    Characterizing viral load burden among HIV-infected women around the time of delivery: Findings from four tertiary obstetric units in Gauteng, South Africa.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002267.
    >> Share

  421. SAJDEYA R, Cook RL
    Letter to the editors.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002238.
    >> Share

  422. DE SOCIO GV, Ricci E, Maggi P, Orofino G, et al
    Is it feasible to impact on smoking habits in HIV-Infected patients? Mission impossible from the STOPSHIV Project cohort.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002284.
    >> Share

  423. SUN X, Wang C, Zhao K, Zhang L, et al
    HIV seroconversion and types of relationships among men who have sex with men: A cohort study in China.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002264.
    >> Share

  424. ECKARD AR, Hughes HY, Hagood NL, O'riordan MA, et al
    Fibroblast Growth Factor 21 is Elevated in HIV and Associated with Interleukin-6.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002285.
    >> Share

  425. PATEL F, Thurman C, Liberty A, Burke M, et al
    Negative diagnostic PCR tests in school-aged, HIV-infected children on antiretroviral therapy since early life in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002265.
    >> Share

  426. CARRERO A, Berenguer J, Hontanon V, Navarro J, et al
    Effects of eradication of HCV on cardiovascular risk and preclinical atherosclerosis in HIV/HCV-coinfected patients.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002260.
    >> Share

  427. CLARKE DF, Acosta EP, Cababasay M, Wang J, et al
    Raltegravir (RAL) in neonates: Dosing, pharmacokinetics (PK), and safety in HIV-1 exposed neonates at risk of infection (IMPAACT P1110).
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002294.
    >> Share

  428. KALICHMAN S, Mathews C, Banas E, Kalichman M, et al
    HIV Status Disclosure and Sexual Transmission Risks among People who are Living with HIV and Receiving Treatment for Non-HIV Sexually Transmitted Infections, Cape Town, South Africa.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002256.
    >> Share

  429. HOLT M, Lee E, Lea T, Bavinton B, et al
    HIV pre-exposure prophylaxis cascades to assess implementation in Australia: results from repeated, national behavioural surveillance of gay and bisexual men, 2014-18.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002243.
    >> Share

  430. MAY PE, Heithoff AJ, Wichman CS, Phatak VS, et al
    Assessing Cognitive Functioning in People Living with HIV (PLWH): Factor Analytic Results from CHARTER and NNTC Cohorts.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002252.
    >> Share

  431. ZHANG Q, Yu X, Wu T, Shang H, et al
    Immunological and Virological Responses in Older HIV-Infected Adults Receiving Antiretroviral Therapy: An Evidence-Based Meta-Analysis.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002266.
    >> Share

  432. SHARMA A, Vance DE, Hoover DR, Shi Q, et al
    Impaired Cognition Predicts Falls Among Women with and Without HIV Infection.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002262.
    >> Share

  433. WEBB K, Chitiyo V, Mahachi N, Mukungunugwa SH, et al
    Improving Early Infant Diagnosis Observations: Estimates of timely HIV testing and mortality among HIV-exposed infants.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002263.
    >> Share

  434. FATIMA B, Matilde SC, Federica C, Marianna M, et al
    Sex Difference In People Aging With Hiv.
    J Acquir Immune Defic Syndr. 2020 Jan 4. doi: 10.1097/QAI.0000000000002259.
    >> Share

  435. VAUGHAN J, Perner Y, McAlpine E, Wiggill T, et al
    HIV-associated Hodgkin lymphoma involving the bone marrow identifies a very high risk sub-population in the era of widescale Anti-retroviral therapy use in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002276.
    >> Share

  436. TOPAZIAN HM, Stoner MCD, Edwards JK, Kahn K, et al
    Variations in HIV risk by young women's age and partner age-disparity in rural South Africa (HPTN 068).
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002270.
    >> Share

  437. STANTON CA, Kumar PN, Moadel AB, Cunningham CO, et al
    A multicenter randomized controlled trial of intensive group therapy for tobacco treatment in HIV-infected cigarette smokers.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002271.
    >> Share

  438. NEILAN AM, Lu F, Gebo KA, Diaz-Reyes R, et al
    Higher acuity resource utilization with older age and poorer HIV control in adolescents and young adults in the HIV Research Network.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002280.
    >> Share

  439. JANUS SE, Sullivan C, Morrison J, McComsey GA, et al
    Positron Emission Tomography to Characterize Dorsocervical Fat Pad Hypertrophy in People with Treated HIV Infection.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002273.
    >> Share

  440. CREPAZ N, Dong X, Hess KL, Bosh K, et al
    Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons aged 13-29 years living with diagnosed HIV infection, United States, 2016.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002277.
    >> Share

  441. FEHER C, Plana M, Guardo AC, Climent N, et al
    A classifier to predict viral control after antiretroviral treatment interruption in chronic HIV-1 infected patients.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002281.
    >> Share

  442. CROCKETT KB, Entler KJ, Brodie E, Kempf MC, et al
    Linking Depressive Symptoms to Viral Non-suppression among Women with HIV through Adherence Self-Efficacy and ART Adherence.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002268.
    >> Share

  443. CASTILHO JL, Rebeiro PF, Shepherd BE, Nash R, et al
    Mood disorders and increased risk of non-communicable disease in adults with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002269.
    >> Share

  444. PATHELA P, Jamison K, Blank S, Daskalakis D, et al
    The HIV Pre-exposure Prophylaxis (PrEP) cascade at NYC Sexual Health Clinics: Navigation is the Key to Uptake.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002274.
    >> Share

  445. DANIEL JACOBUS VH, Andre P K, Gary M, Graeme M, et al
    Point-of-care ultrasound predictors for the diagnosis of tuberculosis in HIV-positive patients presenting to an emergency center.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002279.
    >> Share

  446. MILANINI B, Allen I, Paul R, Bahemana E, et al
    Frequency and Predictors of HIV-related Cognitive Impairment in East Africa: The Africa Cohort Study (AFRICOS).
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002242.
    >> Share

  447. LANG R, Krentz HB, Gill MJ
    In Defense of Baseline Genotypic Antiretroviral Resistance Testing.
    J Acquir Immune Defic Syndr. 2020;83:e1-e2.
    >> Share

  448. WELCH JL, Kaddour H, Winchester L, Fletcher CV, et al
    Semen Extracellular Vesicles From HIV-1-Infected Individuals Inhibit HIV-1 Replication In Vitro, and Extracellular Vesicles Carry Antiretroviral Drugs In Vivo.
    J Acquir Immune Defic Syndr. 2020;83:90-98.
    >> Share

  449. GOGOKHIA L, Taur Y, Juluru K, Yagan N, et al
    Intestinal Dysbiosis and Markers of Systemic Inflammation in Viscerally and Generally Obese Persons Living With HIV.
    J Acquir Immune Defic Syndr. 2020;83:81-89.
    >> Share

  450. NORTHROP AJ, Pomeroy LW
    Forecasting Prevalence of HIV-1 Integrase Strand Transfer Inhibitor (INSTI) Drug Resistance: A Modeling Study.
    J Acquir Immune Defic Syndr. 2020;83:65-71.
    >> Share

  451. WATSON CW, Paolillo EW, Morgan EE, Umlauf A, et al
    Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV.
    J Acquir Immune Defic Syndr. 2020;83:56-64.
    >> Share

  452. SMITH JP, Gandhi NR, Shah NS, Mlisana K, et al
    The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events.
    J Acquir Immune Defic Syndr. 2020;83:47-55.
    >> Share

  453. FRYE V, Nandi V, Hirshfield S, Chiasson MA, et al
    Brief Report: Randomized Controlled Trial of an Intervention to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options in New York City (All About Me).
    J Acquir Immune Defic Syndr. 2020;83:31-36.
    >> Share

  454. BROWN LB, Balzer LB, Kabami J, Kwarisiima D, et al
    The Influence of Social Networks on Antiretroviral Therapy Initiation Among HIV-Infected Antiretroviral Therapy-Naive Youth in Rural Kenya and Uganda.
    J Acquir Immune Defic Syndr. 2020;83:9-15.
    >> Share

  455. STARUP-LINDE J, Rosendahl SB, Storgaard M, Langdahl B, et al
    Management of Osteoporosis in Patients Living With HIV-A Systematic Review and Meta-analysis.
    J Acquir Immune Defic Syndr. 2020;83:1-8.
    >> Share

  456. CRAWFORD M, van Wyk J, Aboud M, Vannappagari V, et al
    Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir Use.
    J Acquir Immune Defic Syndr. 2020;83:e2-e5.
    >> Share

  457. FELDACKER C, Murenje V, Holeman I, Xaba S, et al
    Reducing Provider Workload While Preserving Patient Safety: A Randomized Control Trial Using 2-Way Texting for Postoperative Follow-up in Zimbabwe's Voluntary Medical Male Circumcision Program.
    J Acquir Immune Defic Syndr. 2020;83:16-23.
    >> Share

    December 2019
  458. HUANG Y, Zhang Y, Bailer R, Grunenberg N, et al
    Prediction of Serum HIV-1 Neutralization Titers After Passive Administration of VRC01.
    J Acquir Immune Defic Syndr. 2019 Dec 17. doi: 10.1097/QAI.0000000000002272.
    >> Share

  459. DA RESSUREICAO SGNOTTO F, Souza Santos L, Rodrigues de Sousa T, Feitosa de Lima J, et al
    IgG From HIV-1-Exposed Seronegative and HIV-1-Infected Subjects Differently Modulates IFN-gamma Production by Thymic T and B Cells.
    J Acquir Immune Defic Syndr. 2019;82:e56-e60.
    >> Share

  460. REZAHOSSEINI O, Knudsen AD, Gelpi M, Ronit A, et al
    Plasma Cotinine Cutoff for Distinguishing Smokers From Nonsmokers Among Persons Living With HIV.
    J Acquir Immune Defic Syndr. 2019;82:e54-e56.
    >> Share

  461. O'MEARA T, Kong Y, Chiarella J, Price RW, et al
    Exosomal MicroRNAs Associate With Neuropsychological Performance in Individuals With HIV Infection on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2019;82:514-522.
    >> Share

  462. ZAIDAN SM, Leyre L, Bunet R, Larouche-Anctil E, et al
    Upregulation of IL-32 Isoforms in Virologically Suppressed HIV-Infected Individuals: Potential Role in Persistent Inflammation and Transcription From Stable HIV-1 Reservoirs.
    J Acquir Immune Defic Syndr. 2019;82:503-513.
    >> Share

  463. LUCKETT P, Paul RH, Navid J, Cooley SA, et al
    Deep Learning Analysis of Cerebral Blood Flow to Identify Cognitive Impairment and Frailty in Persons Living With HIV.
    J Acquir Immune Defic Syndr. 2019;82:496-502.
    >> Share

  464. SRINIVASA S, Torriani M, Fitch KV, Maehler P, et al
    Brief Report: Adipogenic Expression of Brown Fat Genes in HIV and HIV-Related Parameters.
    J Acquir Immune Defic Syndr. 2019;82:491-495.
    >> Share

  465. DOMINGUEZ-RODRIGUEZ S, Tagarro A, Palma P, Foster C, et al
    Reduced Time to Suppression Among Neonates With HIV Initiating Antiretroviral Therapy Within 7 Days After Birth.
    J Acquir Immune Defic Syndr. 2019;82:483-490.
    >> Share

  466. SALONER R, Grelotti DJ, Tyree G, Sundermann EE, et al
    Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV.
    J Acquir Immune Defic Syndr. 2019;82:475-482.
    >> Share

  467. YEN YF, Lai YJ, Chen YY, Lai HH, et al
    Association of HIV Infection and Antiretroviral Therapy With Sudden Cardiac Death.
    J Acquir Immune Defic Syndr. 2019;82:468-474.
    >> Share

  468. MARSICO F, Lo Vecchio A, Paolillo S, D'Andrea C, et al
    Left Ventricular Function, Epicardial Adipose Tissue, and Carotid Intima-Media Thickness in Children and Adolescents With Vertical HIV Infection.
    J Acquir Immune Defic Syndr. 2019;82:462-467.
    >> Share

  469. VAN WELZEN BJ, Yesilay S, Arends JE, Hoepelman AIM, et al
    Brief Report: Low Sensitivity of the Fracture Risk Assessment Tool in Young HIV-Infected Patients: Time to Revise Our Screening Strategy.
    J Acquir Immune Defic Syndr. 2019;82:439-442.
    >> Share

  470. BARTLETT AW, Lumbiganon P, Jamal Mohamed TA, Lapphra K, et al
    Dual Analysis of Loss to Follow-up for Perinatally HIV-Infected Adolescents Receiving Combination Antiretroviral Therapy in Asia.
    J Acquir Immune Defic Syndr. 2019;82:431-438.
    >> Share

  471. VAN EPPS P, Wilson BM, Garner W, Beste LA, et al
    Brief Report: Incidence of HIV in a Nationwide Cohort Receiving Pre-exposure Prophylaxis for HIV Prevention.
    J Acquir Immune Defic Syndr. 2019;82:427-430.
    >> Share

  472. CAHN P, Madero JS, Arribas JR, Antinori A, et al
    Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials.
    J Acquir Immune Defic Syndr. 2019 Dec 10. doi: 10.1097/QAI.0000000000002275.
    >> Share

  473. RENDINA HJ, Cienfuegos-Szalay J, Talan A, Jones SS, et al
    Growing acceptability of Undetectable = Untransmittable but widespread misunderstanding of transmission risk: Findings from a very large sample of sexual minority men in the United States.
    J Acquir Immune Defic Syndr. 2019 Dec 5. doi: 10.1097/QAI.0000000000002239.
    >> Share

  474. PEEBLES K, van der Straten A, Palanee-Phillips T, Reddy K, et al
    Anal intercourse, HIV-1 risk, and efficacy in a trial of a dapivirine-containing vaginal ring for HIV-1 prevention.
    J Acquir Immune Defic Syndr. 2019 Dec 3. doi: 10.1097/QAI.0000000000002253.
    >> Share

  475. RUBTSOVA AA, Wingood GM, Ofotokun I, Gustafson D, et al
    Prevalence and Correlates of Self-Rated Successful Aging Among Older Women Living With HIV.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S162-S169.
    >> Share

  476. CAPASSO A, DiClemente RJ, Wingood GM
    Pregnancy Coercion as a Risk Factor for HIV and Other Sexually Transmitted Infections Among Young African American Women.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S155-S161.
    >> Share

  477. RUIZ MS, O'Rourke A, Allen ST, Holtgrave DR, et al
    Using Interrupted Time Series Analysis to Measure the Impact of Legalized Syringe Exchange on HIV Diagnoses in Baltimore and Philadelphia.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S148-S154.
    >> Share

  478. DENIS CM, Morales KH, Wu Q, Metzger DS, et al
    Association Between Diagnoses of Chronic Noncancer Pain, Substance Use Disorder, and HIV-Related Outcomes in People Living With HIV.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S142-S147.
    >> Share

  479. BAUERMEISTER JA, Golinkoff JM, Lin WY, Claude KF, et al
    Testing the Testers: Are Young Men Who Have Sex With Men Receiving Adequate HIV Testing and Counseling Services?
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S133-S141.
    >> Share

  480. BROWN LA, Dangerfield DT 2nd, Meanley S, Hickson D, et al
    Increasing Diversity and Capacity in HIV Behavioral and Social Science Research: Reflections and Recommendations From the Inaugural Cohort of the Mid-Atlantic CFAR Consortium (MACC) Scholars Program.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S128-S132.
    >> Share

  481. LIMAYE RJ, Magnus M, Metzger D, Blank MB, et al
    The Mid-Atlantic Center for AIDS Research Consortium Scholars Program: A Multi-Institutional Approach to Mentoring the Next Generation of Underrepresented Scientists.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S124-S127.
    >> Share

  482. VINCENT W, Sevelius J, Lippman SA, Linnemayr S, et al
    Identifying Opportunities for Collaboration Across the Social Sciences to Reach the 10-10-10: A Multilevel Approach.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S118-S123.
    >> Share

  483. MAYER KH, Allan-Blitz LT
    PrEP 1.0 and Beyond: Optimizing a Biobehavioral Intervention.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S113-S117.
    >> Share

  484. BRAULT MA, Spiegelman D, Hargreaves J, Nash D, et al
    Treatment as Prevention: Concepts and Challenges for Reducing HIV Incidence.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S104-S112.
    >> Share

  485. AUERBACH JD
    Getting to Zero Begins With Getting to Ten.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S99-S103.
    >> Share

  486. KELLY JA
    Ten Things We Need to Do to Achieve the Goals of the End the HIV Epidemic Plan for America.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S94-S98.
    >> Share

  487. COATES TJ
    The Fight Against HIV Is a Fight for Human Rights: A Personal Reflection.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S91-S93.
    >> Share

  488. NEWCOMER SF
    Response to the HIV Epidemic: Perspectives From a Retired NIH Project Officer.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S88-S90.
    >> Share

  489. GOODENOW MM, Gaist P
    Importance of HIV/AIDS-Related Behavioral and Social Sciences Research at the NIH and Beyond.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S84-S87.
    >> Share

  490. BLANK MB, Metzger DS, Wingood GM, DiClemente RJ, et al
    The Social and Behavioral Sciences Research Network: Shaping a Contemporary Agenda for Research in HIV.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S81-S83.
    >> Share

  491. SEMITALA FC, Cattamanchi A, Andama A, Atuhumuza E, et al
    Brief Report: Yield and Efficiency of Intensified Tuberculosis Case-Finding Algorithms in 2 High-Risk HIV Subgroups in Uganda.
    J Acquir Immune Defic Syndr. 2019;82:416-420.
    >> Share

  492. MCCARTHY SDS, Leontyev D, Nicoletti P, Binnington B, et al
    Targeting ABL1 or ARG Tyrosine Kinases to Restrict HIV-1 Infection in Primary CD4+ T-Cells or in Humanized NSG Mice.
    J Acquir Immune Defic Syndr. 2019;82:407-415.
    >> Share

  493. OSETINSKY B, Genberg BL, Bloomfield GS, Hogan J, et al
    Hypertension Control and Retention in Care Among HIV-Infected Patients: The Effects of Co-located HIV and Chronic Noncommunicable Disease Care.
    J Acquir Immune Defic Syndr. 2019;82:399-406.
    >> Share

  494. CLARKE DF, Mirochnick M, Acosta EP, Capparelli E, et al
    Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110.
    J Acquir Immune Defic Syndr. 2019;82:392-398.
    >> Share

  495. MUSINGUZI N, Castillo-Mancilla J, Morrow M, Byakwaga H, et al
    Antiretroviral Therapy Adherence Interruptions Are Associated With Systemic Inflammation Among Ugandans Who Achieved Viral Suppression.
    J Acquir Immune Defic Syndr. 2019;82:386-391.
    >> Share

  496. MUCCINI C, Galli L, Spagnuolo V, Poli A, et al
    Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals.
    J Acquir Immune Defic Syndr. 2019;82:373-376.
    >> Share

  497. TRUONG HM, Akama E, Guze MA, Otieno F, et al
    Implementation of a Community-Based Hybrid HIV Testing Services Program as a Strategy to Saturate Testing Coverage in Western Kenya.
    J Acquir Immune Defic Syndr. 2019;82:362-367.
    >> Share

  498. KASAMBA I, Nash S, Shahmanesh M, Baisley K, et al
    Missed Study Visits and Subsequent HIV Incidence Among Women in a Predominantly Sex Worker Cohort Attending a Dedicated Clinic Service in Kampala, Uganda.
    J Acquir Immune Defic Syndr. 2019;82:343-354.
    >> Share

  499. CASTOR D, Kimmel AL, McFall A, Padian N, et al
    Employing the Payback Framework to Assess Implementation Science Research Utilization: Lessons From the USAID's PEPFAR HIV/AIDS Implementation Science Awards.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S348-S356.
    >> Share

  500. ROBERTS DA, Tan N, Limaye N, Irungu E, et al
    Cost of Differentiated HIV Antiretroviral Therapy Delivery Strategies in Sub-Saharan Africa: A Systematic Review.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S339-S347.
    >> Share

  501. PACKEL L, Fahey C, Njau P, McCoy SI, et al
    Implementation Science Using Proctor's Framework and an Adaptation of the Multiphase Optimization Strategy: Optimizing a Financial Incentive Intervention for HIV Treatment Adherence in Tanzania.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S332-S338.
    >> Share

  502. WAGNER AD, Gimbel S, Asbjornsdottir KH, Cherutich P, et al
    Cascade Analysis: An Adaptable Implementation Strategy Across HIV and Non-HIV Delivery Platforms.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S322-S331.
    >> Share

  503. SALOMON JA
    Integrating Economic Evaluation and Implementation Science to Advance the Global HIV Response.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S314-S321.
    >> Share

  504. STEWART J, Salas-Brooks J, Kelly B
    Implementation of HIV Interventions Into Faith-Based Organizations: Models and Methodological Considerations.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S305-S313.
    >> Share

  505. HARGREAVES J, Dalal S, Rice B, Anderegg N, et al
    Repositioning Implementation Science in the HIV Response: Looking Ahead From AIDS 2018.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S299-S304.
    >> Share

  506. DONENBERG GR, Cohen MH, Ingabire C, Fabri M, et al
    Applying the Exploration Preparation Implementation Sustainment (EPIS) Framework to the Kigali Imbereheza Project for Rwandan Adolescents Living With HIV.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S289-S298.
    >> Share

  507. CZARNOGORSKI M
    Using Implementation Science to Better Integrate Novel Long-Acting Injectable Therapy Into Routine HIV Care.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S286-S288.
    >> Share

  508. DOMBROWSKI JC, Irvine M, Nash D, Harriman G, et al
    Public Health Practice-Driven Research to Improve HIV Prevention in the United States.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S279-S285.
    >> Share

  509. WU D, Ong JJ, Tang W, Ritchwood TD, et al
    Crowdsourcing Methods to Enhance HIV and Sexual Health Services: A Scoping Review and Qualitative Synthesis.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S271-S278.
    >> Share

  510. HARGREAVES JR, Hassan S, Schellenberg J, Hayes R, et al
    Five Challenges in the Design and Conduct of IS Trials for HIV Prevention and Treatment.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S261-S270.
    >> Share

  511. GROV C, Westmoreland D, Rendina HJ, Nash D, et al
    Seeing Is Believing? Unique Capabilities of Internet-Only Studies as a Tool for Implementation Research on HIV Prevention for Men Who Have Sex With Men: A Review of Studies and Methodological Considerations.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S253-S260.
    >> Share

  512. HARLING G, Tsai AC
    Using Social Networks to Understand and Overcome Implementation Barriers in the Global HIV Response.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S244-S252.
    >> Share

  513. BERES LK, Simbeza S, Holmes CB, Mwamba C, et al
    Human-Centered Design Lessons for Implementation Science: Improving the Implementation of a Patient-Centered Care Intervention.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S230-S243.
    >> Share

  514. MINNIS AM, Montgomery ET, Napierala S, Browne EN, et al
    Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S222-S229.
    >> Share

  515. WARE NC
    Qualitative Contributions to Implementation Research on HIV Prevention and Treatment.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S217-S221.
    >> Share

  516. SCHWARTZ SR, Rao A, Rucinski KB, Lyons C, et al
    HIV-Related Implementation Research for Key Populations: Designing for Individuals, Evaluating Across Populations, and Integrating Context.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S206-S216.
    >> Share

  517. MEHROTRA ML, Petersen ML, Geng EH
    Understanding HIV Program Effects: A Structural Approach to Context Using the Transportability Framework.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S199-S205.
    >> Share

  518. SOHAIL M, Rastegar J, Long D, Rana A, et al
    Data for Care (D4C) Alabama: Clinic-Wide Risk Stratification With Enhanced Personal Contacts for Retention in HIV Care via the Alabama Quality Management Group.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S192-S198.
    >> Share

  519. BOR J, Thirumurthy H
    Bridging the Efficacy-Effectiveness Gap in HIV Programs: Lessons From Economics.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S183-S191.
    >> Share

  520. BUCHBINDER SP, Havlir DV
    Getting to Zero San Francisco: A Collective Impact Approach.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S176-S182.
    >> Share

  521. GENG E, Hargreaves J, Peterson M, Baral S, et al
    Implementation Research to Advance the Global HIV Response: Introduction to the JAIDS Supplement.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S173-S175.
    >> Share

  522. EISINGER RW, Dieffenbach CW, Fauci AS
    Role of Implementation Science: Linking Fundamental Discovery Science and Innovation Science to Ending the HIV Epidemic at the Community Level.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S171-S172.
    >> Share

    November 2019
  523. FOURMAN LT, Pan CS, Zheng I, Gerard ME, et al
    Association of In Utero HIV Exposure with Obesity and Reactive Airway Disease in HIV-Negative Adolescents and Young Adults.
    J Acquir Immune Defic Syndr. 2019 Nov 14. doi: 10.1097/QAI.0000000000002235.
    >> Share

  524. PHILLIPS TK, Mogoba P, Brittain K, Gomba Y, et al
    Long-term outcomes of HIV-infected women receiving antiretroviral therapy after transferring out of an integrated maternal and child health service in South Africa.
    J Acquir Immune Defic Syndr. 2019 Nov 8. doi: 10.1097/QAI.0000000000002236.
    >> Share

  525. YAMAGUCHI J, McArthur C, Vallari A, Sthreshley L, et al
    Complete genome sequence of CG-0018a-01 establishes HIV-1 subtype L.
    J Acquir Immune Defic Syndr. 2019 Nov 6. doi: 10.1097/QAI.0000000000002246.
    >> Share

  526. RANGANATHAN M, Kilburn K, Stoner MCD, Hughes JP, et al
    The mediating role of partner selection in the association between transactional sex and HIV incidence among young women.
    J Acquir Immune Defic Syndr. 2019 Nov 6. doi: 10.1097/QAI.0000000000002225.
    >> Share

  527. KITYO C, Hagins D, Koenig E, Avihingsanon A, et al
    Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial.
    J Acquir Immune Defic Syndr. 2019;82:321-328.
    >> Share

  528. LODI S, Gunthard HF, Gill J, Phillips AN, et al
    Effectiveness of Transmitted Drug Resistance Testing Before Initiation of Antiretroviral Therapy in HIV-Positive Individuals.
    J Acquir Immune Defic Syndr. 2019;82:314-320.
    >> Share

  529. SALVATORE P, Johnson K, Vojnov L, Doherty M, et al
    Clinical Consequences of Using an Indeterminate Range for Early Infant Diagnosis of HIV: A Decision Model.
    J Acquir Immune Defic Syndr. 2019;82:287-296.
    >> Share

  530. LUO R, Boeras D, Broyles LN, Fong Y, et al
    Use of an Indeterminate Range in HIV Early Infant Diagnosis: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2019;82:281-286.
    >> Share

  531. DIRAJLAL-FARGO S, Yu J, Kulkarni M, Sattar A, et al
    Brief Report: Zinc Supplementation and Inflammation in Treated HIV.
    J Acquir Immune Defic Syndr. 2019;82:275-280.
    >> Share

  532. GILBERT HN, Wyatt MA, Pisarski EE, Muwonge TR, et al
    PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
    J Acquir Immune Defic Syndr. 2019;82:265-274.
    >> Share

    October 2019
  533. HOFFMAN RM, Warshaw MG, Amico KR, Pilotto J, et al
    Predictors of Viremia in Postpartum Women on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2019 Oct 22. doi: 10.1097/QAI.0000000000002228.
    >> Share

  534. HUERGA H, Mathabire Rucker SC, Bastard M, Dimba A, et al
    Should urine-LAM tests be used in TB symptomatic HIV-positive patients when no CD4 count is available? A prospective observational cohort study from Malawi.
    J Acquir Immune Defic Syndr. 2019 Oct 16. doi: 10.1097/QAI.0000000000002206.
    >> Share

  535. ORTBLAD KF, Musoke DK, Chanda MM, Ngabirano T, et al
    Knowledge of HIV status is associated with a decrease in the severity of depressive symptoms among female sex workers in Uganda and Zambia.
    J Acquir Immune Defic Syndr. 2019 Oct 16. doi: 10.1097/QAI.0000000000002224.
    >> Share

  536. RB-SILVA R, Goios A, Kelly C, Teixeira P, et al
    Definition of Immunological Non-Response to Antiretroviral Therapy: a Systematic Review.
    J Acquir Immune Defic Syndr. 2019 Oct 4. doi: 10.1097/QAI.0000000000002157.
    >> Share

  537. DEGUIT CDT, Hough M, Hoh R, Krone M, et al
    Some Aspects of CD8+ T Cell Exhaustion are Associated with Altered T Cell Mitochondrial Features and ROS content in HIV Infection.
    J Acquir Immune Defic Syndr. 2019 Oct 3. doi: 10.1097/QAI.0000000000002121.
    >> Share

  538. MERLIN JS, Samet JH, Cheng DM, Lira MC, et al
    Marijuana Use and Its Associations With Pain, Opioid Dose, and HIV Viral Suppression Among Persons Living With HIV on Chronic Opioid Therapy.
    J Acquir Immune Defic Syndr. 2019;82:195-201.
    >> Share

  539. MADDALI MV, Mehtani NJ, Converse C, Kapoor S, et al
    Development and Validation of HIV-ASSIST, an Online, Educational, Clinical Decision Support Tool to Guide Patient-Centered ARV Regimen Selection.
    J Acquir Immune Defic Syndr. 2019;82:188-194.
    >> Share

  540. KERRIGAN D, Mbwambo J, Likindikoki S, Davis W, et al
    Project Shikamana: Community Empowerment-Based Combination HIV Prevention Significantly Impacts HIV Incidence and Care Continuum Outcomes Among Female Sex Workers in Iringa, Tanzania.
    J Acquir Immune Defic Syndr. 2019;82:141-148.
    >> Share

  541. CHRISTOPOULOS KA, Neilands TB, Hartogensis W, Geng EH, et al
    Internalized HIV Stigma Is Associated With Concurrent Viremia and Poor Retention in a Cohort of US Patients in HIV Care.
    J Acquir Immune Defic Syndr. 2019;82:116-123.
    >> Share


  542. Chronic Distal Sensory Polyneuropathy Is a Major Contributor to Balance Disturbances in Persons Living With HIV: Erratum.
    J Acquir Immune Defic Syndr. 2019;82:e43.
    >> Share


  543. "Impact of HIV Self-Test Distribution to Male Partners of ANC Clients: Results of a Randomized Controlled Trial in Kenya: Erratum".
    J Acquir Immune Defic Syndr. 2019;82:e42.
    >> Share


  544. Detecting Disengagement From HIV Care Before It Is Too Late: Development and Preliminary Validation of a Novel Index of Engagement in HIV Care: Erratum.
    J Acquir Immune Defic Syndr. 2019;82:e42.
    >> Share

  545. TAN CS, Ghofrani J, Geiger E, Koralnik IJ, et al
    Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors.
    J Acquir Immune Defic Syndr. 2019;82:220-224.
    >> Share

  546. DEGUIT CDT, Hough M, Hoh R, Krone M, et al
    Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T-Cell Mitochondrial Features and ROS Content in HIV Infection.
    J Acquir Immune Defic Syndr. 2019;82:211-219.
    >> Share

  547. WEINBERG A, Huo Y, Kacanek D, Patel K, et al
    Brief Report: Markers of Spontaneous Preterm Delivery in Women Living With HIV: Relationship With Protease Inhibitors and Vitamin D.
    J Acquir Immune Defic Syndr. 2019;82:181-187.
    >> Share

  548. STEPHENS F, Gandhi NR, Brust JCM, Mlisana K, et al
    Treatment Adherence Among Persons Receiving Concurrent Multidrug-Resistant Tuberculosis and HIV Treatment in KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr. 2019;82:124-130.
    >> Share

    September 2019
  549. RAGGIO GA, Psaros C, Fatch R, Goodman G, et al
    High Rates of Biomarker-Confirmed Alcohol Use among Pregnant Women Living with HIV in South Africa and Uganda.
    J Acquir Immune Defic Syndr. 2019 Sep 18. doi: 10.1097/QAI.0000000000002156.
    >> Share

  550. ONYANGO-MAKUMBI C, Owora AH, Mwiru RS, Mwatha A, et al
    EXTENDED PROPHYLAXIS WITH NEVIRAPINE DOES NOT AFFECT GROWTH IN HIV-EXPOSED INFANTS.
    J Acquir Immune Defic Syndr. 2019 Sep 13. doi: 10.1097/QAI.0000000000002145.
    >> Share

  551. DODGE B, Ford J, Bo N, Tu W, et al
    HIV Risk and Prevention Outcomes in a Probability-Based Sample of Gay and Bisexual Men in the United States.
    J Acquir Immune Defic Syndr. 2019 Sep 11. doi: 10.1097/QAI.0000000000002151.
    >> Share

  552. KERSCHBERGER B, Ntshalintshali N, Mpala Q, Diaz Uribe PA, et al
    Field Suitability and Diagnostic Accuracy of the Biocentric Open Real-Time PCR Platform for Dried Blood Spot-Based HIV Viral Load Quantification in Eswatini.
    J Acquir Immune Defic Syndr. 2019;82:96-104.
    >> Share

  553. HEVEY MA, Presti RM, O'Halloran JA, Larson L, et al
    Mortality After Cryptococcal Infection in the Modern Antiretroviral Therapy Era.
    J Acquir Immune Defic Syndr. 2019;82:81-87.
    >> Share

  554. BRENNAN AT, Bonawitz R, Gill CJ, Thea DM, et al
    A Meta-analysis Assessing Diarrhea and Pneumonia in HIV-Exposed Uninfected Compared With HIV-Unexposed Uninfected Infants and Children.
    J Acquir Immune Defic Syndr. 2019;82:1-8.
    >> Share

  555. BRAHME R, Godbole S, Sonawale S, Kadu C, et al
    Declining Trends in HIV Prevalence Among Women Attending Antenatal Care Clinics Obfuscate the Continued Vulnerability of Adolescent Girls in Maharashtra, India (2005-2017).
    J Acquir Immune Defic Syndr. 2019;82:e13-e17.
    >> Share

  556. LACOURSE SM, Wagner AD, Cranmer LM, Copeland A, et al
    Brief Report: High Programmatic Isoniazid Preventive Therapy (IPT) Use in Pregnancy Among HIV-Infected Women.
    J Acquir Immune Defic Syndr. 2019;82:41-45.
    >> Share

  557. MOKOTOFF ED, Green Ruth K, Benbow N, Sweeney P, et al
    Data to Care: Lessons Learned From Delivering Technical Assistance to 20 Health Departments.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S74-S79.
    >> Share

  558. MACOMBER KE, Viall A, Ramakrishnan V, Wilson J, et al
    Operationalizing a Data to Care Strategy in Michigan Through Cross-Agency Collaborations.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S69-S73.
    >> Share

  559. DAVIES C, Klein PW, Okoye ID, Heitgerd J, et al
    Short-Term Outcomes and Lessons Learned From the Federal HIV Health Improvement Affinity Group for State Medicaid/Children's Health Insurance Program Agencies and State Health Departments.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S62-S68.
    >> Share

  560. NEBLETT FANFAIR R, Shrestha RK, Randall L, Lucas C, et al
    Implementing Data to Care-What Are the Costs for the Health Department?
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S57-S61.
    >> Share

  561. BYRD KK, Camp NM, Iqbal K, Weidle PJ, et al
    Pharmacy Data as an Alternative Data Source for Implementation of a Data to Care Strategy.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S53-S56.
    >> Share

  562. LEWIS S, Morrison M, Randall LM, Roosevelt K, et al
    The Partnerships for Care Project in Massachusetts: Developing Partnerships and Data Systems to Increase Linkage and Engagement in Care for Individuals Living With HIV.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S47-S52.
    >> Share

  563. HART-MALLOY R, Rajulu DT, Johnson MC, Shrestha T, et al
    Cross-Jurisdictional Data to Care: Lessons Learned in New York State and Florida.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S42-S46.
    >> Share

  564. KUNZWEILER C, Kishore N, John B, Roosevelt K, et al
    Using HIV Surveillance and Clinic Data to Optimize Data to Care Efforts in Community Health Centers in Massachusetts: The Massachusetts Partnerships for Care Project.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S33-S41.
    >> Share

  565. AREY AL, Cassidy-Stewart H, Kurowski PL, Hitt JC, et al
    Evaluating HIV Surveillance Completeness Along the Continuum of Care: Supplementing Surveillance With Health Center Data to Increase HIV Data to Care Efficiency.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S26-S32.
    >> Share

  566. HART-MALLOY R, Shrestha T, Pezzulo MC, Patterson W, et al
    Data to Care Opportunities: An Evaluation of Persons Living With HIV Reported to Be "Current to Care" Without Current HIV-Related Labs.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S20-S25.
    >> Share

  567. OCAMPO JMF, Hamp A, Rhodes A, Smart JC, et al
    Improving HIV Surveillance Data by Using the ATra Black Box System to Assist Regional Deduplication Activities.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S13-S19.
    >> Share

  568. BEER L, Bosh KA, Chowdhury PP, Craw J, et al
    Informing Data to Care: Contacting Persons Sampled for the Medical Monitoring Project.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S6-S12.
    >> Share

  569. SWEENEY P, DiNenno EA, Flores SA, Dooley S, et al
    HIV Data to Care-Using Public Health Data to Improve HIV Care and Prevention.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S1-S5.
    >> Share

    August 2019
  570. HOLTZ TH, Chitwarakorn A, Hughes JP, Curlin ME, et al
    HPTN 067/ADAPT: Correlates of sex-related pre-exposure prophylaxis adherence, Thai men who have sex with men, and transgender women, 2012-2013.
    J Acquir Immune Defic Syndr. 2019 Aug 30. doi: 10.1097/QAI.0000000000002131.
    >> Share

  571. CHIKWARI CD, Njuguna IN, Neary J, Rainer C, et al
    Diagnostic accuracy of oral mucosal transudate tests compared to blood-based rapid tests for HIV among children ages 18 months to 18 years in Kenya and Zimbabwe.
    J Acquir Immune Defic Syndr. 2019 Aug 16. doi: 10.1097/QAI.0000000000002146.
    >> Share

  572. WONG A, Goldstein D, Mallolas J, DeJesus E, et al
    Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive HIV-1 Infected Adults with Transmitted Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance Mutations.
    J Acquir Immune Defic Syndr. 2019 Aug 16. doi: 10.1097/QAI.0000000000002153.
    >> Share

  573. LIU AY, Norwood A, Gundacker H, Carballo-Dieguez A, et al
    Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017).
    J Acquir Immune Defic Syndr. 2019;81:516-520.
    >> Share

  574. BECKER ML, Bhattacharjee P, Blanchard JF, Cheuk E, et al
    Reply.
    J Acquir Immune Defic Syndr. 2019;81:e163-e165.
    >> Share

  575. SEBIKARI D, Farhad M, Fenton T, Owor M, et al
    Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial.
    J Acquir Immune Defic Syndr. 2019;81:521-532.
    >> Share

  576. SHAVA E, Moyo S, Zash R, Diseko M, et al
    Brief Report: High Rates of Adverse Birth Outcomes in HIV and Syphilis Coinfected Women in Botswana.
    J Acquir Immune Defic Syndr. 2019;81:e135-e140.
    >> Share

  577. MAHEU-GIROUX M, Diabate S, Boily MC, Jean-Paul N, et al
    Cost-Effectiveness of Accelerated HIV Response Scenarios in Cote d'Ivoire.
    J Acquir Immune Defic Syndr. 2019 Aug 1. doi: 10.1097/QAI.0000000000001956.
    >> Share

  578. ERLANDSON KM, Zhang L, Ng DK, Althoff KN, et al
    Risk Factors for Falls, Falls With Injury, and Falls With Fracture Among Older Men With or at Risk of HIV Infection.
    J Acquir Immune Defic Syndr. 2019;81:e117-e126.
    >> Share

  579. HAAS AD, Johnson LF, Grimsrud A, Ford N, et al
    Extending Visit Intervals for Clinically Stable Patients on Antiretroviral Therapy: Multicohort Analysis of HIV Programs in Southern Africa.
    J Acquir Immune Defic Syndr. 2019;81:439-447.
    >> Share

  580. WHITE DL, Oluyomi A, Royse K, Dong Y, et al
    Incidence of AIDS-Related Kaposi Sarcoma in All 50 United States From 2000 to 2014.
    J Acquir Immune Defic Syndr. 2019;81:387-394.
    >> Share

  581. HOARE J, Phillips N, Brittain K, Myer L, et al
    Mental Health and Functional Competence in the Cape Town Adolescent Antiretroviral Cohort.
    J Acquir Immune Defic Syndr. 2019;81:e109-e116.
    >> Share

  582. BWAKURA DANGAREMBIZI M, Samson P, Capparelli EV, Moore CB, et al
    Establishing Dosing Recommendations for Efavirenz in HIV/TB-Coinfected Children Younger Than 3 Years.
    J Acquir Immune Defic Syndr. 2019;81:473-480.
    >> Share

  583. SERETI I, Gulick RM, Krishnan S, Migueles SA, et al
    ART in HIV-Positive Persons With Low Pretreatment Viremia: Results From the START Trial.
    J Acquir Immune Defic Syndr. 2019;81:456-462.
    >> Share

    July 2019
  584. ASCHER SB, Scherzer R, Nishtala A, Jotwani V, et al
    Association of Statin Use with Kidney Damage and Function Among HIV-infected Men.
    J Acquir Immune Defic Syndr. 2019 Jul 24. doi: 10.1097/QAI.0000000000002122.
    >> Share

  585. LEVY ME, Monroe AK, Horberg MA, Benator DA, et al
    Pharmacologic Treatment of Psychiatric Disorders and Time with Unsuppressed HIV Viral Load in a Clinical HIV Cohort.
    J Acquir Immune Defic Syndr. 2019 Jul 24. doi: 10.1097/QAI.0000000000002138.
    >> Share

  586. GIGUERE K, Behanzin L, Guedou FA, Talbot D, et al
    PrEP Use Among Female Sex Workers: No Evidence for Risk Compensation.
    J Acquir Immune Defic Syndr. 2019 Jul 23. doi: 10.1097/QAI.0000000000002134.
    >> Share

  587. BYRD KK, Hou JG, Hazen R, Kirkham H, et al
    Antiretroviral Adherence Level Necessary for HIV Viral Suppression using Real-World Data.
    J Acquir Immune Defic Syndr. 2019 Jul 18. doi: 10.1097/QAI.0000000000002142.
    >> Share

  588. MILLS JC, Pence BW, Edmonds A, Adedimeji A, et al
    The Impact of Cumulative Depression along the HIV Care Continuum in Women Living with HIV during the Era of Universal Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2019 Jul 16. doi: 10.1097/QAI.0000000000002140.
    >> Share

  589. SHORT WR, Sutton MY, Luo Q, Frazier EL, et al
    Use of recommended preventive health care services and variations in HIV care among women with HIV in the United States, 2013-2014: Opportunities for expanded partnerships in support of ending the HIV epidemic.
    J Acquir Immune Defic Syndr. 2019 Jul 16. doi: 10.1097/QAI.0000000000002141.
    >> Share

  590. MODONGO C, Wang Q, Dima M, Matsiri O, et al
    Clinical and virological outcomes of TB/HIV co-infected patients treated with dolutegravir-based HIV antiretroviral regimens: Programmatic experience from Botswana.
    J Acquir Immune Defic Syndr. 2019 Jul 10. doi: 10.1097/QAI.0000000000002126.
    >> Share

  591. WOMACK JA, Murphy TE, Rentsch CT, Tate JP, et al
    Polypharmacy, hazardous alcohol and illicit substance use and serious falls among PLWH and uninfected comparators.
    J Acquir Immune Defic Syndr. 2019 Jul 4. doi: 10.1097/QAI.0000000000002130.
    >> Share

  592. HAALAND RE, Martin A, Livermont T, Fountain J, et al
    Urine emtricitabine and tenofovir concentrations provide markers of recent antiretroviral drug exposure among HIV-negative men who have sex with men.
    J Acquir Immune Defic Syndr. 2019 Jul 4. doi: 10.1097/QAI.0000000000002133.
    >> Share

  593. KERR SJ, Puthanakit T, Malee KM, Thongpibul K, et al
    Increased risk of executive function and emotional-behavioural problems among virologically well-controlled perinatally HIV-infected adolescents in Thailand and Cambodia.
    J Acquir Immune Defic Syndr. 2019 Jul 4. doi: 10.1097/QAI.0000000000002132.
    >> Share

  594. VELLOZA J, Bacchetti P, Hendrix CW, Murnane P, et al
    Short and long-term pharmacologic measures of HIV pre-exposure prophylaxis use among high-risk men who have sex with men in HPTN 067/ADAPT.
    J Acquir Immune Defic Syndr. 2019 Jul 4. doi: 10.1097/QAI.0000000000002128.
    >> Share

  595. ARCHAMPONG T, Ojewale O, Bears K, Chen Y, et al
    Relationship between ABCC4 SNPs and hepatitis B virus suppression during tenofovir-containing antiretroviral therapy in patients with HIV/HBV coinfection.
    J Acquir Immune Defic Syndr. 2019 Jul 3. doi: 10.1097/QAI.0000000000002136.
    >> Share

  596. SHABA F, Offorjebe OA, Phiri K, Lungu E, et al
    Perceived Acceptability of a Facility-Based HIV Self-Test Intervention in Outpatient Waiting Spaces Among Adult Outpatients in Malawi: A Formative Study.
    J Acquir Immune Defic Syndr. 2019;81:e92-e94.
    >> Share

  597. EL-SADR WM, Beauchamp G, Hall HI, Torian LV, et al
    Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 Study.
    J Acquir Immune Defic Syndr. 2019;81:300-303.
    >> Share

  598. LAM JO, Hurley LB, Udaltsova N, Alexeeff SE, et al
    Colorectal Cancer Screening in People With and Without HIV in an Integrated Health Care Setting.
    J Acquir Immune Defic Syndr. 2019;81:284-291.
    >> Share

  599. CHAPIN-BARDALES J, Rosenberg ES, Sullivan PS, Jenness SM, et al
    Trends in Number and Composition of Sex Partners Among Men Who Have Sex With Men in the United States, National HIV Behavioral Surveillance, 2008-2014.
    J Acquir Immune Defic Syndr. 2019;81:257-265.
    >> Share

  600. ROTHENBERGER M, Nganou-Makamdop K, Kityo C, Ssali F, et al
    Impact of Integrase Inhibition Compared With Nonnucleoside Inhibition on HIV Reservoirs in Lymphoid Tissues.
    J Acquir Immune Defic Syndr. 2019;81:355-360.
    >> Share

    June 2019
  601. GOLUB SA, Fikslin RA, Starbuck L, Klein A, et al
    High Rates of PrEP Eligibility but Low Rates of PrEP Access Among a National Sample of Transmasculine Individuals.
    J Acquir Immune Defic Syndr. 2019 Jun 20. doi: 10.1097/QAI.0000000000002116.
    >> Share

  602. BEDIMO RJ, Mar H, Bosch RJ, Drechsler H, et al
    No Evidence for an Association between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART.
    J Acquir Immune Defic Syndr. 2019 Jun 20. doi: 10.1097/QAI.0000000000002124.
    >> Share

  603. HAGHIGHAT R, Toska E, Cluver L, Gulaid L, et al
    Transition Pathways out of Pediatric Care and Associated HIV Outcomes for Adolescents Living with HIV in South Africa.
    J Acquir Immune Defic Syndr. 2019 Jun 20. doi: 10.1097/QAI.0000000000002125.
    >> Share

  604. GRAY KM, Banez Ocfemia MC, Wang X, Li J, et al
    Characteristics and care outcomes among persons living with perinatally acquired HIV infection in the United States, 2015.
    J Acquir Immune Defic Syndr. 2019 Jun 4. doi: 10.1097/QAI.0000000000002091.
    >> Share

  605. EL KAMARI V, Thomas A, Shan L, Sattar A, et al
    Advanced Glycation End Products Are Associated With Inflammation and Endothelial Dysfunction in HIV.
    J Acquir Immune Defic Syndr. 2019;81:e55-e62.
    >> Share

  606. LEMOS MP, Lazarus E, Isaacs A, Dietrich J, et al
    Daily Vaginal Swabs and Mobile Phone Sex Report for Assessing HIV Virion Exposure Prospectively Among a Cohort of Young Sexually Active Women in South Africa (HVTN 915).
    J Acquir Immune Defic Syndr. 2019;81:e39-e48.
    >> Share

  607. KOURTIS AP, Wiener J, Hurst S, Nelson JAE, et al
    Brief Report: HIV Shedding in the Female Genital Tract of Women on ART and Progestin Contraception: Extended Follow-up Results of a Randomized Clinical Trial.
    J Acquir Immune Defic Syndr. 2019;81:163-165.
    >> Share

  608. SPINELLI MA, Glidden DV, Anderson PL, Gandhi M, et al
    Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing.
    J Acquir Immune Defic Syndr. 2019;81:158-162.
    >> Share

  609. NJUGUNA IN, Cranmer LM, Wagner AD, LaCourse SM, et al
    Brief Report: Cofactors of Mortality Among Hospitalized HIV-Infected Children Initiating Antiretroviral Therapy in Kenya.
    J Acquir Immune Defic Syndr. 2019;81:138-144.
    >> Share

    May 2019
  610. NGUYEN N, Powers KA, Miller WC, Howard AG, et al
    Sexual Partner Types and Incident HIV Infection among Rural South African Adolescent Girls and Young Women Enrolled in HPTN 068: A Latent Class Analysis.
    J Acquir Immune Defic Syndr. 2019 May 29. doi: 10.1097/QAI.0000000000002096.
    >> Share

  611. VOJNOV L, Penazzato M, Sherman G, Ghadrshenas A, et al
    Implementing an indeterminate range for more accurate early infant diagnosis.
    J Acquir Immune Defic Syndr. 2019 May 29. doi: 10.1097/QAI.0000000000002081.
    >> Share

  612. HARGREAVES S, Rustage K, Nellums LB, Bardfield JE, et al
    Do quality improvement initiatives improve outcomes for patients in antiretroviral programmes in low- and middle-income countries? a systematic review.
    J Acquir Immune Defic Syndr. 2019 May 29. doi: 10.1097/QAI.0000000000002085.
    >> Share

  613. FAVARATO G, Townsend CL, Peters H, Sconza R, et al
    Stillbirth in women living with HIV delivering in the UK and Ireland: 2007-2015.
    J Acquir Immune Defic Syndr. 2019 May 29. doi: 10.1097/QAI.0000000000002087.
    >> Share

  614. WEINBERG A, Huo Y, Kacanek D, Patel K, et al
    Markers of Spontaneuous Preterm Delivery in Women living with HIV: Relationship with Protease Inhibitors and Vitamin D.
    J Acquir Immune Defic Syndr. 2019 May 28. doi: 10.1097/QAI.0000000000002111.
    >> Share

  615. BONACCI RA, Bradley H, Rosenberg ES, Holtgrave DR, et al
    Evaluating HIV Transmission Rates for the US National HIV/AIDS Strategy, 2010-2015.
    J Acquir Immune Defic Syndr. 2019 May 28. doi: 10.1097/QAI.0000000000002113.
    >> Share

  616. POTEAT T, Wirtz A, Malik M, Cooney E, et al
    A Gap Between Willingness and Uptake: Findings from Mixed Methods Research on HIV Prevention among Black and Latina Transgender Women.
    J Acquir Immune Defic Syndr. 2019 May 28. doi: 10.1097/QAI.0000000000002112.
    >> Share

  617. CHAN P, Dumrongpisutikul N, Subra C, Colby DJ, et al
    Neurosyphilis during Acute HIV Infection: A CNS Immunologic and Virologic Characterization.
    J Acquir Immune Defic Syndr. 2019 May 28. doi: 10.1097/QAI.0000000000002114.
    >> Share

  618. NOEL N, Gominet M, Meyer L, Boufassa F, et al
    Cardiovascular events in the French ANRS HIV controller cohort.
    J Acquir Immune Defic Syndr. 2019 May 27. doi: 10.1097/QAI.0000000000002108.
    >> Share

  619. JOHNSON KA, Hessol NA, Kohn R, Nguyen TQ, et al
    HIV Seroconversion in the Era of Pharmacologic Prevention: A Case-Control Study at a San Francisco STD Clinic.
    J Acquir Immune Defic Syndr. 2019 May 27. doi: 10.1097/QAI.0000000000002107.
    >> Share

  620. MORSICA G, Galli L, Bossolasco S, Bagaglio S, et al
    OUTCOME OF ACUTE HEPATITIS B VIRUS INFECTION IN HIV-1 INFECTED PATIENTS: POSSIBLE FACTORS ASSOCIATED WITH RESOLUTION OR CHRONICITY.
    J Acquir Immune Defic Syndr. 2019 May 27. doi: 10.1097/QAI.0000000000002106.
    >> Share

  621. BECKER ML, Bhattacharjee P, Blanchard JF, Cheuk E, et al
    Response to Hodson and Bewley Letter to the Editor.
    J Acquir Immune Defic Syndr. 2019 May 21. doi: 10.1097/QAI.0000000000002102.
    >> Share

  622. MATHUR S, Roberts-Toler C, Tassiopoulos K, Goodkin K, et al
    Detrimental Effects of Psychotropic Medications Differ by Sex in Aging People with HIV.
    J Acquir Immune Defic Syndr. 2019 May 21. doi: 10.1097/QAI.0000000000002100.
    >> Share

  623. VICTORIA D O, Rivet AK, James P H, Ethan W, et al
    Low Disclosure of PrEP nonadherence and HIV risk behaviors associated with poor HIV PrEP adherence in the HPTN 067/ADAPT Study.
    J Acquir Immune Defic Syndr. 2019 May 21. doi: 10.1097/QAI.0000000000002103.
    >> Share

  624. NGUYEN T, Delaugerre C, Valantin MA, Amiel C, et al
    Shared HCV Transmission Networks among HIV-1 Positive and Negative Men Having Sex with Men by Ultra-Deep Sequencing.
    J Acquir Immune Defic Syndr. 2019 May 21. doi: 10.1097/QAI.0000000000002099.
    >> Share

  625. JAUMDALLY SZ, Liebenberg LJP, Gumbi PP, Little F, et al
    Partner HIV serostatus impacts viral load, genital HIV shedding and immune activation in HIV-infected individuals.
    J Acquir Immune Defic Syndr. 2019 May 21. doi: 10.1097/QAI.0000000000002089.
    >> Share

  626. CRANE HM, Nance RM, Heckbert SR, Ritchings C, et al
    Association between bilirubin, atazanavir, and cardiovascular disease events among people living with HIV across the US.
    J Acquir Immune Defic Syndr. 2019 May 16. doi: 10.1097/QAI.0000000000002071.
    >> Share

  627. ESCOTA G, Baker J, Bush T, Conley L, et al
    Aging attenuates the association between coronary artery calcification and bone loss among HIV-infected persons.
    J Acquir Immune Defic Syndr. 2019 May 6. doi: 10.1097/QAI.0000000000002092.
    >> Share


  628. Transmission Networks of HCV Genotype 1a Enriched With Pre-existing Polymorphism Q80K Among HIV-Infected Patients With Acute Hepatitis C in Poland: Erratum.
    J Acquir Immune Defic Syndr. 2019;81:e27.
    >> Share

  629. CAI J, Sebastiani G
    HIV, Elevated Transaminases, Fatty Liver: The Perfect Storm?
    J Acquir Immune Defic Syndr. 2019;81:e23-e25.
    >> Share

  630. MORAKA NO, Moyo S, Mayondi G, Leidner J, et al
    Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health Outcomes.
    J Acquir Immune Defic Syndr. 2019;81:118-124.
    >> Share

  631. MCCREE DH, Williams AM, Chesson HW, Beer L, et al
    Changes in Disparities in Estimated HIV Incidence Rates Among Black, Hispanic/Latino, and White Men Who Have Sex With Men (MSM) in the United States, 2010-2015.
    J Acquir Immune Defic Syndr. 2019;81:57-62.
    >> Share

  632. FEARON E, Phillips A, Mtetwa S, Chabata ST, et al
    How Can Programs Better Support Female Sex Workers to Avoid HIV Infection in Zimbabwe? A Prevention Cascade Analysis.
    J Acquir Immune Defic Syndr. 2019;81:24-35.
    >> Share

  633. NYAGAH LM, Young PW, Kim AA, Wamicwe J, et al
    HIV-Related Deaths in Nairobi, Kenya: Results From a HIV Mortuary Surveillance Study, 2015.
    J Acquir Immune Defic Syndr. 2019;81:18-23.
    >> Share

    April 2019
  634. SALONER R, Marquine MJ, Sundermann EE, Hong S, et al
    COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk for Neurocognitive Impairment in Men Living with HIV.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002083.
    >> Share

  635. REIF LK, Rivera V, Bertrand R, Belizaire M, et al
    "FANMI": A Promising Differentiated Model of HIV Care for Adolescents in Haiti.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002088.
    >> Share

  636. LO RE V 3RD, Newcomb CW, Carbonari DM, Roy JA, et al
    Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002094.
    >> Share

  637. SHAVA E, Moyo S, Zash R, Diseko M, et al
    High rates of adverse birth outcomes in HIV and syphilis co-infected women in Botswana.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002082.
    >> Share

  638. DASTGHEYB RM, Sacktor N, Franklin D, Letendre S, et al
    Cognitive trajectory phenotypes in human immunodeficiency virus infected patients.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002093.
    >> Share

  639. NGUYEN H, Thorball CW, Fellay J, Boni J, et al
    HIV transmission chains exhibit greater HLA-B homogeneity than randomly expected.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002077.
    >> Share

  640. JANUEL E, Godin O, Moulignier A, Lescure FX, et al
    Impact of ART classes on the increasing risk of cerebral small-vessel disease in middle-aged, well-controlled, cART-treated, HIV-infected individuals.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002084.
    >> Share

  641. NANCE RM, Vannappagari V, Smith K, Calingaert B, et al
    Virologic failure among people living with HIV initiating dolutegravir-based versus other recommended regimens in real-world clinical care settings.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002075.
    >> Share

  642. BILLINGS E, Kijak GH, Sanders-Buell E, Ndembi N, et al
    New Subtype B Containing HIV-1 Circulating Recombinant of sub-Saharan Africa Origin in Nigerian Men who have Sex with Men.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002076.
    >> Share

  643. SEBIKARI D, Farhad M, Fenton T, Owor M, et al
    Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial.
    J Acquir Immune Defic Syndr. 2019 Apr 23. doi: 10.1097/QAI.0000000000002072.
    >> Share

  644. ASUNDI A, Robles Y, Starr T, Landay A, et al
    Immunological and Neurometabolite Changes associated with switch from Efavirenz to an Integrase Inhibitor.
    J Acquir Immune Defic Syndr. 2019 Apr 23. doi: 10.1097/QAI.0000000000002079.
    >> Share

  645. MUDDU M, Tusubira AK, Sharma SK, Akiteng AR, et al
    Integrated Hypertension and HIV Care Cascades in an HIV Treatment Program in Eastern Uganda: a retrospective cohort study.
    J Acquir Immune Defic Syndr. 2019 Apr 23. doi: 10.1097/QAI.0000000000002067.
    >> Share

  646. VAN ZOEST RA, Law M, Sabin CA, Vaartjes I, et al
    Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living with HIV.
    J Acquir Immune Defic Syndr. 2019 Apr 23. doi: 10.1097/QAI.0000000000002069.
    >> Share

  647. KEATING SM, Jones RB, Lalama CM, Bosch RJ, et al
    HIV Antibodies Decline During Antiretroviral Therapy but Remain Correlated with HIV DNA and HIV-specific T Cell Responses.
    J Acquir Immune Defic Syndr. 2019 Apr 23. doi: 10.1097/QAI.0000000000002080.
    >> Share

  648. CHOUCHANA L, Beeker N, Treluyer JM
    Is there a safety signal for dolutegravir and integrase inhibitors during pregnancy?
    J Acquir Immune Defic Syndr. 2019 Apr 19. doi: 10.1097/QAI.0000000000002065.
    >> Share

  649. JOBSON G, Khoza S, Mbeng R, Befula N, et al
    Bridging the gap: reaching men for HIV testing through religious congregations in South Africa.
    J Acquir Immune Defic Syndr. 2019 Apr 19. doi: 10.1097/QAI.0000000000002078.
    >> Share

  650. ESHUN-WILSON I, Mukumbwa-Mwenechanya M, Kim HY, Zannolini A, et al
    Differentiated care preferences of stable patients on ART in Zambia: A discrete choice experiment.
    J Acquir Immune Defic Syndr. 2019 Apr 19. doi: 10.1097/QAI.0000000000002070.
    >> Share

  651. BALL L, Venner C, Tirona RG, Arts E, et al
    Heating Injection Drug Preparation Equipment Used for Opioid Injection May Reduce HIV Transmission Associated with Sharing Equipment.
    J Acquir Immune Defic Syndr. 2019 Apr 19. doi: 10.1097/QAI.0000000000002063.
    >> Share

  652. BALL LJ, Puka K, Speechley M, Wong R, et al
    Sharing of Injection Drug Preparation Equipment is Associated with HIV Infection: A Cross Sectional Study.
    J Acquir Immune Defic Syndr. 2019 Apr 19. doi: 10.1097/QAI.0000000000002062.
    >> Share

  653. KANDASAMI S, Shobiye H, Fakoya A, Asiimwe S, et al
    Can changes in service delivery models improve program quality and efficiency? A closer look at HIV programs in Kenya and Uganda.
    J Acquir Immune Defic Syndr. 2019 Apr 19. doi: 10.1097/QAI.0000000000002064.
    >> Share

  654. GULHATI V, Soo J, Ransy DG, Brophy J, et al
    Brief Report: Higher Levels of Angiopoietin-1 Are Associated With Early and Sustained Viral Suppression in Children Living With Vertically Acquired HIV.
    J Acquir Immune Defic Syndr. 2019;80:590-595.
    >> Share

  655. MONTGOMERY ET, Atujuna M, Krogstad E, Hartmann M, et al
    The Invisible Product: Preferences for Sustained-Release, Long-Acting Pre-exposure Prophylaxis to HIV Among South African Youth.
    J Acquir Immune Defic Syndr. 2019;80:542-550.
    >> Share

  656. JESSICA M S, Carrie C, Lisa B H, Ashley P, et al
    Impact of PrEP Training for Family Planning Providers on HIV Prevention Counseling and Patient Interest in PrEP in Atlanta, Georgia.
    J Acquir Immune Defic Syndr. 2019 Apr 11. doi: 10.1097/QAI.0000000000002057.
    >> Share

  657. ZUCKER J, Carnevale C, Richards P, Slowikowski J, et al
    Predictors of Disengagement in Care for Individuals Receiving Pre-Exposure Prophylaxis (PrEP).
    J Acquir Immune Defic Syndr. 2019 Apr 11. doi: 10.1097/QAI.0000000000002054.
    >> Share

  658. JOHNSON M, Kumar P, Molina JM, Rizzardini G, et al
    Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial.
    J Acquir Immune Defic Syndr. 2019 Apr 11. doi: 10.1097/QAI.0000000000002056.
    >> Share

  659. JOHN SA, Robles G, Starks TJ, Rendina HJ, et al
    Differences between groups of pre-exposure prophylaxis (PrEP) using couples in HIV-negative/unknown relationships.
    J Acquir Immune Defic Syndr. 2019 Apr 11. doi: 10.1097/QAI.0000000000002058.
    >> Share

  660. KAIDA A, Kabakyenga J, Bwana M, Bajunirwe F, et al
    High incidence of intended partner pregnancy among men living with HIV in rural Uganda: Implications for safer conception services.
    J Acquir Immune Defic Syndr. 2019 Apr 8. doi: 10.1097/QAI.0000000000002053.
    >> Share

  661. SERETI I, Gulick RM, Krishnan S, Migueles SA, et al
    ART in HIV-positive persons with low pre-treatment viremia: results from the START trial.
    J Acquir Immune Defic Syndr. 2019 Apr 6. doi: 10.1097/QAI.0000000000002052.
    >> Share

  662. CALABRESE SK, Willie TC, Galvao RW, Tekeste M, et al
    Current US Guidelines for Prescribing HIV Pre-Exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP.
    J Acquir Immune Defic Syndr. 2019 Apr 6. doi: 10.1097/QAI.0000000000002042.
    >> Share

  663. JANET J M, Mi-Suk KD, Kimberly A K, Ifeoma U, et al
    Adherence to PrEP among young men who have sex with men participating in a sexual health services demonstration project in Alameda County, California.
    J Acquir Immune Defic Syndr. 2019 Apr 6. doi: 10.1097/QAI.0000000000002051.
    >> Share

  664. WILLIAMS EC, McGinnis KA, Tate JP, Matson TE, et al
    HIV Disease Severity is Sensitive to Temporal Changes in Alcohol Use: A National Study of VA Patients with HIV.
    J Acquir Immune Defic Syndr. 2019 Apr 6. doi: 10.1097/QAI.0000000000002049.
    >> Share

  665. HAMMOUD MA, Vaccher S, Jin F, Bourne A, et al
    HIV pre-exposure prophylaxis (PrEP) uptake among gay and bisexual men in Australia and factors associated with the non-use of PrEP among eligible men: Results from a prospective cohort study.
    J Acquir Immune Defic Syndr. 2019 Apr 4. doi: 10.1097/QAI.0000000000002047.
    >> Share

  666. NYAMATHI AN, Shin SS, Sinha S, Carpenter CL, et al
    Sustained Effect of a Community-based Behavioral and Nutrition Intervention on HIV-related Outcomes among Women living with HIV in Rural India: A Quasi-experimental Trial.
    J Acquir Immune Defic Syndr. 2019 Apr 4. doi: 10.1097/QAI.0000000000002044.
    >> Share

  667. DAVEY DJ, Wall KM, Serrao C, Prins M, et al
    HIV positivity and referral to treatment following index testing of partners and children of HIV-infected patients in public sector facilities in South Africa.
    J Acquir Immune Defic Syndr. 2019 Apr 4. doi: 10.1097/QAI.0000000000002048.
    >> Share

  668. VIDOT DC, Manuzak JA, Klatt NR, Pallikkuth S, et al
    Hazardous Cannabis Use and Monocyte Activation Among Methamphetamine Users with Treated HIV Infection.
    J Acquir Immune Defic Syndr. 2019 Apr 3. doi: 10.1097/QAI.0000000000002046.
    >> Share

  669. LE BERRE AP, Fama R, Sassoon SA, Pfefferbaum A, et al
    Cognitive and Motor Impairment Severity Related to Signs of Subclinical Wernicke's Encephalopathy in HIV Infection.
    J Acquir Immune Defic Syndr. 2019 Apr 3. doi: 10.1097/QAI.0000000000002043.
    >> Share

  670. LOPEZ-VARELA E, Respeito D, Blanco S, Gimo M, et al
    High Yield of Home-Based TB Diagnosis Among Newly Diagnosed Patients With HIV.
    J Acquir Immune Defic Syndr. 2019;80:e103-e105.
    >> Share

  671. IOGNA PRAT L, Roccarina D, Lever R, Lombardi R, et al
    Etiology and Severity of Liver Disease in HIV-Positive Patients With Suspected NAFLD: Lessons From a Cohort With Available Liver Biopsies.
    J Acquir Immune Defic Syndr. 2019;80:474-480.
    >> Share

  672. AYIEKO J, Petersen ML, Charlebois ED, Brown LB, et al
    A Patient-Centered Multicomponent Strategy for Accelerated Linkage to Care Following Community-Wide HIV Testing in Rural Uganda and Kenya.
    J Acquir Immune Defic Syndr. 2019;80:414-422.
    >> Share

  673. SUDFELD CR, Jacobson DL, Rueda NM, Neri D, et al
    Third trimester vitamin D status is associated with birth outcomes and linear growth of HIV-exposed uninfected infants in the United States.
    J Acquir Immune Defic Syndr. 2019 Apr 1. doi: 10.1097/QAI.0000000000002041.
    >> Share

    March 2019
  674. THRIFT AP, Kramer JR, Hartman CM, Royse K, et al
    Risk and predictors of esophageal and stomach cancers in HIV-infected veterans: A matched cohort study.
    J Acquir Immune Defic Syndr. 2019 Mar 29. doi: 10.1097/QAI.0000000000002038.
    >> Share

  675. VANNAPPAGARI V, Thorne C
    Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir.
    J Acquir Immune Defic Syndr. 2019 Mar 29. doi: 10.1097/QAI.0000000000002035.
    >> Share

  676. BRITTAIN K, Mellins CA, Remien RH, Phillips TK, et al
    Impact of HIV-status disclosure on HIV viral load in pregnant and postpartum women on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2019 Mar 29. doi: 10.1097/QAI.0000000000002036.
    >> Share

  677. GONCIULEA A, Wang R, Althoff KN, Estrella MM, et al
    Proteinuria is Associated with Increased Risk of Fragility Fracture in Men With or at Risk for HIV infection Proteinuria and Fracture Risk Association.
    J Acquir Immune Defic Syndr. 2019 Mar 29. doi: 10.1097/QAI.0000000000002039.
    >> Share

  678. BARNELL GM, Merchant M, Lam JO, Silverberg MJ, et al
    Early outcomes of a high-resolution anoscopy-based anal cancer screening program among people with HIV enrolled in an integrated healthcare system.
    J Acquir Immune Defic Syndr. 2019 Mar 29. doi: 10.1097/QAI.0000000000002040.
    >> Share

  679. KALAYJIAN RC, Robertson KR, Albert JM, Fichthenbaum CJ, et al
    Plasma Cystatin C Associates with HIV-Associated Neurocognitive Disorder but is a Poor Diagnostic Marker in Antiretroviral Therapy Treated Individuals.
    J Acquir Immune Defic Syndr. 2019 Mar 27. doi: 10.1097/QAI.0000000000002016.
    >> Share

  680. ROTHENBERGER M, Nganou-Makamdop K, Kityo C, Ssali F, et al
    Impact of Integrase Inhibition compared to non-nucleoside inhibition on HIV reservoirs in Lymphoid Tissues.
    J Acquir Immune Defic Syndr. 2019 Mar 15. doi: 10.1097/QAI.0000000000002026.
    >> Share

  681. RUBIN LH, Springer G, Martin EM, Seaberg EC, et al
    Elevated depressive symptoms are a stronger predictor of executive dysfunction in HIV-infected women than men.
    J Acquir Immune Defic Syndr. 2019 Mar 8. doi: 10.1097/QAI.0000000000002029.
    >> Share

  682. PHILLIPS TK, Sinxadi P, Abrams EJ, Zerbe A, et al
    A comparison of plasma efavirenz and tenofovir, dried blood spot tenofovir-diphosphate, and self-reported adherence to predict virologic suppression among South African women.
    J Acquir Immune Defic Syndr. 2019 Mar 8. doi: 10.1097/QAI.0000000000002032.
    >> Share

  683. RELF MV, Pan W, Edmonds A, Ramirez C, et al
    Discrimination, medical distrust, stigma, depressive symptoms, antiretroviral medication adherence, engagement in care and quality of life among women living with HIV in North Carolina: a mediated structural equation model.
    J Acquir Immune Defic Syndr. 2019 Mar 8. doi: 10.1097/QAI.0000000000002033.
    >> Share

  684. GIBBS A, Hatcher A, Jewkes R, Sikweyiya Y, et al
    Associations between lifetime traumatic experiences and HIV-risk behaviours amongst young men living in informal settlements in South Africa: A cross-sectional analysis and structural equation model.
    J Acquir Immune Defic Syndr. 2019 Mar 6. doi: 10.1097/QAI.0000000000002010.
    >> Share

  685. NIJHAWAN AE, Metsch LR, Zhang S, Feaster DJ, et al
    Clinical and Sociobehavioral Prediction Model of 30-Day Hospital Readmissions Among People With HIV and Substance Use Disorder: Beyond Electronic Health Record Data.
    J Acquir Immune Defic Syndr. 2019;80:330-341.
    >> Share

  686. BOWRING AL, Ketende S, Billong SC, Mfochive Njindam I, et al
    Characterizing Sociostructural Associations With New HIV Diagnoses Among Female Sex Workers in Cameroon.
    J Acquir Immune Defic Syndr. 2019;80:e64-e73.
    >> Share

  687. AISSANI B, Martinez-Maza O, Kaslow RA, Wiener HW, et al
    Increasing levels of serum heat shock protein 70 precede the development of AIDS-defining non-Hodgkin lymphoma among carriers of HLA-B8-DR3.
    J Acquir Immune Defic Syndr. 2019 Mar 1. doi: 10.1097/QAI.0000000000002027.
    >> Share

    February 2019
  688. JAO J, Jacobson DL, Yu W, Borkowsky W, et al
    A comparison of metabolic outcomes between obese HIV-exposed uninfected youth from the PHACS SMARTT Study and HIV-unexposed youth from the NHANES Study in the U.S.
    J Acquir Immune Defic Syndr. 2019 Feb 27. doi: 10.1097/QAI.0000000000002018.
    >> Share

  689. LIU Y, Silenzio VMB, Nash R, Luther P, et al
    Suboptimal recent and regular HIV testing among Black men who have sex with men in the United States: Implications from a meta-analysis.
    J Acquir Immune Defic Syndr. 2019 Feb 27. doi: 10.1097/QAI.0000000000002013.
    >> Share

  690. VAN DER STRATEN A, Browne EN, Shapley-Quinn MK, Brown ER, et al
    First Impressions Matter: How Initial Worries Influence Adherence to the Dapivirine Vaginal Ring.
    J Acquir Immune Defic Syndr. 2019 Feb 27. doi: 10.1097/QAI.0000000000002028.
    >> Share

  691. SLOGROVE AL, Powis KM, Zash R
    Methodological considerations in evaluating pregnancy outcomes in women living with HIV.
    J Acquir Immune Defic Syndr. 2019 Feb 25. doi: 10.1097/QAI.0000000000002014.
    >> Share

  692. ZHANG Y, Barnighausen T, Eyal N
    When Global ART Budgets Cannot Cover All Patients, Who Should Be Eligible?
    J Acquir Immune Defic Syndr. 2019 Feb 25. doi: 10.1097/QAI.0000000000002017.
    >> Share

  693. MIMIAGA MJ, Hughto JMW, Biello KB, Santostefano CM, et al
    Longitudinal analysis of syndemic psychosocial problems predicting HIV risk behavior among a multicity prospective cohort of sexually active young transgender women in the United States.
    J Acquir Immune Defic Syndr. 2019 Feb 25. doi: 10.1097/QAI.0000000000002009.
    >> Share

  694. HOOVER KW, Hu X, Porter SE, Buchacz K, et al
    HIV diagnoses and the HIV care continuum among women and girls aged >/=13 years - 39 states and the District of Columbia, 2015-2016.
    J Acquir Immune Defic Syndr. 2019 Feb 25. doi: 10.1097/QAI.0000000000002023.
    >> Share

  695. BOWLER S, Chew GM, Budoff M, Chow D, et al
    PD-1+ AND TIGIT+ CD4 T CELLS ARE ASSOCAITED WITH CORONARY ARTERY CALCIUM PROGRESSION IN HIV-INFECTED TREATED ADULTS.
    J Acquir Immune Defic Syndr. 2019 Feb 21. doi: 10.1097/QAI.0000000000002001.
    >> Share

  696. DANIEL JACOBUS VH, Sa'ad L, Hendrick Jaco L, Mark Patrick N, et al
    The real-world performance and inter-observer agreement of urine lipoarabinomannan in diagnosing HIV-associated tuberculosis in an emergency center.
    J Acquir Immune Defic Syndr. 2019 Feb 21. doi: 10.1097/QAI.0000000000002002.
    >> Share

  697. HOENIGL M, Hassan A, Moore DJ, Anderson PL, et al
    Predictors of Long Term HIV Pre Exposure Prophylaxis Adherence after Study Participation in Men who have Sex with Men.
    J Acquir Immune Defic Syndr. 2019 Feb 21. doi: 10.1097/QAI.0000000000002003.
    >> Share

  698. SPINELLI MA, Glidden DV, Anderson PL, Gandhi M, et al
    Short-Term Adherence Marker to PrEP Predicts Future Non-Retention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing.
    J Acquir Immune Defic Syndr. 2019 Feb 21. doi: 10.1097/QAI.0000000000002005.
    >> Share

  699. ROSS JL, Teeraananchai S, Lumbiganon P, Hansudewechakul R, et al
    A longitudinal study of behavioral risk, adherence and virologic control in adolescents living with HIV in Asia.
    J Acquir Immune Defic Syndr. 2019 Feb 21. doi: 10.1097/QAI.0000000000002008.
    >> Share

  700. HILL BJ, Rosentel K, Hebert L
    Brief Report: Assessing the impact of race on HIV/STI risk perceptions among young men who have sex with men using an experimental approach.
    J Acquir Immune Defic Syndr. 2019 Feb 21. doi: 10.1097/QAI.0000000000002004.
    >> Share

  701. LIPIRA L, Williams EC, Nevin PE, Kemp CG, et al
    Religiosity, social support and ethnic identity: Exploring "resilience resources" for African-American women experiencing HIV-related stigma.
    J Acquir Immune Defic Syndr. 2019 Feb 21. doi: 10.1097/QAI.0000000000002006.
    >> Share

  702. MARGOSSIAN R, Williams PL, Yu W, Jacobson DL, et al
    Markers of Bone Mineral Metabolism and Cardiac Structure and Function in Perinatally HIV-Infected and HIV-Exposed but Uninfected Children and Adolescents.
    J Acquir Immune Defic Syndr. 2019 Feb 21. doi: 10.1097/QAI.0000000000002007.
    >> Share

  703. SCHACKMAN BR, Jeng PJ, Flash MJE, Mejia M, et al
    Cost of an HIV Medical Care Coordination Program in Los Angeles County.
    J Acquir Immune Defic Syndr. 2019 Feb 21. doi: 10.1097/QAI.0000000000001994.
    >> Share

  704. GANDHI M, Devi S, Bacchetti P, Chandy S, et al
    Measuring adherence to antiretroviral therapy via hair concentrations in India.
    J Acquir Immune Defic Syndr. 2019 Feb 20. doi: 10.1097/QAI.0000000000001993.
    >> Share

  705. MERLIN JS, Long D, Becker WC, Cachay ER, et al
    Marijuana Use is Not Associated with Changes in Opioid Prescriptions or Pain Severity Among People Living with HIV and Chronic Pain.
    J Acquir Immune Defic Syndr. 2019 Feb 20. doi: 10.1097/QAI.0000000000001998.
    >> Share

  706. JOHNSON MO, Neilands TB, Koester KA, Wood T, et al
    Detecting Disengagement from HIV Care Before It's Too Late: Development and Preliminary Validation of a Novel Index of Engagement in HIV Care.
    J Acquir Immune Defic Syndr. 2019 Feb 20. doi: 10.1097/QAI.0000000000002000.
    >> Share

  707. RAO SG, Galaviz KI, Gay HC, Wei J, et al
    Factors Associated with Excess Myocardial Infarction Risk in HIV-infected Adults: a Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2019 Feb 20. doi: 10.1097/QAI.0000000000001996.
    >> Share

  708. WAMOYI J, Ranganathan M, Kyegombe N, Stoebenau K, et al
    Improving the measurement of transactional sex in sub-Saharan Africa: A critical review.
    J Acquir Immune Defic Syndr. 2019 Feb 15. doi: 10.1097/QAI.0000000000001928.
    >> Share

  709. SACKTOR N, Saylor D, Nakigozi G, Nakasujja N, et al
    Effect of HIV Subtype and Antiretroviral therapy on HIV-associated neurocognitive disorder (HAND) stage in Rakai, Uganda.
    J Acquir Immune Defic Syndr. 2019 Feb 15. doi: 10.1097/QAI.0000000000001992.
    >> Share

  710. NEUKAM K, Fernandez MD, Quero JH, Rivero-Juarez A, et al
    Response to hepatitis A virus vaccine in HIV-infected patients within a retrospective, multicentric cohort: Facing hepatitis A outbreaks in the clinical practice.
    J Acquir Immune Defic Syndr. 2019 Feb 14. doi: 10.1097/QAI.0000000000001990.
    >> Share

  711. REVELL AD, Wang D, Perez-Elias MJ, Wood R, et al
    Predicting virological response to HIV treatment over time: a tool for settings with different definitions of virological response.
    J Acquir Immune Defic Syndr. 2019 Feb 14. doi: 10.1097/QAI.0000000000001989.
    >> Share

  712. TWAHIRWA RWEMA JO, Lyons CE, Ketende S, Bowring AL, et al
    Characterizing the Influence of Structural Determinants of HIV Risk on Consistent Condom Use among female sex workers in Senegal.
    J Acquir Immune Defic Syndr. 2019 Feb 14. doi: 10.1097/QAI.0000000000001991.
    >> Share

  713. LIN J, Xue X, Anastos K, Cohen MH, et al
    Elevated Microparticle Tissue Factor Activity is Associated with Carotid Artery Plaque in HIV Infected Women.
    J Acquir Immune Defic Syndr. 2019 Feb 13. doi: 10.1097/QAI.0000000000001988.
    >> Share

  714. ABULIZI X, Ribaudo HJ, Flandre P
    The use of the Restricted Mean Survival Time as a treatment measure in HIV/AIDS clinical trial: reanalysis of the ACTG A5257 trial.
    J Acquir Immune Defic Syndr. 2019 Feb 13. doi: 10.1097/QAI.0000000000001978.
    >> Share

  715. CHOWDHURY P, Beer L, Shouse RL, Bradley H, et al
    Clinical outcomes of young black men receiving HIV medical care in the United States, 2009-2014.
    J Acquir Immune Defic Syndr. 2019 Feb 13. doi: 10.1097/QAI.0000000000001987.
    >> Share

  716. BENKI-NUGENT SF, Martopullo I 1st, Laboso T, Tamasha N, et al
    High plasma soluble CD163 during infancy is a marker for neurocognitive outcomes in early treated HIV-infected children.
    J Acquir Immune Defic Syndr. 2019 Feb 7. doi: 10.1097/QAI.0000000000001979.
    >> Share

  717. MAHER L, Grulich A, Bourne A, Hammoud BPsych M, et al
    Changes in behavior following PrEP initiation among Australian gay and bisexual men.
    J Acquir Immune Defic Syndr. 2019 Feb 7. doi: 10.1097/QAI.0000000000001976.
    >> Share

  718. LIU Y, Su B, Zhang Y, Jia L, et al
    Onward transmission of multiple HIV-1 unique recombinant forms among men who have sex with men in Beijing, China.
    J Acquir Immune Defic Syndr. 2019 Feb 7. doi: 10.1097/QAI.0000000000001983.
    >> Share

  719. POLANKA BM, Kundu S, So-Armah KA, Freiberg MS, et al
    Insomnia as an Independent Predictor of Incident Cardiovascular Disease in HIV: Data from the Veterans Aging Cohort Study.
    J Acquir Immune Defic Syndr. 2019 Feb 7. doi: 10.1097/QAI.0000000000001981.
    >> Share

  720. FEARON E, Phillips A, Mtetwa S, Chabata ST, et al
    Title: How can programmes better support female sex workers to avoid HIV infection in Zimbabwe? A prevention cascade analysis.
    J Acquir Immune Defic Syndr. 2019 Feb 7. doi: 10.1097/QAI.0000000000001980.
    >> Share

  721. KULA A, Delacourt N, Bouchat S, Darcis G, et al
    Heterogeneous HIV-1 reactivation patterns of disulfiram and combined disulfiram+romidepsin treatments.
    J Acquir Immune Defic Syndr. 2019 Feb 7. doi: 10.1097/QAI.0000000000001958.
    >> Share

  722. VENTER WDF, Kambugu A, Chersich MF, Becker S, et al
    Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial.
    J Acquir Immune Defic Syndr. 2019;80:224-233.
    >> Share

  723. ARRINGTON-SANDERS R, Wilson CM, Perumean-Chaney SE, Patki A, et al
    Brief Report: Role of Sociobehavioral Factors in Subprotective TFV-DP Levels Among YMSM Enrolled in 2 PrEP Trials.
    J Acquir Immune Defic Syndr. 2019;80:160-165.
    >> Share

    January 2019
  724. DARBES LA, Mcgrath NM, Hosegood V, Johnson MO, et al
    Results of a couples-based randomized controlled trial aimed to increase testing for HIV.
    J Acquir Immune Defic Syndr. 2019 Jan 30. doi: 10.1097/QAI.0000000000001948.
    >> Share

  725. HOJILLA JC, Satre DD, Glidden DV, McMahan VM, et al
    Cocaine Use and Pre-Exposure Prophylaxis: Adherence, Care Engagement, and Kidney Function.
    J Acquir Immune Defic Syndr. 2019 Jan 25. doi: 10.1097/QAI.0000000000001972.
    >> Share

  726. GREWAL R, Allen VG, Bayoumi AM, Gardner SL, et al
    Syphilis co-infection is not associated with an increased risk of virologic failure among HIV-positive men who have sex with men on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2019 Jan 25. doi: 10.1097/QAI.0000000000001962.
    >> Share

  727. O'BRIEN DP, Ford N, Djirmay AG, Calmy A, et al
    Female Genital Schistosomiasis and HIV: Research urgently needed to improve understanding of the health impacts of this important co-infection.
    J Acquir Immune Defic Syndr. 2019 Jan 25. doi: 10.1097/QAI.0000000000001957.
    >> Share

  728. BRAHMBHATT H, Santelli J, Kaagayi J, Lutalo T, et al
    Pregnancy Incidence and Fertility Desires Among Couples by HIV Status in Rakai, Uganda.
    J Acquir Immune Defic Syndr. 2019 Jan 17. doi: 10.1097/QAI.0000000000001951.
    >> Share

  729. SIBIUDE J, Warszawski J, Tubiana R, Chenadec JL, et al
    Liver Enzyme Elevation in Pregnant Women Receiving Antiretroviral Therapy in the ANRS-French Perinatal Cohort.
    J Acquir Immune Defic Syndr. 2019 Jan 17. doi: 10.1097/QAI.0000000000001963.
    >> Share

  730. GANDHI M, Bacchetti P, SpinelliI MA, Okochi H, et al
    Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cut-Off for a Point-of-Care Test.
    J Acquir Immune Defic Syndr. 2019 Jan 11. doi: 10.1097/QAI.0000000000001971.
    >> Share

  731. GOGIA S, Zanni MV
    Authors' Reply to Comments on "Cardiovascular Risk Profile of Transgender Women with HIV: A U.S. Healthcare Database Study".
    J Acquir Immune Defic Syndr. 2019 Jan 9. doi: 10.1097/QAI.0000000000001944.
    >> Share

  732. BAUMANN A, Musaazi J, Kambugu A, Kalin M, et al
    Virological outcome of patients with HIV drug resistance attending an urban out-patient clinic in Uganda: a need for structured adherence counselling and third line treatment options.
    J Acquir Immune Defic Syndr. 2019 Jan 9. doi: 10.1097/QAI.0000000000001943.
    >> Share

  733. MINNIS AM, Browne EN, Boeri M, Agot K, et al
    Young women's stated preferences for biomedical HIV prevention: results of a discrete choice experiment in Kenya and South Africa.
    J Acquir Immune Defic Syndr. 2019 Jan 9. doi: 10.1097/QAI.0000000000001945.
    >> Share

  734. YU B, Pasipanodya E, Montoya JL, Moore RC, et al
    Metabolic Syndrome and Neurocognitive Deficits in HIV infection.
    J Acquir Immune Defic Syndr. 2019 Jan 9. doi: 10.1097/QAI.0000000000001964.
    >> Share

  735. TRAN NK, Hatzenbuehler ML, Goldstein ND
    Potential Relationship between HIV Criminalization and Structural Stigma Related to Sexual Orientation in the U.S.
    J Acquir Immune Defic Syndr. 2019 Jan 9. doi: 10.1097/QAI.0000000000001961.
    >> Share

  736. BOATMAN JA, Baker JV, Emery S, Furrer H, et al
    Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression among Participants Initiating Antiretroviral Treatment with CD4+ Counts > 500 cells/mm3: Findings from the Strategic Timing of AntiRetroviral Treatment (START) Trial.
    J Acquir Immune Defic Syndr. 2019 Jan 9. doi: 10.1097/QAI.0000000000001967.
    >> Share

  737. LONG J, Montano M, Cabello R, Sanchez H, et al
    Comparing sexual risk behavior in a high-risk group of men who have sex with men and transgender women in Lima, Peru.
    J Acquir Immune Defic Syndr. 2019 Jan 9. doi: 10.1097/QAI.0000000000001966.
    >> Share

  738. KATZ DA, Dombrowski JC, Barry M, Spellman D, et al
    STD Partner Services to Monitor and Promote HIV Pre-Exposure Prophylaxis Use Among Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2019 Jan 8. doi: 10.1097/QAI.0000000000001952.
    >> Share

  739. AKILIMALI NA, Muema DM, Specht C, Chang CC, et al
    Cryptococcosis-associated Immune Reconstitution Inflammatory Syndrome is associated with Dysregulation of IL-7/IL-7 Receptor Signaling Pathway in T-cells and Monocyte Activation.
    J Acquir Immune Defic Syndr. 2019 Jan 8. doi: 10.1097/QAI.0000000000001946.
    >> Share

  740. RADWAN D, Cachay E, Falade-Nwulia O, Moore RD, et al
    HCV Screening and Treatment Uptake among Patients in HIV care During 2014-2015.
    J Acquir Immune Defic Syndr. 2019 Jan 8. doi: 10.1097/QAI.0000000000001949.
    >> Share

  741. SHERMAN SG, Park JN, Galai N, Allen ST, et al
    Drivers of HIV infection among cisgender and transgender female sex worker populations in Baltimore city: Results from the SAPPHIRE study.
    J Acquir Immune Defic Syndr. 2019 Jan 8. doi: 10.1097/QAI.0000000000001959.
    >> Share

  742. CURTIS KA, Campbell EM, Hanson DL, Rudolph DL, et al
    A Multiplex HIV Incidence Assay for Inferring Recent HIV-1 Transmission and Time of Infection.
    J Acquir Immune Defic Syndr. 2019 Jan 7. doi: 10.1097/QAI.0000000000001937.
    >> Share

  743. PATEL AS, Goparaju L, Sales JM, Mehta CC, et al
    PrEP Eligibility among At-Risk Women in the Southern US: Associated Factors, Awareness and Acceptability.
    J Acquir Immune Defic Syndr. 2019 Jan 3. doi: 10.1097/QAI.0000000000001950.
    >> Share

  744. SAKABUMI DZ, Moore RC, Tang B, Delaney PA, et al
    Chronic Distal Sensory Polyneuropathy is a Major Contributor to Balance Disturbances in Persons Living with HIV.
    J Acquir Immune Defic Syndr. 2019 Jan 3. doi: 10.1097/QAI.0000000000001953.
    >> Share

  745. RAIFMAN JR, Schwartz SR, Sosnowy CD, Montgomery MC, et al
    Brief Report: Pre-exposure Prophylaxis Awareness and Use Among Cisgender Women at a Sexually Transmitted Disease Clinic.
    J Acquir Immune Defic Syndr. 2019;80:36-39.
    >> Share

  746. HESTAD KA, Chinyama J, Anitha MJ, Ngoma MS, et al
    Cognitive Impairment in Zambians With HIV Infection and Pulmonary Tuberculosis.
    J Acquir Immune Defic Syndr. 2019;80:110-117.
    >> Share

    December 2018
  747. AYIEKO J, Petersen ML, Charlebois ED, Brown LB, et al
    A patient-centered multi-component strategy for accelerated linkage to care following community-wide HIV testing in rural Uganda and Kenya.
    J Acquir Immune Defic Syndr. 2018 Dec 20. doi: 10.1097/QAI.0000000000001939.
    >> Share

  748. GOSSET A, Protopopescu C, Larmarange J, Orne-Gliemann J, et al
    Retention in care trajectories of HIV-positive individuals participating in a universal test and treat programme in rural South Africa (ANRS 12249 TasP trial).
    J Acquir Immune Defic Syndr. 2018 Dec 18. doi: 10.1097/QAI.0000000000001938.
    >> Share

  749. MARTINEZ DE TEJADA B
    Birth Defects Following Exposure to Efavirenz-Based Antiretroviral Therapy at Conception/First Trimester of Pregnancy: A Multi-Cohort Analysis.
    J Acquir Immune Defic Syndr. 2018 Dec 14. doi: 10.1097/QAI.0000000000001922.
    >> Share

  750. PRAT LI, Roccarina D, Lever R, Lombardi R, et al
    Aetiology and severity of liver disease in HIV positive patients with suspected NAFLD: lessons from a cohort with available liver biopsies.
    J Acquir Immune Defic Syndr. 2018 Dec 12. doi: 10.1097/QAI.0000000000001942.
    >> Share

  751. LEMOINE M, Assoumou L, De Wit S, Girard PM, et al
    Diagnostic accuracy of noninvasive markers of steatosis, NASH and liver fibrosis in HIV-monoinfected individuals at-risk of non-alcoholic fatty liver disease (NAFLD): results from the ECHAM study.
    J Acquir Immune Defic Syndr. 2018 Dec 12. doi: 10.1097/QAI.0000000000001936.
    >> Share

  752. WILLIE TC, Stockman JK, Keene DE, Calabrese SK, et al
    Social networks and its impact on women's awareness, interest, and uptake of HIV pre-exposure prophylaxis (PrEP): Implications for women experiencing intimate partner violence.
    J Acquir Immune Defic Syndr. 2018 Dec 12. doi: 10.1097/QAI.0000000000001935.
    >> Share

  753. DAVIS NL, Corbett A, Kaullen J, Nelson JAE, et al
    Antiretroviral drug concentrations in breastmilk, maternal HIV viral load, and HIV transmission to the infant: results from the BAN study.
    J Acquir Immune Defic Syndr. 2018 Dec 12. doi: 10.1097/QAI.0000000000001941.
    >> Share

  754. POIZOT-MARTIN I, Rosenthal E, Gilbert C, Cano CE, et al
    Nadir CD4 is negatively associated with antinuclear antibody detection in HCV/HIV coinfected patients.
    J Acquir Immune Defic Syndr. 2018 Dec 12. doi: 10.1097/QAI.0000000000001940.
    >> Share

  755. PASAYAN MKU, Mationg MLS, Boettiger D, Lam W, et al
    Effect of Macrolide Prophylactic Therapy on AIDS-Defining Conditions and HIV-Associated Mortality.
    J Acquir Immune Defic Syndr. 2018 Dec 10. doi: 10.1097/QAI.0000000000001933.
    >> Share

  756. NOWAK RG, Mitchell A, Crowell TA, Liu H, et al
    Individual and sexual network predictors of HIV incidence among men who have sex with men in Nigeria.
    J Acquir Immune Defic Syndr. 2018 Dec 10. doi: 10.1097/QAI.0000000000001934.
    >> Share

  757. ISHIDA Y, Hayashida T, Sugiyama M, Tsuchiya K, et al
    Full-genome analysis of hepatitis C virus in Japanese and non-Japanese patients coinfected with HIV-1 in Tokyo.
    J Acquir Immune Defic Syndr. 2018 Dec 6. doi: 10.1097/QAI.0000000000001919.
    >> Share

  758. BERNAL E, Torres M, Alcaraz A, Alcaraz MJ, et al
    Association Between Erectile Dysfunction and Carotid Subclinical Atherosclerosis in HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2018 Dec 4. doi: 10.1097/QAI.0000000000001932.
    >> Share

  759. GRAS L, May M, Ryder LP, Trickey A, et al
    Determinants of Restoration of CD4 and CD8 Cell Counts and their Ratio in HIV-1 Positive Individuals with Sustained Virological Suppression on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2018 Dec 3. doi: 10.1097/QAI.0000000000001913.
    >> Share


  760. HIV-1 Proviral Sequence and Treatment Outcome of Virologically Suppressed Patients Switching to Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate: Erratum.
    J Acquir Immune Defic Syndr. 2018;79:e111.
    >> Share

  761. AMMASSARI A, Stohr W, Antinori A, Molina JM, et al
    Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial.
    J Acquir Immune Defic Syndr. 2018;79:481-490.
    >> Share

  762. MWINNYAA G, Gray RH, Grabowski MK, Ssekasanvu J, et al
    Brief Report: Age-Disparate Relationships and HIV Prevalence Among Never Married Women in Rakai, Uganda.
    J Acquir Immune Defic Syndr. 2018;79:430-434.
    >> Share

  763. OCTAVIANA F, Safri AY, Setiawan DD, Estiasari R, et al
    Detectable Plasma HIV RNA Is Associated With Sensory Neuropathy in Patients With HIV Treated Without Stavudine.
    J Acquir Immune Defic Syndr. 2018;79:e108-e110.
    >> Share

  764. GOMES-NETO M, Rodriguez I, Ledo AP, Vieira JPB, et al
    Muscle Strength and Aerobic Capacity in HIV-Infected Patients: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2018;79:491-500.
    >> Share

  765. THOMA BC, Huebner DM
    Brief Report: HIV Pre-exposure Prophylaxis Engagement Among Adolescent Men Who Have Sex With Men: The Role of Parent-Adolescent Communication About Sex.
    J Acquir Immune Defic Syndr. 2018;79:453-457.
    >> Share

    November 2018
  766. FALASCA F, De Vito C, Mazzuti L, di Carlo D, et al
    Copy-Years Viremia and Risk of Virological Failure in Long-Term Treated HIV Patients.
    J Acquir Immune Defic Syndr. 2018 Nov 29. doi: 10.1097/QAI.0000000000001931.
    >> Share

  767. HULGAN T, Kallianpur AR, Guo Y, Barnholtz-Sloan JS, et al
    Peripheral blood mitochondrial DNA copy number obtained from genome-wide genotype data is associated with neurocognitive impairment in persons with chronic HIV infection.
    J Acquir Immune Defic Syndr. 2018 Nov 29. doi: 10.1097/QAI.0000000000001930.
    >> Share

  768. YIN MT, RoyChoudhury A, Bucovsky M, Colon I, et al
    A randomized placebo-controlled trial of low versus moderate dose Vitamin D3 supplementation on bone mineral density in postmenopausal women with HIV.
    J Acquir Immune Defic Syndr. 2018 Nov 29. doi: 10.1097/QAI.0000000000001929.
    >> Share

  769. HULGAN T, Ramsey BS, Koethe JR, Samuels DC, et al
    Relationships between Adipose Mitochondrial Function, Serum Adiponectin, and Insulin Resistance in Persons with HIV after 96 weeks of Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2018 Nov 29. doi: 10.1097/QAI.0000000000001926.
    >> Share

  770. JIAMSAKUL A, Polizzotto M, Wen-Wei Ku S, Tanuma J, et al
    Malignancies in adults living with HIV in Asia.
    J Acquir Immune Defic Syndr. 2018 Nov 29. doi: 10.1097/QAI.0000000000001918.
    >> Share

  771. TURAN B, Crockett KB, Buyukcan-Tetik A, Kempf MC, et al
    Buffering Internalization of HIV-Stigma: Implications for Treatment Adherence and Depression.
    J Acquir Immune Defic Syndr. 2018 Nov 22. doi: 10.1097/QAI.0000000000001915.
    >> Share

  772. WRAY TB, Chan PA, Kahler CW, Simpanen EM, et al
    Vulnerable Periods: Characterizing Patterns of Sexual Risk and Substance Use During Lapses in Adherence to HIV Pre-Exposure Prophylaxis among Men who have Sex with Men.
    J Acquir Immune Defic Syndr. 2018 Nov 20. doi: 10.1097/QAI.0000000000001914.
    >> Share

  773. YEN YF, Ko MC, Yen MY, Hu BS, et al
    Human Immunodeficiency Virus Increases the Risk of Incident Heart Failure.
    J Acquir Immune Defic Syndr. 2018 Nov 20. doi: 10.1097/QAI.0000000000001917.
    >> Share

  774. RASI V, Cortina-Borja M, Peters H, Sconza R, et al
    Surveillance of congenital anomalies following exposure to Raltegravir or Elvitegravir during pregnancy in the UK and Ireland, 2008-2018.
    J Acquir Immune Defic Syndr. 2018 Nov 20. doi: 10.1097/QAI.0000000000001924.
    >> Share

  775. MU W, Bartlett AW, Bunupuradah T, Chokephaibulkit K, et al
    Early and late virologic failure following virologic suppression in HIV-infected Asian children and adolescents.
    J Acquir Immune Defic Syndr. 2018 Nov 20. doi: 10.1097/QAI.0000000000001921.
    >> Share

  776. ORTBLAD KF, Harling G, Chimbindi N, Tanser F, et al
    Does incident circumcision lead to risk compensation? Evidence from a population cohort in KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr. 2018 Nov 20. doi: 10.1097/QAI.0000000000001912.
    >> Share

  777. HALEC G, Waterboer T, Brenner N, Butt J, et al
    Serological Assessment of 18 Pathogens and Risk for AIDS-associated Non-Hodgkin Lymphoma.
    J Acquir Immune Defic Syndr. 2018 Nov 20. doi: 10.1097/QAI.0000000000001916.
    >> Share

  778. VENTER WDF, Kambugu A, Chersich MF, Becker S, et al
    Efficacy and safety of tenofovir disoproxil fumarate versus low-dose stavudine over 96 weeks: a multi-country randomised, non-inferiority trial.
    J Acquir Immune Defic Syndr. 2018 Nov 12. doi: 10.1097/QAI.0000000000001908.
    >> Share

  779. ARPADI S, Lamb M, Isaie Nzeyimana N, Vandebriel G, et al
    Better outcomes among HIV-infected Rwandan children 18-60 months following the implementation of "treat all".
    J Acquir Immune Defic Syndr. 2018 Nov 12. doi: 10.1097/QAI.0000000000001907.
    >> Share

  780. WELD ED, Rana MS, Dallas RH, Camacho-Gonzalez AF, et al
    Interest of Youth Living with HIV in Long-Acting Antiretrovirals.
    J Acquir Immune Defic Syndr. 2018 Nov 8. doi: 10.1097/QAI.0000000000001896.
    >> Share

  781. FAYORSEY RN, Wang C, Chege D, Reidy W, et al
    Effectiveness of a lay counsellor-led combination intervention for retention of mothers and infants in HIV care: A randomized trial in Kenya.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001882.
    >> Share

  782. MEYA DB, Kiragga AN, Nalintya E, Morawski BM, et al
    Reflexive laboratory-based cryptococcal antigen screening and preemptive fluconazole therapy for cryptococcal antigenemia in HIV-infected individuals with CD4 <100 cells/microL: a stepped-wedge, cluster-randomized trial.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001894.
    >> Share

  783. BILLOCK RM, Powers KA, Pasquale DK, Samoff E, et al
    Prediction OF HIV Transmission Cluster Growth with Statewide Surveillance Data.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001905.
    >> Share

  784. PHILLIPS TK, Wilson IB, Brittain K, Zerbe A, et al
    Decreases in self-reported ART adherence predict HIV viremia among pregnant and postpartum South African women.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001909.
    >> Share

  785. JUMARE J, El-Kamary SS, Magder L, Hungerford L, et al
    Body Mass Index and Cognitive Function among HIV-1 Infected Individuals in China, India and Nigeria.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001906.
    >> Share

  786. FAINI D, Kalinjuma AV, Katende A, Mbwaji G, et al
    Laboratory-reflex cryptococcal antigen screening is associated with a survival benefit in Tanzania.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001899.